
<html lang="en"     class="pb-page"  data-request-id="3492b1f9-ad5f-418d-9571-50cd3836085e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm500031w;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2014.57.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)" /></meta><meta name="dc.Creator" content="Koen  Jansen" /></meta><meta name="dc.Creator" content="Leen  Heirbaut" /></meta><meta name="dc.Creator" content="Robert  Verkerk" /></meta><meta name="dc.Creator" content="Jonathan D.  Cheng" /></meta><meta name="dc.Creator" content="Jurgen  Joossens" /></meta><meta name="dc.Creator" content="Paul  Cos" /></meta><meta name="dc.Creator" content="Louis  Maes" /></meta><meta name="dc.Creator" content="Anne-Marie  Lambeir" /></meta><meta name="dc.Creator" content="Ingrid  De Meester" /></meta><meta name="dc.Creator" content="Koen  Augustyns" /></meta><meta name="dc.Creator" content="Pieter  Van der Veken" /></meta><meta name="dc.Description" content="Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV (DPPIV). It has been convincingly linked to multiple disease states involving remodeling of the extracell..." /></meta><meta name="Description" content="Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV (DPPIV). It has been convincingly linked to multiple disease states involving remodeling of the extracell..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 24, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500031w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500031w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500031w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500031w" /></link>
        
    
    

<title>Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500031w" /></meta><meta property="og:title" content="Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0011.jpeg" /></meta><meta property="og:description" content="Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV (DPPIV). It has been convincingly linked to multiple disease states involving remodeling of the extracellular matrix. FAP inhibition is investigated as a therapeutic option for several of these diseases, with most attention so far devoted to oncology applications. We previously discovered the N-4-quinolinoyl-Gly-(2S)-cyanoPro scaffold as a possible entry to highly potent and selective FAP inhibitors. In the present study, we explore in detail the structure–activity relationship around this core scaffold. We report extensively optimized compounds that display low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (DPPs) DPPIV, DPP9, DPPII, and prolyl oligopeptidase (PREP). The log D values, plasma stabilities, and microsomal stabilities of selected compounds were found to be highly satisfactory. Pharmacokinetic evaluation in mice of selected inhibitors demonstrated high oral bioavailability, plasma half-life, and the potential to selectively and completely inhibit FAP in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500031w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500031w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500031w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500031w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500031w&amp;href=/doi/10.1021/jm500031w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3053-3074</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5000112" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500039e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Jansen">Koen Jansen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leen++Heirbaut">Leen Heirbaut</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Verkerk">Robert Verkerk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Cheng">Jonathan D. Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jurgen++Joossens">Jurgen Joossens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Cos">Paul Cos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louis++Maes">Louis Maes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Marie++Lambeir">Anne-Marie Lambeir</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ingrid++De+Meester">Ingrid De Meester</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Koen++Augustyns">Koen Augustyns</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pieter++Van+der+Veken">Pieter Van der Veken</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Laboratory of Microbiology, Parasitology, and Hygiene, Departments of Pharmaceutical Sciences and Biomedical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#53233a362736217d25323d373621253638363d1326323d2724362123363d7d3136"><span class="__cf_email__" data-cfemail="b3c3dad6c7d6c19dc5d2ddd7d6c1c5d6d8d6ddf3c6d2ddc7c4d6c1c3d6dd9dd1d6">[email protected]</span></a>. Phone: +32-3 265 27 08.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500031w&amp;href=/doi/10.1021%2Fjm500031w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3053–3074</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 11, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2014</li><li><span class="item_label"><b>Published</b> online</span>24 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 April 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500031w" title="DOI URL">https://doi.org/10.1021/jm500031w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3053%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKoen%2BJansen%252C%2BLeen%2BHeirbaut%252C%2BRobert%2BVerkerk%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D7%26contentID%3Djm500031w%26title%3DExtended%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BPharmacokinetic%2BInvestigation%2Bof%2B%25284-Quinolinoyl%2529glycyl-2-cyanopyrrolidine%2BInhibitors%2Bof%2BFibroblast%2BActivation%2BProtein%2B%2528FAP%2529%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3074%26publicationDate%3DApril%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500031w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4633</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">76</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500031w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Jansen&quot;},{&quot;first_name&quot;:&quot;Leen&quot;,&quot;last_name&quot;:&quot;Heirbaut&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Verkerk&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Cheng&quot;},{&quot;first_name&quot;:&quot;Jurgen&quot;,&quot;last_name&quot;:&quot;Joossens&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Cos&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;Maes&quot;},{&quot;first_name&quot;:&quot;Anne-Marie&quot;,&quot;last_name&quot;:&quot;Lambeir&quot;},{&quot;first_name&quot;:&quot;Ingrid&quot;,&quot;last_name&quot;:&quot;De Meester&quot;},{&quot;first_name&quot;:&quot;Koen&quot;,&quot;last_name&quot;:&quot;Augustyns&quot;},{&quot;first_name&quot;:&quot;Pieter&quot;,&quot;last_name&quot;:&quot;Van der Veken&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;3053-3074&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500031w&quot;},&quot;abstract&quot;:&quot;Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV (DPPIV). It has been convincingly linked to multiple disease states involving remodeling of the extracellular matrix. FAP inhibition is investigated as a therapeutic option for several of these diseases, with most attention so far devoted to oncology applications. We previously discovered the N-4-quinolinoyl-Gly-(2S)-cyanoPro scaffold as a possible entry to highly potent and selective FAP inhibitors. In the present study, we explore in detail the structure–activity relationship around this core scaffold. We report extensively optimized compounds that display low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (DPPs) DPPIV, DPP9, DPPII, and prolyl oligopeptidase (PREP). The log D values, plasma stabilities, and microsomal stabilities of selected compounds were found to be highly satisfactory. Pharmacokinetic evaluation in mice of selected inhibitors demonstrated high oral bioa&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500031w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500031w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500031w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500031w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500031w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500031w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500031w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500031w&amp;href=/doi/10.1021/jm500031w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500031w" /></input><a href="/doi/pdf/10.1021/jm500031w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500031w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500031w%26sid%3Dliteratum%253Aachs%26pmid%3D24617858%26genre%3Darticle%26aulast%3DJansen%26date%3D2014%26atitle%3DExtended%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BPharmacokinetic%2BInvestigation%2Bof%2B%25284-Quinolinoyl%2529glycyl-2-cyanopyrrolidine%2BInhibitors%2Bof%2BFibroblast%2BActivation%2BProtein%2B%2528FAP%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D7%26spage%3D3053%26epage%3D3074%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291553" title="Granular materials">Granular materials</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291255" title="Ultraperformance liquid chromatography">Ultraperformance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jmcmar.2014.57.issue-7/production/jmcmar.2014.57.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fibroblast activation protein (FAP) is a serine protease related to dipeptidyl peptidase IV (DPPIV). It has been convincingly linked to multiple disease states involving remodeling of the extracellular matrix. FAP inhibition is investigated as a therapeutic option for several of these diseases, with most attention so far devoted to oncology applications. We previously discovered the <i>N</i>-4-quinolinoyl-Gly-(2<i>S</i>)-cyanoPro scaffold as a possible entry to highly potent and selective FAP inhibitors. In the present study, we explore in detail the structure–activity relationship around this core scaffold. We report extensively optimized compounds that display low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (DPPs) DPPIV, DPP9, DPPII, and prolyl oligopeptidase (PREP). The log <i>D</i> values, plasma stabilities, and microsomal stabilities of selected compounds were found to be highly satisfactory. Pharmacokinetic evaluation in mice of selected inhibitors demonstrated high oral bioavailability, plasma half-life, and the potential to selectively and completely inhibit FAP in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fibroblast activation protein (FAP, FAP-α, seprase) belongs to the prolyl oligopeptidase family S9, which consists of serine proteases that cleave peptide substrates preferentially after proline residues. Other members of this family include the dipeptidyl peptidases (DPPs: DPPIV, DPP8, DPP9) and prolyl oligopeptidase (PREP, POP).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> FAP has been linked to multiple disease states involving remodeling of the extracellular matrix such as hepatic and pulmonary fibrosis, keloid formation, rheumatoid arthritis, and osteoarthritis.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7">(2-7)</a> FAP is also highly expressed on activated fibroblasts in over 90% of common human epithelial tumors.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> It has been demonstrated in syngeneic mouse models that FAP activity promotes tumorigenesis and that FAP inhibition attenuates tumor growth.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> The enzyme is furthermore expressed only transiently during wound healing and is essentially absent in normal adult tissues and in nonmalignant tumors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These appealing characteristics of FAP account for its ongoing evaluation as a drug target. Both immunotherapy and small-molecule based approaches have so far been reported, most of them focusing on applications in the oncology domain (vide infra).</div><div class="NLM_p">FAP possesses both dipeptidyl peptidase and endopeptidase activity, catalyzed by the same active center. This is in contrast with the DPPs, possessing only the former activity type, and PREP, which is an enzyme of strict endopeptidase capability.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> While designing out DPP affinity in FAP inhibitors is relatively straightforward, obtaining inhibitors possessing selectivity for FAP over PREP is considered to be far more challenging. This is, among others, illustrated by the significant overlap between in vitro processable substrate sequences for FAP and PREP and the fact that numerous reported FAP inhibitors have limited or no selectivity with respect to PREP.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Given that recent findings indicate that PREP deficient mice have impaired spatial learning, memory, and neuronal development, FAP over PREP selectivity could nonetheless be an important feature for inhibitors.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The availability of such compounds can already have significant impact when applied as tool compounds to study the role of FAP in pathophysiology. In some cancer types for example, FAP and PREP are simultaneously overexpressed by cell types that are part of the metastatic tumor microenvironments, and there are currently no reports available that quantitatively discrimate between the potential contributions of both proteolytic activities to disease progression.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Several of the relevant FAP inhibitors reported in the literature were used as reference compounds in this study. Val-boroPro <b>1</b> (talabostat, PT-100) is an nonselective boronic acid inhibitor that reached phase II clinical trials for several cancer types before it was withdrawn, apparently because of both safety and efficacy reasons (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Linagliptin <b>2</b> has received clinical approval as a DPPIV inhibitor but also displays substantial FAP affinity.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compound <b>3</b> is a representative of a series of pyroglutamyl(2-cyanopyrrolidine) derivatives reported by Jiaang et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Compounds <b>4</b> and <b>5</b> are part of the quinolinoylglycyl(2-cyanopyrrolidine) class of FAP inhibitors reported recently by our group.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Although no PREP-assay results were published by Jiaang, we report here that compound <b>3</b> does have highly satisfactory FAP over PREP selectivity. Therefore, Jiaang’s and our molecules represent the only two reported inhibitor chemotypes with potential for full FAP selectivity across the panel of related enzymes evaluated. Jiaang’s compounds nonetheless were reported to have poor pharmacokinetic (PK) behavior in mice. The corresponding PK data for selected representatives of our own molecules are reported in this manuscript. In addition, Bachovchin et al. have also recently reported the <span class="smallcaps smallerCapital">d</span>-Ala-boroPro based FAP inhibitor <b>6</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This compound’s approximate 40-fold selectivity toward PREP (determined under our assay conditions) is remarkable for a boronic acid, certainly since a recently published pseudo peptide boronic acid inhibitor with the same <span class="smallcaps smallerCapital">d</span>-Ala-boroPro scaffold but with an acetyl-Arg-2-(2-(2-aminoethoxy)ethoxy)acetamide group as the N-substituent instead of a 4-pyridinoyl group was found not to be selective toward PREP.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Nonetheless, no in vivo PK data have so far been published for <b>6</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">In our earlier report on FAP inhibitors related to <b>4</b>, we have investigated the quinolinoyl moiety’s substitution pattern and the influence of the position of the heterocyclic N-atom on FAP affinity and selectivity. No heterocyclic scaffolds other than quinoline and isoquinoline were so far built in at this position. Evaluating the impact of other azaheteroaromatic rings was therefore considered a first goal of this study with which we aimed to significantly expand our current SAR knowledge for this part of the molecule. Second, SAR for the P2 glycine residue also remained underexplored, as no fragments other than glycine have been introduced at this position. Several P2-modified analogues were therefore made. Furthermore, these molecules were deemed of additional interest to anticipate on potential sensitivity of the P2 glycine amide bonds to unspecific proteases in vivo. Third, we sought to further optimize the P1 cyanopyrrolidine residue of our inhibitors. This was done by applying predictive SAR data that we derived earlier for inhibitors containing a P1-(2-cyanopyrrolidine) moiety.<a onclick="showRef(event, 'ref24 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref27">(24, 27)</a> In the P1-modified series, we also investigated the importance of the warhead on our molecules and the influence on inhibitory potency of changing the carbonitrile function for other electrophilic warhead types (boronic acid, chloromethyl ketone). Fourth, in vitro PK and cellular toxicity data are reported for five optimized inhibitors. On the basis of these data, we selected four compounds for in vivo PK studies and in vivo inhibition experiments in mice.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Relevant FAP inhibitors used as references in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> of Reference FAP Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">FAP</th><th class="colsep0 rowsep0" align="center">PREP</th><th class="colsep0 rowsep0" align="center">DPPIV</th><th class="colsep0 rowsep0" align="center">DPP9</th><th class="colsep0 rowsep0" align="center">DPP2</th><th class="colsep0 rowsep0" align="center">SI (FAP/PREP)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.066 ± 0.011</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.022 ± 0.001</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.086 ± 0.007</td><td class="colsep0 rowsep0" align="left">14.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.37 ± 0.002</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">0.0020 ± 0.0002</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.017 ± 0.001</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">5882.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.0103 ± 0.0004</td><td class="colsep0 rowsep0" align="left">0.86 ± 0.07</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">83.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">0.011 ± 0.0004</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>4500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">0.025 ± 0.001</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.04</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">39.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Determined under our own assay conditions.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">SI stands for “selectivity Index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">ND stands for “not determined”.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A total of around 60 novel inhibitors were synthesized for this study. All compounds were prepared following the general strategies in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, in which target compounds are clustered according to the modification type they contain, relative to reference compound <b>4</b>. The preparation of inhibitors containing an adapted P2 group (<b>9</b>–<b>11</b> and <b>16</b>–<b>27</b>) is summarized in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Three types of modifications were included in this series: (1) attachment of a side chain to the α-methylene group of the P2 moiety, (2) introduction of N-substituents, and (3) replacement of the P2–P3 amide bond by a reduced analogue or a peptidomimetic triazole ring. For the preparation of the α-methylene substituted series (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, entry 1), the corresponding, commercially available Boc-protected P2-amino acids were coupled to 2-cyanopyrrolidine. The Boc group of the coupled products was then removed using tosylic acid in acetonitrile under conditions we identified as optimal to avoid Ritter-type addition of the intermediate <i>tert</i>-butyl cation to the nitrile group of products <b>7</b>–<b>9</b>. These products were coupled with 4-quinolinoyl chloride hydrochloride to yield final compounds <b>11</b>–<b>13</b>. The 2-cyanopyrrolidine starting material was obtained as described earlier.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For molecules involving the introduction of N-substituents or P2–P3 amide group modifications, (<i>S</i>)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile <b>15</b> was used as a central intermediate<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, entry 2). Reaction of <b>15</b> with primary amines and subsequent coupling with 4-quinolinoyl chloride hydrochloride yielded compounds <b>16</b>–<b>20</b>. To obtain target compounds <b>21</b> and <b>22</b> with a reduced P2–P3 amide group, the chloroacetyl group of <b>15</b> was substituted with N-substituted (4-quinolinyl)methylamines. Finally, the peptidomimetic triazole containing compounds were made by nucleophilic substitution of <b>15</b>’s chloro group with sodium azide and subsequent Cu(I)-catalyzed 1,3-dipolar addition with the desired alkynes to give products <b>24</b>–<b>27</b>.</div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> describes the preparation of P3- and P1-modified analogues. Two strategies were followed for all reported compounds bearing a 2-cyanopyrrolidine derivative in P1 (<b>29</b>–<b>63</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, entry 1). For molecules designed to mainly generate SAR data for the P3 position, diverse heteroarylcarboxylates were coupled to a specific glycyl-(2-cyanopyrrolidine) derivative using standard peptide coupling reagents. Alternatively, for a number of compounds designed mainly to render P1 SAR information, <i>N</i>-(4-quinolinoyl)glycine <b>28</b> was coupled to a desired 2-cyanopyrrolidine derivative. The 2-cyanopyrrolidine, its 4<i>S</i>-fluoro, 4<i>R</i>-fluoro, and 4,4-difluoro congeners and all glycine adducts of these molecules were prepared as reported earlier or as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Heteroarylcarboxylates were acquired commercially or, in the case of substituted 4-quinolinoyl derivatives, synthesized using the Sandmeyer isatin synthesis followed by the Pfitzinger reaction and decarboxylation.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> Detailed procedures for all intermediates and compounds in this report are given in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The boronate, the chloromethyl ketone, and unsubstituted pyrrolidine derivatives were synthesized in an analogous manner (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, entry 2). Again, <i>N</i>-(4-quinolinoyl)glycine <b>28</b> was coupled to the desired pyrrolidine derivative using standard peptide coupling techniques. Both the required 2-boronyl- and chloromethylacylpyrrolidine derivatives were obtained as described in the literature.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> To obtain boronic acid final compound <b>66</b>, its pinanediol ester precursor <b>65</b> was deprotected using phenylboronic acid.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of P2-Modified FAP Inhibitors <b>11</b>–<b>14</b> and <b>16</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, <i>N</i>-Boc-AA-OH, DIPEA, 75–80%; (b) TsOH 1.4 equiv, MeCN, 24 h, 84–86%; (c) 4-quinolinoyl chloride hydrochloride, DIPEA, 25–86%; (d) (2<i>S</i>)-(2-cyanopyrrolidine) tosylate, HATU, DIPEA, 64%; (e) K<sub>2</sub>CO<sub>3</sub>, RNH<sub>2</sub>, 13–52%; (f) K<sub>2</sub>CO<sub>3</sub>, quinolin-4-ylmethanamine, 25–49%; (g) NaN<sub>3</sub>, DMF; (h) CuI, THF, 17–50%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Strategies for the Synthesis of P1 and/or P3 Modified Target Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) YCOOH, HATU, DIPEA, 3 h, 43–67%, or YCOOH, HOBT, EDC, DIPEA, 16 h, 84–86%, or YCOOH, (CH<sub>3</sub>)<sub>2</sub>C═C(Cl)N(CH<sub>3</sub>)<sub>2</sub>, DIPEA, 25–70%, or quinoline-4-carbonyl chloride hydrochloride, DIPEA, 55–59%; (b) pyrrolidine derivative, HOBT, EDC, DIPEA, 16 h, 65–86%; (c) phenylboronic acid, MTBE–H<sub>2</sub>O, 79%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All synthesized compounds were evaluated as inhibitors of FAP, DPPIV, DPP9, DPPII, and PREP.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> No separate screening experiments were carried out on DPP8. On the basis of the enzyme’s close homology with DPP9 and the outcome of earlier directed studies, potencies toward both enzymes can be expected to be comparable with a high degree of confidence. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> summarizes the assay results of the P2-modified analogues. In a first set of compounds (<b>11</b>–<b>14</b>), the P2-glycine residue of <b>4</b> was replaced by <span class="smallcaps smallerCapital">d</span>-Ser and related <span class="smallcaps smallerCapital">d</span>-Ala, <span class="smallcaps smallerCapital">l</span>-Ala, and 1-amino-1-carboxycyclopropane moieties. The choice for the first two residues was based on an extensive screening of fluorogenic peptide substrates by Edosada et al., demonstrating that FAP’s endopeptidase capability is strictly limited to peptides with a P2-Gly, <span class="smallcaps smallerCapital">d</span>-Ser, or <span class="smallcaps smallerCapital">d</span>-Ala residue.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As an additional illustration, a P2-<span class="smallcaps smallerCapital">d</span>-Ala residue present in Bachovchin’s boronic acid FAP-inhibitor <b>6</b> also demonstrated low nanomolar FAP affinity and good selectivity toward PREP.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> When introduced as a replacement for compound <b>4</b>’s glycine residue however (<b>11</b> and <b>12</b>), the FAP affinities observed dropped 600- and 300-fold, respectively. FAP inhibition was completely abolished by introducing the closely related amino acids <span class="smallcaps smallerCapital">l</span>-Ala and 1-amino-1-carboxycyclopropane at P2. While these data underscore the importance of a P2-glycine in our inhibitors, the lack of affinity of <b>13</b> and <b>14</b> also serves as confirmation that Edosada’s original findings on substrates translate similarly for inhibitors. Finally, <span class="smallcaps smallerCapital">l</span>-Ala containing analogue <b>13</b> has a PREP potency that stands out among the four congeneric inhibitors discussed.</div><div class="NLM_p">Moving further with our SAR exploration of the P2 position, we decided to synthesize analogues with an N-alkylated and/or a reduced P2–P3 amide bond. Taking into account that N-alkylation of amide bonds in peptides is a well-known way of reducing susceptibility to (non-FAP-related) proteolytic activity, both modification types could increase the metabolic stability of this potentially labile part of the inhibitors’ basic structure. In the N-alkylated amide series (compounds <b>16</b>–<b>20</b>), substituents of varying size and electronic properties were tested. All these interventions were found to lead to a nearly complete loss of FAP potency, even in the case of the smallest methyl substituent. Remarkably, PREP affinity was affected to a significantly smaller extent, bringing on additional evidence that the 4-quinolinoyl substituent of <b>4</b> is involved in a specific interaction with FAP’s active center that significantly adds to target affinity but is disrupted by small structural changes. Similar conclusions were drawn from the assay results of the reduced analogues: tertiary amines <b>21</b>–<b>23</b> also had strongly reduced FAP inhibition. It is, however, impossible to state to what extent the increased conformational freedom of the quinolinylmethyl substituent or the lack of a conjugated, electron withdrawing carbonyl function contributes to these findings. Furthermore, a basic amine functionality is present in these molecules. Apparently this feature does not allow picking up additional potency from salt-bridge formation with FAP’s Glu203 and Glu204 residues, the interaction responsible for FAP’s recognition of dipeptide substrates. Neither does it seem to be involved in a significant interaction with the other DPPs’ homologous GluGlu motifs, as reflected by the assay results for these enzymes. On the basis of the obtained results with the set of inhibitors <b>16</b>–<b>23</b>, we did not prepare any additional analogues in this series. Fitting in the same framework of metabolic P2–P3 amide stabilization, molecules (<b>24</b>–<b>27</b>) were then prepared in which this amide group is replaced by an isosteric, 4-substituted 1,2,3-triazole ring. The 4-alkynyl derivatized quinolines required to obtain triazole analogues of <b>4</b> were, however, found not to be readily accessible. This led us to prepare analogues of older FAP inhibitors that we reported: N-acylated glycyl(2-cyanopyrrolidines) with a P3-benzoyl or naphthoyl substituent. The compounds obtained were again found to have reduced inhibitory affinity, with phenyl analogue <b>24</b> possessing around 8-fold less potency compared to the benzoyl amide. Naphthyl-containing <b>27</b> is characterized by an even higher affinity loss compared to its 1-naphthoyl substituted parent compound that possesses FAP submicromolar potency. Not satisfied by these results, we concluded that the 4-substituted-1,2,3-triazole is not a good amide isostere at the glycine P2 position.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Data of Inhibitors with a Modified P2 Residue</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0004.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0005.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">SI stands for “selectivity index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div></div><div></div></div><div class="NLM_p">Investigations of the P3 region of inhibitors related to <b>4</b> was aimed at replacing its quinoline ring with various other azaheterocycles. Our earlier studies, during which we had already investigated quinoline and isoquinoline isomers, clearly demonstrated the position of the azaheteroaromatic nitrogen to be crucial, with appreciable FAP affinity only present in case of the 4-quinolinoyl isomer of compound <b>4</b>. In all compounds reported here, we therefore limited the selection of heterocycles to systems that have a azaheteroatom topology for at least one nitrogen that is comparable to that of the 4-quinolinoyl ring nitrogen. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes the data obtained for a number of (substituted) five- and six-membered heteroaromatic containing analogues of <b>4</b>. The closely related pyridine <b>29</b> was found to have a 6-fold reduced FAP potency compared to <b>4</b>. In spite of its lower absolute affinity, <b>29</b> has the highest ligand efficiency (0.38) of all compounds we hitherto prepared. Introduction of substituents in 2-position of the pyridine ring as in compounds <b>30</b>–<b>35</b> resulted in a further decrease of inhibitory potency, but no additional steric or electronic determinants of FAP potency could be discerned here: all compounds from this subset seem to have inhibitory potential within the same order of magnitude. Additionally, an analogue containing an extra methylene linker (<b>36</b>) and a reduced P3-heteroaromatic ring system (piperidine <b>37</b>) were prepared. Similarly, these molecules did not demonstrate better FAP affinities than <b>29</b> and also convey the hypothesis that high FAP-affinity-conferring P3 substituents are mainly present in limited parts of heteroaromatic chemical space.</div><div class="NLM_p">Identification of these other potentially interesting parts of chemical space was then attempted with compounds <b>38</b>–<b>44</b>. These contain heteroaromatic P3 substituents that are more distant from the pyridine- or quinoline-based systems that we so far discovered to be optimal. Pyridazine (in inhibitor <b>38</b>) was the only azine with more than one nitrogen heteroatom that we evaluated. Already, this compound had a 3-fold decreased FAP potency relative to <b>29</b>. This finding withheld us from investing effort in preparing target molecules with a triazine isomer at P3. Conversely, we shifted attention to more electron-rich, five-membered azaheterocycles. Pyrrole was not selected for this subset because of stability reasons, but a suitable (vide supra) imidazole derivative and two triazole isomers were included (compounds <b>39</b>–<b>41</b>). These molecules, together with the homologated <b>42</b> and the thia- and oxazole derivatives <b>43</b> and <b>44</b>, all performed significantly less than <b>29</b> in the FAP inhibition assay. Finally, mutation of the pyridine ring into an aniline was found not to be beneficial for FAP affinity either: the aniline <b>45</b> and its trifluoroacetylated precursor <b>46</b> have IC<sub>50</sub> values in the low micromolar range, more than 100-fold less than pyridine <b>29</b>. Taken altogether, the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were not compelling enough to immediately continue further structural exploration of monocyclic heteroaromatic P3 rings: FAP potencies observed in this series were not able to compete with reference <b>4</b>. In the case of the highly efficiently binding inhibitor <b>29</b>, further optimization did not seem obvious. In addition, the FAP/PREP selectivity indices observed, so far not mentioned in the framework of this series, were generally very satisfactory for the pyridine subset but again not significantly better than the optimal quinolines described earlier. It deserves highlighting however that as reported by Poplawski et al., introduction of a P3–P4-pyridinoyl substituent has been used to obtain a series of highly potent, boronate-based FAP inhibitors represented by reference compound <b>6</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. IC<sub>50</sub> Data of Five- and Six-Membered P3 Heterocycles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0006.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0007.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">SI stands for “selectivity index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div></div><div></div></div><div class="NLM_p">For the reasons cited above, we then turned attention to bicyclic P3 heteroaromatics with at least one nitrogen atom that is equivalent to the azaheteroatom in quinoline <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). With the set of inhibitors <b>47</b>–<b>51</b>, 2,3-annelated pyridines were evaluated. Pyrrolopyridine <b>47</b> was found to be a nanomolar FAP inhibitor but still almost 5-fold less potent than <b>4</b>. Selectivity indices with respect to PREP were largely comparable for both (SI<sub>[FAP/Prep]</sub> values were calculated to be ∼50 and 80 for <b>47</b> and <b>4</b>, respectively). Substituted imidazopyridines <b>48</b> and <b>49</b> and certainly triazolopyridine <b>50</b> were significantly less potent as FAP inhibitors than <b>4</b>, suggesting that introduction of additional nitrogen atoms in the annelated five-membered heterocycle leads to lower target affinities. A similar effect seems to be in place when a six-membered heterocycle is annelated with pyridine (1,7-naphthyridine <b>51</b>). The IC<sub>50</sub> value of this azaquinoline derivative is roughly 3 times higher than that of quinoline <b>4</b>; nonetheless, selectivity toward PREP is slightly better than that of the reference.</div><div class="NLM_p">Since a P3-quinoline residue out of all the heterocycles investigated still proved to be optimal, we decided to return to this scaffold and investigate the effect of hitherto unexplored substitution patterns at its 5 and 7 positions. Our preliminary data had already indicated that introduction of 5- or 7-chloro and bromo substituents resulted in low nanomolar FAP inhibitors with optimal selectivity toward PREP (SI<sub>[FAP/Prep]</sub> of up to 10<sup>3</sup>). Similar FAP potencies were obtained here with the methyl-substituted analogues <b>52</b> and <b>53</b>, of which the 5-substituted congener clearly had the best FAP/PREP selectivity seen so far (SI<sub>[FAP/Prep]</sub> = 2 × 10<sup>3</sup>). Introduction of bulkier phenyl-based groups (compounds <b>54</b>–<b>56</b>) seems less desirable at both the 5 and 7 positions: FAP potencies drop close to 1 order of magnitude. Because of the relatively small size of the methoxy substituent, one would furthermore expect the 5-methoxylated inhibitor <b>57</b> to have potencies in the same range as <b>5</b> or <b>53</b>. Surprisingly however, potency was reduced more than 1000-fold, again indicating that the supposed specific interaction of the quinolinoyl system with FAP’s active center can be critically disturbed by small structural changes. Additional investigation of this finding was undertaken during the optimization of the P1 position (vide infra, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. IC<sub>50</sub> Data of Bicyclic P3 Heterocycles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0008.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">SI stands for “selectivity index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Solubility problems upon dilution of compounds in aqueous buffer, resulting in poor reducibility of inhibition curves.</p></div></div><div></div></div><div class="NLM_p">As part of an earlier study, we had shown that in the glycyl(2-cyanopyrrolidine) series, FAP’s S1 pocket preferentially accommodates 2-cyanopyrrolidine and a limited number of derivatives with 4-substituents of minimal steric bulk, e.g., a 4<i>S</i>-fluoride. Similarly, (2<i>S</i>,4<i>S</i>)-2-cyano-4-fluoropyrrolidine and its 4,4-difluorinated analogue were also used earlier as P1 residues by Jiaang in FAP inhibitors related to <b>6</b>. Depending on the target, these residues have also been investigated with considerable success in compounds targeting DPPIV and DPP8/9. The same strategy was applied to the inhibitor series studied here.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Complementarily, we also prepared the (2<i>S</i>,4<i>R</i>)-2-cyano-4-fluoropyridine diastereomer and introduced it as a P1 residue. Supposedly relating to its more elaborate synthesis involving a chirality inversion step on the 4-position of starting material <i>trans</i>-4-hydroxyproline, this isomer so far had not been investigated in FAP or related DPP inhibitors. To allow efficient assessment of the effect of introducing each of the three mono- and difluorinated P1 isomers, direct analogues of reference compound <b>4</b> were prepared (<b>58</b>–<b>60</b>). Grossly in line with expectations, the 4<i>S</i>-fluoropyrrolidine <b>58</b> displayed around 3-fold higher FAP affinity than the parent compound. PREP-affinity however had also increased slightly more than proportionally with FAP-potency. This is consistent with our earlier mentioned report that included 4<i>S</i>-fluorinated (2-cyano)pyrrolidine inhibitors.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Most remarkably, the 4<i>R</i>-fluoropyrrolidine isomer <b>59</b> has lost FAP affinity compared to <b>4</b> and <b>58</b>, amounting to up to 3 orders of magnitude. Making steric factors less likely to be accountable for this effect, the corresponding 4,4-difluorinated analogue of <b>4</b> (UAMC-1110, vide infra) was one of the most potent FAP inhibitors identified to date. Seminal studies by Raines et al. have shown that 4<i>S</i>-fluoroproline derivatives possess a hyperconjugatively stabilized endo-puckered ring conformation, while in 4<i>R</i>-fluoroprolines an exo-puckered ring conformer is more favored. This difference, which should also be present with 2-cyanopyrrolidine derivatives, could be contributing to the large potency differences observed between <b>58</b> and <b>59</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Analogously, 4,4-difluoroproline derivatives have been demonstrated to have endo- and exo-puckered conformations of comparable energy, similar to unsubstituted prolines.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Although this would imply that the slightly higher FAP affinity of <b>60</b> compared to <b>4</b> cannot be rationalized using conformational arguments, increased hydrophobicity resulting from difluorination might be in play here. Noteworthy, <b>60</b> was also found to have better FAP/PREP selectivity and a very proficient ligand efficiency of 0.34, which is significantly higher than the corresponding value calculated for <b>4</b> (0.27).</div><div class="NLM_p">To further expand the P1-4,4-difluorinated subset, compounds <b>61</b>–<b>63</b> were synthesized. These differ by their P3-quinoline residues’ substitution patterns. The 6-methoxyquinoline <b>61</b> is the difluorinated analogue of an inhibitor that we reported in our foregoing study.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Both the low nanomolar FAP potency and thousandfold FAP/PREP selectivity of these two molecules are highly comparable. Compounds <b>62</b> and <b>63</b> were specifically included to extract additional information on the SAR of the P3-quinoline’s 5-position (vide supra). Surprisingly, <b>62</b> and <b>63</b> were found to be micromolar FAP inhibitors. Although the 5-methoxylated compound <b>57</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) had a similar profile, drawing the general conclusion that introduction of substituents at the 5-position reduces FAP affinity, would oversee reference molecule <b>5</b>. The latter all but compares to its difluorinated counterpart <b>62</b>, but together with its 5-chlorinated analogue that we also published earlier, it belongs to the set of most potent and selective molecules discovered.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> More subtle hypotheses related to the compound’s binding kinetics might therefore be required to tentatively explain the observed behavior. It is clear that invoking only the steric or electronic parameters of the quinolone substituents is not sufficient to rationalize the assay data of all 5-substituted molecules we prepared.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Data of Inhibitors with a Modified P1 Residue</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0009.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">SI stands for “selectivity index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div></div><div></div></div><div class="NLM_p">Finally, we investigated how either omitting or changing the warhead function to a boronic acid would impact FAP potency and selectivity of our molecules. We also selected the well-known chloromethyl ketone warhead to verify whether modification to irreversible inhibitors could be possible. All molecules prepared were analogues of reference <b>4</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). First, building in an unsubstituted pyrrolidine residue at P1 in <b>64</b> was found to give a 3 log reduction in potency compared to reference compound <b>4</b>. Qualitatively, this finding is in line with earlier reports by our own group and by Jiaang et al. and underscores the very considerable contribution to inhibitor affinity from the warhead function. Compared to the mentioned examples though, the residual micromolar affinity of <b>64</b> still is significant and one of the best potencies reported for FAP inhibitors without a warhead group. Next, the boronic acid warhead, present in many of the older series of (mostly nonselective) FAP inhibitors, was evaluated in <b>66</b>. This molecule was found to be highly potent but also considerably less selective toward PREP when compared to its nitrile-based counterpart <b>4</b> ((SI<sub>[FAP/Prep]</sub> of 3 vs ∼85, respectively). Evaluation data of Bachovchin et al.’s most promising boronate <b>6</b> (that under our conditions had SI<sub>[FAP/Prep]</sub> = 40) together with the PREP affinities of our own inhibitors <b>12</b> and <b>13</b> nonetheless suggest that this selectivity could be improved by selecting a <span class="smallcaps smallerCapital">d</span>-Ala P2 group. Finally, the enzymatic assay data for chloromethyl ketone <b>67</b>show this compound to be 17 times less potent than nitrile <b>4</b>. Detailed kinetic analysis also revealed this molecule not to bind irreversibly to the target enzyme.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Influence of the Warhead on IC<sub>50</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0010.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">SI stands for “selectivity index” (calculated as [IC<sub>50</sub>(PREP)/IC<sub>50</sub>(FAP)]).</p></div></div><div></div></div><div class="NLM_p">Taking into account the number of low nanomolar FAP inhibitors with high FAP/PREP selectivity that we had discovered as part of this and the foregoing study, four of the most promising compounds were then selected for which in vitro pharmacokinetic parameters were determined (log <i>D</i><sub>7.4</sub>, kinetic solubility, stabilities in mouse, rat, and/or human plasma) (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Compound <b>4</b>, for which we reported these parameters earlier, was used as a reference. In general, no large differences between individual inhibitors were observed for the evaluated parameters. Compounds with a P1-(2-cyano-4,4-difluoropyrrolidine) residue were found to behave similarly to the nonfluorinated molecules in the series (<b>4</b>, <b>5</b>, and <b>46</b> vs <b>60</b> and <b>61</b>). The log <i>D</i><sub>7.4</sub> values determined varied between 0.5 and 1. Kinetic solubility in all cases was >200 μM, and plasma stabilities were satisfactory throughout the assay results with half-lives exceeding 6 h for all inhibitors and in all media tested. For compounds <b>5</b>, <b>60</b>, and <b>61</b>, stability in the presence of mouse and/or rat hepatic microsomes was also tested. Gratifyingly, these molecules were found not to be subject of fast oxidative metabolization and, again, displayed half-lives of more than 6 h. Finally, cytotoxicity was evaluated on MRC-5 cells. At the highest concentration measured (64 μM), no signs of cellular toxicity could be observed for the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Additional cytotoxicity data for other compounds in this report can be retrieved from the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. These are comparable with the data shown here, although compound <b>57</b> did show slight toxicity at concentrations greater than 24 μM.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Pharmacokinetic Properties of Selected FAP Inhibitors<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>68</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th><th class="colsep0 rowsep0" align="center"><b>61</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility (μM)</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma stability (% unchanged at 6 h) (mouse/rat/human)</td><td class="colsep0 rowsep0" align="left">100/90/nd</td><td class="colsep0 rowsep0" align="left">90/nd/100</td><td class="colsep0 rowsep0" align="left">nd/100/80</td><td class="colsep0 rowsep0" align="left">85/95/nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomal stability (% unchanged at 6 h) (mouse/rat)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">75/nd</td><td class="colsep0 rowsep0" align="left">90/nd</td><td class="colsep0 rowsep0" align="left">90/94/nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytotoxicity (MRC-5 cells) (μM)</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">nd stands for “not determined”.</p></div></div></div><div class="NLM_p">The in vivo PK parameters were then determined for inhibitors <b>4</b>, <b>5</b>, <b>60</b>, and <b>61</b> in rats. Six male rats were treated for each inhibitor tested, three of which received the compound via a single intravenous (iv) administration at 5 mg/kg. The other three animals were dosed per os (po) at 20 mg/kg. Blood samples were collected at 0.083, 0.25, 0.5, 1, 2, 4, 6, and 24 h after administration. Inhibitor concentrations were determined using UPLC–MS/MS, and pharmacokinetic parameters were calculated using standard algorithms. Notably, all rats subjected to <b>4</b> were found to die within 6 h. No signs of toxicity were observed during the observation period or upon autopsy in any of the other animals treated with compounds <b>5</b>, <b>60</b>, and <b>61</b>, and parameters for these molecules are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. Taking into account the high degree of structural similarity between the four compounds evaluated, we do not have a clear view on possible factors that could explain the singular toxicity to rats of <b>4</b>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vivo PK Properties of Selected FAP Inhibitors in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μg·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub> (L)</th><th class="colsep0 rowsep0" align="center" char=".">relative bioavailability (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (iv)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">1.73</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">11.7</td><td class="colsep0 rowsep0" align="char" char=".">1.75</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (po)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">13.4</td><td class="colsep0 rowsep0" align="char" char=".">23.0</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b> (iv)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">1.74</td><td class="colsep0 rowsep0" align="char" char=".">23.4</td><td class="colsep0 rowsep0" align="char" char=".">2.83</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b> (po)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">76.7</td><td class="colsep0 rowsep0" align="char" char=".">1.55</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b> (iv)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">1.40</td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b> (po)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">1.22</td><td class="colsep0 rowsep0" align="char" char=".">39.39</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">0.86</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Compound was formulated in PEG<sub>200</sub> and administered via single intravenous injection at 5 mg/kg.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Compound was formulated in PEG<sub>200</sub> and administered per os (gavage) at 20 mg/kg.</p></div></div></div><div class="NLM_p last">All inhibitors evaluated displayed significant, roughly comparable oral bioavailabilities (50–79%) and reasonable elimination half-lives (1.5–3 h). These data were complemented with experiments in which we followed up the extent of plasma FAP inhibition in the inhibitor-treated rats. A soluble form of the enzyme is present in plasma, where it was originally characterized as α<sub>2</sub>-antiplasmin cleaving enzyme (APCE).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In brief, residual FAP activity was determined in the same plasma samples that were collected for the determination of inhibitor concentrations after iv and po administration. FAP activity was measured using the commercially available substrate Z-Gly-Pro-AMC under conditions that excluded interference from soluble PREP activity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It deserves mentioning that for the ex vivo assay plasma samples are diluted 100-fold, potentially leading to underestimation of the amount of FAP that is blocked in vivo. At each of the investigated time points (5 min to 24 h) after iv or oral administration of compound <b>60</b>, the residual FAP activity measured ex vivo was less than 15% when compared with vehicle controls. Also after oral administration of compounds <b>5</b> and <b>61</b>, more than 85% inhibition of FAP activity was observed for all time points. Whereas at the 4 h time point after iv administration of the latter two compounds, the measured % inhibition still reached more than 75%. The FAP activity measured at the 24 h time point was around 50% compared to vehicle controls. All ex vivo FAP measurements point to a complete or near complete and prolonged inhibition of plasma FAP activity in vivo after single doses of compounds <b>5</b>, <b>60</b>, and <b>61</b>. The in vivo observations corroborate the in vivo p<i>K</i> parameters <i>C</i><sub>max</sub> and <i>T</i><sub>1/2</sub> and the in vitro stability testing. To check whether slow, tight binding might be contributing to maintaining long-term FAP inhibition, a kinetic and mechanistic investigation was performed for compound <b>60</b>, as this compound resulted in the most extensive and prolonged inhibition of FAP in the PK studies. No tight binding behavior was observed, and the inhibitor proved to bind reversibly to FAP. We therefore conclude that the longer in vivo half-life of <b>60</b> (compared to <b>5</b> and <b>61</b>) is the main contributor to the prolonged ex vivo inhibition of FAP activity observed for this compound. On the basis of the high degree of structural similarity between <b>5</b>, <b>60</b>, and <b>61</b>, we assume comparable kinetic behavior for these molecules. A more extended in vivo study using several, especially lower doses of these compounds is needed to confirm this hypothesis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study we have built a thorough structure–activity relationship around the 4-quinolinoyl-Gly-cyanoPro scaffold. First, replacing the P2 glycine residue with a limited set of other amino acids was found to decrease FAP potency significantly for each alternative residue evaluated. Adding substituents to the P2–P3 amide bond or changing it with a triazole peptide bond isostere abolished almost all FAP affinity. Second, an extended series of azaheterocycles was evaluated at the P3 position in order to identify alternatives for the quinoline group. Of all moieties evaluated, only pyridines resulted in inhibitors with appreciable FAP affinity, albeit in absolute terms still less potent than their quinoline-bearing analogues. Furthermore, we extended our investigation of the quinoline ring’s substitution pattern. We confirmed with more potent inhibitors our earlier preliminar observation that substituents at the 5-position of the quinoline moiety can improve selectivity toward PREP while maintaining FAP affinity. Nonetheless, notable outliers of this hypothesis were identified as well (vide infra). Third, the P1 position was investigated. We found that either 4<i>S</i>-fluoro or 4,4-difluoro substitution of the 2-cyanopyrrolidine ring can be used to optimize FAP affinity and selectivity with respect to PREP. Introduction of a 4<i>R</i>-fluoro substituent on the other hand was found to give rise to far less potent compounds, a feature that we tentatively rationalized using stereoelectronic arguments. Furthermore, we found that the combined presence of a 5-substituted quinolinoyl residue in P3 and a 2-cyano-4,4-difluoropyrrolidine in P1 unexpectedly leads to drastic FAP affinity loss. Although we do not have a clear explanation, this finding suggests that FAP imposes strict structural requirements on its inhibitors that seem related to the possibility of covalent bond formation between the enzyme and the nitrile warhead present in these molecules. Investigating this feature in depth, we prepared compounds in which the nitrile warhead was either omitted or replaced by a boronate or chloromethyl ketone. The presence of a warhead in the studied series of molecules was shown to be indispensable for high affinity, and a nitrile group was found to be preferable above the boronate function, mainly in terms of inhibitor selectivity. The chloromethyl ketone function, although of potential interest for the synthesis of activity-based probes for FAP, did not lead to irreversible inhibition or to high target affinity, again suggesting defected interaction with the enzyme’s catalytic serine.</div><div class="NLM_p">A selection was made among the most promising FAP inhibitors discovered so far in the studied series. In vitro PK and toxicity parameters were determined for these, generally predicting potential for satisfactory in vivo behavior. Four of these compounds were then submitted to in vivo PK analysis in rats. The corresponding data show that all four compounds tested had good oral bioavailability and half-lives. However, some questions remain with respect to compound <b>4</b>. We were surprised to see that all rats treated with this compound died within 6 h after compound administration, while the rats treated with the other, structurally highly similar inhibitors did not show signs of toxicity under an identical dosing regimen. Related to this, we do not have indications of a likely off-target of <b>4.</b> It is also highly speculative to suggest that the toxicity mechanism of <b>4</b> could be related to that of <i>allo</i>-Ile-isoindoline, a DPP8/9 inhibitor for which a putative off-target effect has been invoked to rationalize in vivo toxicity in rats and dogs.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">Summarizing, we have identified a series of highly potent FAP inhibitors with promising pharmacokinetic behavior. We believe that our selective, in vivo active inhibitors are currently best placed among all published compounds to help elucidate the function of FAP in different animal models of disease and to allow its continuing validation as a drug target.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise stated, laboratory reagent grade solvents were used. Reagents were obtained from Sigma-Aldrich, Acros Organics, Apollo Scientific, Manchester Organics, or Fluorochem and were used without further purification unless otherwise indicated. Characterization of all compounds was done with <sup>1</sup>H NMR and mass spectrometry. <sup>1</sup>H NMR spectra were recorded on a 400 MHz Bruker Avance III Nanobay spectrometer with Ultrashield. Chemical shifts are in ppm, and coupling constants are in hertz (Hz). Minor rotamers of the amide bond, which were less than 10% of the major rotamer, are not reported in the NMR data. ES mass spectra were obtained from an Esquire 3000plus ion trap mass spectrometer from Bruker Daltonics. Purity was verified using two different LC/MS systems, and purities of all final products were found to be >95%. Water (A) and MeCN (B) were used as eluents. LC–MS spectra were recorded on an Agilent 1100 series HPLC system using a Alltech Prevail C18 column (2.1 mm × 50 mm, 3 μm) coupled with an Esquire 3000plus as MS detector, and a “method A” 5–100% B, 20 min gradient was used with a flow rate of 0.2 mL/min. Formic acid, 0.1%, was added to solvents A and B. UPLC involved the following: Waters Acquity H-class UPLC system coupled to a Waters TQD ESI mass spectrometer and Waters TUV detector. A Waters Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column was used. Solvent A consisted of water with 0.1% formic acid. Solvent B consisted of acetonitrile with 0.1% formic acid. Method I involved the following: 0.15 min 95% A, 5% B, then in 1.85 min from 95% A, 5% B to 95% B, 5% A, then 0.25 min (0.350 mL/min), 95% B, 5% A. The wavelength for UV detection was 254 nm. Method II involved the following: flow 0.4 mL/min, 0.25 min 95% A, 5% B, then in 4.75 min to 95% B, 5% A, then 0.25 min 95% B, 5% A, followed by 0.75 min 95% A, 5% B. The wavelength for UV detection was 214 nm. Where necessary, flash purification was performed on a Biotage  ISOLERA One flash system equipped with an internal variable dual-wavelength diode array detector (200–400 nm). For normal phase purifications SNAP cartridges (10–340 g, flow rate of 10–100 mL/min) were used, and reversed phase purifications were done making use of KP-C18 containing cartridges. Dry sample loading was done by self-packing samplet cartridges using silica and Celite 545, respectively, for normal and reversed phase purifications. Gradients used varied for each purification. However, typical gradients used for normal phase were 30 min gradient of 0–50% EtOAc in hexane to 100% hexane or 0–5% methanol in DCM to 20% methanol in DCM. For reversed phase a gradient of 5% MeCN in water to 50% MeCN in water was used. HRMS involved the following: The dry samples were dissolved in 1 mL of methanol and diluted <sup>1</sup>/<sub>100</sub> in MeCN/H<sub>2</sub>O, 0.1% formic acid. Then 10 μL of each sample was injected using the CapLC system (Waters, Manchester, U.K.) and electrosprayed through the Nanomate (Advion, Ithaca, NY) nanoelectrospray source. The Nanomate was operated in positive ion mode at an electrospray potential of 1.5 kV. Samples were injected with an interval of 3 min. Positive ion mode accurate mass spectra were acquired using a Q-TOF II instrument (Waters, Manchester, U.K.). The mass spectrometer was calibrated prior to use with a 0.2% H<sub>3</sub>PO<sub>4</sub> solution. The spectra were lock-mass-corrected using the known mass of the nearest H<sub>3</sub>PO<sub>4</sub> cluster or the phthalate background ions. The Waters Acquity UPLC system coupled to a Waters TQD ESI mass spectrometer was also used for LC/MS/MS measurements. Enzymes used in the IC<sub>50</sub> measurements were purified from human or animal sources (human seminal plasma for DPPIV and DPPII, bovine testes for DPP9) or were isolated from recombinant sources (recombinant murine FAP from human HEK293 kidney cells; recombinant human PREP from <i>E. coli</i>). Substrates used in the IC<sub>50</sub> measurements were Ala-Pro-<i>p</i>-nitroanilide (2 mM) at pH 7.4 for FAP assays and Z-Gly-Pro-<i>p</i>-nitroanilide (0.25 mM) at pH 7.5 for PREP assays. DPPIV assays used Gly-Pro-<i>p</i>-nitroanilide (100 μM) at pH 8.3. DPPII assays were carried out using Lys-Ala-<i>p</i>-nitroanilide (1 mM) at pH 5.5, and DPP9 assays used Ala-Pro-<i>p</i>-nitroanilide (300 μM) at pH 7.4 . The substrate concentrations were chosen around the <i>K</i><sub>m</sub> value obtained under the assay conditions used. Mouse and rat plasma came from Innovative Research. The turbidity in the kinetic solubility experiments was measured using the UV/vis spectrophotometer Synergy MX, Biotek with Gen5. MRC-5SV2 cells (human embryonic diploid fibroblasts) were obtained from Sigma and cultured in MEM + Earl’s salts medium, supplemented with <span class="smallcaps smallerCapital">l</span>-glutamine, NaHCO<sub>3</sub>, and 5% inactivated fetal calf serum. All cultures and assays were conducted at 37 °C under an atmosphere of 5% CO<sub>2</sub>. Male Wistar rats (body weight of ∼250 g) were acquired from Janvier (France).</div><div class="NLM_p">The following section comprises the synthetic procedures and analytical data for all final compounds reported in this manuscript. The corresponding data for synthesis intermediates en route to final compounds can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Synthesis procedures that were used in the preparation of several final products are summarized here as “General Procedures”.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure A (Formation of the P2–P3 Amide Bond)</h3><div class="NLM_p last">The carboxylic acid (0.065 g, 0.377 mmol) was dissolved in 3 mL of DMF, and <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (0.210 mL, 1.168 mmol) and HATU (0.121 g, 0.377 mmol) were added. After 15 min a solution of (<i>S</i>)-1-(2-aminoacetyl)-pyrrolidine-2-carbonitrile trifluoroacetate or tosylate (0.085 g, 0.377 mmol) in DMF was added. The mixture was stirred for 3–4 h at room temperature. The volatiles were evaporated. The residue was dissolved in ethyl acetate and washed with 1 N citric acid, saturated sodium bicarbonate, and brine. The solution was dried over sodium sulfate, filtered, and evaporated. It was purified using column chromatography using DCM–methanol.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedure B (Deprotection of Boc Groups)</h3><div class="NLM_p last">Tosylic acid (1.4 equiv) was added to a cold (0 °C) solution of the Boc-protected product (1 equiv) in acetonitrile (0.4 M) at 0 °C. After 30 min the mixture was allowed to warm to room temperature and stirred for 24 h. The volatiles were evaporated and the mixture was washed with cold ethyl acetate to remove <i>N</i>-<i>tert</i>-butylacetamide. The white precipitate formed is the product.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure C (Formation of the P2–P3 Amide Bond of Compounds with a P3-(4-Quinolinoyl) Residue)</h3><div class="NLM_p last">Quinoline-4-carbonyl chloride hydrochloride (0.102 g, 0.448 mmol) was added to a solution of the amine (0.448 mmol) and DIPEA (0.217 mL, 1.242 mmol) in DCM and stirred until completion as followed with LC–MS (usually 2–3 h). On completion of the reaction, it was diluted with DCM–isopropanol (4:1), washed with saturated aqueous NaHCO<sub>3</sub> solution (10 mL), 0.1 N aqueous citric acid solution (10 mL), and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated and purified with flash chromatography.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure D (Preparation of Final Products with an N-Alkylated P2–P3 Amide Bond)</h3><div class="NLM_p last">(<i>S</i>)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile <b>15</b> (0.400 g, 2.317 mmol, 1 equiv) in THF (0.5M) was added dropwise to a 0.3 M ice–water cooled mixture of primary amine and K<sub>2</sub>CO<sub>3</sub> (0.961 g, 6.95 mmol, 3 equiv) in THF. The mixture was stirred for 2 h at 0 °C, then another 3 days at room temperature. After filtration of K<sub>2</sub>CO<sub>3</sub> and evaporation of volatiles, the concentrate was dissolved in 30 mL of DCM and washed with saturated sodium bicarbonate (3×), brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the secondary amine as an oily substance. If necessary the product was purified using silica gel column chromatography with 0.1 N ammonia as an additive. Quinoline-4-carbonyl chloride hydrochloride (0.102 g, 0.448 mmol) was added to a solution of the secondary amine and DIPEA (0.217 mL, 1.242 mmol) in DCM and stirred until completion as followed with LC–MS (usually 2–3 h). On completion of the reaction, it was diluted with DCM–isopropanol (4:1) and washed with saturated aqueous NaHCO<sub>3</sub> solution (10 mL), 0.1 N aqueous citric acid solution (10 mL), and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated and purified with flash chromatography using a DCM–methanol gradient and/or preparative HPLC.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure E (Preparation of Final Products with a P2–P3 Triazole Isostere)</h3><div class="NLM_p last">Sodium azide (0.863 g, 13.27 mmol) was added to a solution of (<i>S</i>)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile <b>15</b> (1.27 g, 7.4 mmol) in DMF (25 mL) and stirred for 24 h. After evaporation of the volatiles, the residue was dissolved in ethyl acetate and washed with water and brine. Purification was done using column chromatography with a hexane–ethyl acetate gradient (20–35%) to give (1.1 g, 83%) white crystals of (<i>S</i>)-1-(2-azidoacetyl)pyrrolidine-2-carbonitrile. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (4:1 mixture of trans–cis rotamers) δ 4.80 (d, <i>J</i> = 5.8 Hz, 0.8H), 4.63 (dd, <i>J</i> = 12.8, 6.4 Hz, 0.2H), 3.93 (d, <i>J</i> = 14.5 Hz, 1H), 3.86 (d, <i>J</i> = 16.0 Hz, 1H), 3.64–3.54 (m, 1H), 3.47–3.38 (m, 1H), 2.38–2.02 (m, 4H); MS (ESI) <i>m</i>/<i>z</i> 180.2 [M + H]<sup>+</sup>. The alkyne (0.096 mL, 0.837 mmol) was added to a mixture of (<i>S</i>)-1-(2-azidoacetyl)pyrrolidine-2-carbonitrile (0.075 g, 0.419 mmol) and copper(I) iodide (7.97 mg, 0.042 mmol) in THF (volume, 4 mL) with one drop of triethylamine. The reaction mixture was stirred at room temperature for 24 h. The reaction mixture was then filtered, the filtrate evaporated and the residue chromatographed, yielding the title compound as a slightly yellowish transparent colorless oil.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure F (Formation of the P2–P3 Amide Bond)</h3><div class="NLM_p last">The carboxylic acid (0.092 g, 0.814 mmol) was dispersed in dry dioxane (3 mL) in a round-bottom flask with nitrogen. To this 1-chloro-<i>N</i>,<i>N</i>,2-trimethylprop-1-en-1-amine (0.151 mL, 1.139 mmol) was added, and the mixture was stirred for 30 min at room temperature. The starting material dissolved over time. Then (<i>S</i>)-1-(2-aminoacetyl)pyrrolidine-2-carbonitrile hydrochloride (0.247 g, 1.302 mmol) with <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (0.307 mL, 1.709 mmol) was added, and the mixture was stirred for 2 h, evaporated to dryness, and redissolved in ethyl acetate. This was followed by washing with 0.1 N citric acid and saturated sodium bicarbonate and brine. After drying over sodium sulfate, filtration, and evaporation, the product was purified using column chromatography.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure G (Formation of the P2–P3 Amide Bond)</h3><div class="NLM_p">To a solution containing the carboxylic acid (0.058 g, 0.333 mmol) and hydroxybenzotriazole (0.056 g, 0.366 mmol) in 1,4-dioxane (3 mL) was added a solution of EDC (0.070 g, 0.366 mmol) in DCM (2 mL). The mixture was stirred for 10 min at room temperature. To the resulting solution were added the appropriate amine (<i>S</i>)-1-(2-aminoacetyl)pyrrolidine-2-carbonitrile 4-methylbenzenesulfonate (0.130 g, 0.400 mmol) and DIPEA (0.122 mL, 0.699 mmol) in DCM (4 mL), with stirring. After 2 h or when the reaction was complete according to HPLC, the reaction mixture was diluted with DCM and washed with saturated aqueous NaHCO<sub>3</sub> solution (10 mL), 0.1 N aqueous citric acid solution (10 mL), and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated and purified with flash chromatography.</div><div class="NLM_p last">General procedures A–G were used for the preparation of all final compounds present in the publication.</div></div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-1-((<i>R</i>)-2-Amino-3-hydroxypropanoyl)pyrrolidine-2-carbonitrile 4-Methylbenzenesulfonate (<b>7</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl (<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-((<i>S</i>)-2-cyanopyrrolidin-1-yl)-1-oxopropan-2-ylcarbamate was prepared according to general procedure A using (<i>S</i>)-pyrrolidine-2-carbonitrile 4-methylbenzenesulfonate and (<i>R</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-(<i>tert</i>-butyldimethylsilyloxy)propanoic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.31–5.22 (d, <i>J</i> = 8.4 Hz, 1H), 4.72–4.66 (m, 1H), 4.66–4.56 (td, <i>J</i> = 8.9, 5.3 Hz, 1H), 3.86–3.70 (m, 3H), 3.69–3.61 (t, <i>J</i> = 9.1 Hz, 1H), 2.36–2.07 (m, 4H), 1.50–1.37 (s, 9H), 0.88–0.78 (s, 9H), 0.03–0.02 (s, 3H), 0.015–0.00 (s, 3H); UPLC I (ESI) <i>t</i><sub>R</sub> 2.25 min, <i>m</i>/<i>z</i> 398.67 [M + H]<sup>+</sup> (96%); 0.260g, 65%). Then Boc deprotection was done using general procedure B. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.73–7.66 (m, 2H), 7.40–7.35 (m, 2H), 4.84–4.81 (m, 1H), 4.43 (dd, <i>J</i> = 5.5, 4.3 Hz, 1H), 4.02–3.91 (m, 1H), 3.99 (dd, <i>J</i> = 12.6, 4.3 Hz, 1H), 3.94 (dd, <i>J</i> = 12.6, 5.6 Hz, 1H), 3.62 (dt, <i>J</i> = 9.8, 7.9 Hz, 1H), 2.41 (s, 3H), 2.39–2.16 (m, 4H); white powder, 0.220 g, 95%.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-1-((<i>R</i>)-2-Aminopropanoyl)pyrrolidine-2-carbonitrile 4-Methylbenzenesulfonate (<b>8</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl (<i>R</i>)-1-((<i>S</i>)-2-cyanopyrrolidin-1-yl)-1-oxopropan-2-ylcarbamate was made using general procedure A and purified by column chromatography with a gradient DCM to DCM–MeOH (95:5), yielding white crystals. UPLC I (ESI) <i>t</i><sub>R</sub> 1.44 min, <i>m</i>/<i>z</i> 268.5 [M + H]<sup>+</sup> (96%); 0.47g, 83%. Then the Boc deprotection was done using general procedure B. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.73–7.65 (d, <i>J</i> = 8.0 Hz, 3H), 7.40–7.34 (d, <i>J</i> = 7.9 Hz, 3H), 4.79–4.75 (m, 1H), 4.39–4.29 (q, <i>J</i> = 7.1 Hz, 1H), 3.83–3.73 (dt, <i>J</i> = 10.6, 5.7 Hz, 1H), 3.60–3.49 (q, <i>J</i> = 8.8 Hz, 1H), 2.45–2.36 (s, 3H), 2.37–2.12 (m, 4H), 1.54–1.44 (dd, <i>J</i> = 7.1 Hz, 3H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.25 min, <i>m</i>/<i>z</i> 168.4 [M + H]<sup>+</sup> (95%); 0.5 g, 84%.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>S</i>)-1-((<i>S</i>)-2-Aminopropanoyl)pyrrolidine-2-carbonitrile 4-Methylbenzenesulfonate (<b>9</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl (<i>S</i>)-1-((<i>S</i>)-2-cyanopyrrolidin-1-yl)-1-oxopropan-2-ylcarbamate was made using general procedure A and purified by column chromatography with a gradient DCM to DCM–MeOH (95:5). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.26 (d, <i>J</i> = 7.9 Hz, 1H), 4.78 (dd, <i>J</i> = 6.8, 3.7 Hz, 1H), 4.47–4.37 (m, 1H), 3.77–3.58 (m, 2H), 2.33–2.12 (m, 4H), 1.42 (s, <i>J</i> = 6.3 Hz, 9H), 1.35 (d, <i>J</i> = 6.9 Hz, 3H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.45 min, <i>m</i>/<i>z</i> 268.5 [M + H]<sup>+</sup> (96%); 0.46 g, 81%. Then Boc deprotection was done using general procedure B, yielding a white powder. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 7.73–7.66 (d, <i>J</i> = 7.9, 2H), 7.41–7.34 (d, <i>J</i> = 7.9 Hz, 2H), 4.87–4.80 (dd, <i>J</i> = 7.5, 5.2 Hz, 1H), 4.38–4.29 (q, <i>J</i> = 7.1 Hz, 1H), 3.75–3.59 (m, 2H), 2.43–2.38 (s, 3H), 2.37–2.09 (m, 4H), 1.58–1.51 (d, <i>J</i> = 7.1 Hz, 3H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.19 min, <i>m</i>/<i>z</i> 168.4 [M + H]<sup>+</sup> (97%); 0.43 g, 77%. Optical purity was confirmed with Marfey’s reagent.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl 1-(Quinoline-4-carboxamido)cyclopropanecarboxylate (<b>10</b>)</h3><div class="NLM_p last">The title compound was prepared using general procedure C starting from 1-aminocyclopropanecarboxylic acid, producing a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92 (d, <i>J</i> = 4.3 Hz, 1H), 8.33 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (ddd, <i>J</i> = 8.4, 6.9, 1.4 Hz, 1H), 7.63 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.44 (d, <i>J</i> = 4.3 Hz, 1H), 6.66 (s, 1H), 3.81–3.76 (m, 3H), 1.76–1.72 (m, 2H), 1.38 (dd, <i>J</i> = 8.1, 4.9 Hz, 2H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.14 min, <i>m</i>/<i>z</i> 271.6 [M + H]<sup>+</sup> (93%).</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-((<i>R</i>)-1-((<i>S</i>)-2-Cyanopyrrolidin-1-yl)-3-hydroxy-1-oxopropan-2-yl)quinoline-4-carboxamide (<b>11</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure C, yielding a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) cis/trans amide conformers (3/10) δ 8.91 (d, <i>J</i> = 4.35 Hz, 0.3H), 8.89 (d, <i>J</i> = 4.33 Hz, 1H), 8.19 (dd, <i>J</i> = 1.29, 8.69 Hz, 1H), 8.19–8.16 (m, 0.3H), 8.13 (d, <i>J</i> = 8.75 Hz, 0.3H), 8.11 (dd, <i>J</i> = 1.09, 8.75 Hz, 1H), 7.77–7.74 (m, 0.3H), 7.73 (ddd, <i>J</i> = 1.39, 6.87, 8.40 Hz, 1H), 7.63–7.59 (d, <i>J</i> = 1.35 Hz, 0.3H), 7.58 (ddd, <i>J</i> = 1.30, 6.82, 8.36 Hz, 1H), 7.51 (d, <i>J</i> = 7.87 Hz, 1H), 7.46 (d, <i>J</i> = 4.31 Hz, 1.3H), 7.43 (d, <i>J</i> = 7.26 Hz, 0.3H), 5.62 (dd, <i>J</i> = 2.08, 7.73 Hz, 0.3H), 5.11 (dt, <i>J</i> = 4.58, 7.87 Hz, 1H), 4.94 (dt, <i>J</i> = 3.82, 7.23 Hz, 0.3H), 4.60–4.55 (m, 1H), 4.15 (dd, <i>J</i> = 3.43, 11.74 Hz, 0.3H), 4.02 (dd, <i>J</i> = 4.18, 11.36 Hz, 1,3H), 3.97–3.89 (m, 2.3H), 3.73–3.62 (m, 2H), 3.59–3.50 (m, 0.6H), 2.46–2.10 (m, 5.2H); major conformer, <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 169.42, 167.55, 149.86, 148.70, 140.63, 130.31, 129.98, 128.14, 125.17, 124.37, 119.00, 117.90, 77.36, 63.36, 53.19, 47.01, 30.08, 25.24; minor conformer, <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.61, 168.09, 149.86, 148.76, 140.21, 130.34, 130.10, 128.18, 125.02, 124.37, 119.07, 117.90, 77.36, 62.35, 52.11, 46.65, 32.30, 23.27; UPLC I (ESI) <i>t</i><sub>R</sub> 1.10 min, <i>m</i>/<i>z</i> 339.6 [M + H]<sup>+</sup> (95%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.5 min, <i>m</i>/<i>z</i> 339.0 [M + H]<sup>+</sup> (95%); 42 mg, 40%.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-((<i>R</i>)-1-((<i>S</i>)-2-Cyanopyrrolidin-1-yl)-1-oxopropan-2-yl)quinoline-4-carboxamide (<b>12</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure C. Major conformer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (d, <i>J</i> = 4.31 Hz, 1H), 8.24 (dd, <i>J</i> = 1.16, 8.99 Hz, 1H), 8.16–8.11 (m, 1H), 7.76 (ddd, <i>J</i> = 1.41, 6.93, 8.38 Hz, 1H), 7.62 (ddd, <i>J</i> = 1.36, 6.84, 8.32 Hz, 1H), 7.49 (d, <i>J</i> = 4.29 Hz, 1H), 7.19 (d, <i>J</i> = 7.55 Hz, 1H), 5.04 (qd, <i>J</i> = 2.10, 6.79 Hz, 1H), 4.68 (dd, <i>J</i> = 2.00, 8.01 Hz, 1H), 4.00–3.91 (m, 1H), 3.59–3.51 (m, 1H), 2.49–2.10 (m, 4H), 1.52 (d, <i>J</i> = 6.83 Hz, 3H); minor conformer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93 (d, <i>J</i> = 4.30 Hz, 1H), 8.20 (dd, <i>J</i> = 1.15, 8.41 Hz, 1H), 8.16–8.11 (m, 1H), 7.76 (ddd, <i>J</i> = 1.41, 6.93, 8.38 Hz, 1H), 7.62 (ddd, <i>J</i> = 1.36, 6.84, 8.32 Hz, 1H), 7.46 (d, <i>J</i> = 4.29 Hz, 1H), 6.93 (d, <i>J</i> = 7.24 Hz, 1H), 5.38 (dd, <i>J</i> = 2.16, 7.68 Hz, 1H), 5.01–4.95 (m, 1H), 4.00–3.91 (m, 1H), 3.68–3.61 (m, 1H), 2.49–2.10 (m, 4H), 1.62 (d, <i>J</i> = 6.87 Hz, 3H); major conformer, <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.10, 166.71, 149.92, 148.79, 141.13, 130.17, 130.02, 127.96, 125.29, 124.50, 118.86, 117.97, 47.67, 47.06, 46.59, 30.15, 25.23, 18.31; minor conformer, <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.07, 166.63, 149.88, 148.76, 141.09, 130.23, 130.07, 128.03, 125.12, 124.43, 118.91, 117.97, 47.56, 47.06, 46.59, 29.82, 23.23, 17.93; UPLC I (ESI) <i>t</i><sub>R</sub> 1.18 min, <i>m</i>/<i>z</i> 323.6 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.2 min, <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup> (97%); 48 mg, 50%.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-((<i>S</i>)-1-((<i>S</i>)-2-Cyanopyrrolidin-1-yl)-1-oxopropan-2-yl)quinoline-4-carboxamide (<b>13</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure C to give a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.91–8.88 (d, <i>J</i> = 4.3 Hz, 1H), 8.26–8.20 (dd, <i>J</i> = 8.7, 1.5 Hz, 1H), 8.15–8.09 (dt, <i>J</i> = 8.5, 1.0 Hz, 1H), 7.78–7.71 (ddd, <i>J</i> = 8.4, 6.9, 1.4 Hz, 1H), 7.63–7.56 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.46–7.43 (d, <i>J</i> = 4.2 Hz, 1H), 7.43–7.41 (s, 1H), 5.23–5.16 (p, <i>J</i> = 7.1 Hz, 0.05H), 5.05–4.93 (p, <i>J</i> = 7.1 Hz, 0.95H), 4.86–4.84 (d, <i>J</i> = 7.5 Hz, 0.05H), 4.74–4.67 (m, 0.95H), 3.88–3.78 (qd, <i>J</i> = 7.0, 3.1 Hz, 1H), 3.76–3.68 (m, 1H), 2.36–2.16 (m, 4H), 1.56 (d, <i>J</i> = 6.96 Hz, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.35, 166.89, 149.79, 148.57, 141.08, 130.03, 129.84, 127.76, 125.21, 124.39, 118.85, 118.09, 47.39, 46.65, 46.52, 29.78, 25.34, 17.89; UPLC I (ESI) <i>t</i><sub>R</sub> 1.20 min, <i>m</i>/<i>z</i> 323.6 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.5 min, <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup> (97%); 53 mg, 59%.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-<i>N</i>-(1-(2-Cyanopyrrolidine-1-carbonyl)cyclopropyl)quinoline-4-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Methyl 1-(quinoline-4-carboxamido)cyclopropanecarboxylate was prepared using general procedure C starting from methyl 1-aminocyclopropanecarboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92 (d, <i>J</i> = 4.3 Hz, 1H), 8.33 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (ddd, <i>J</i> = 8.4, 6.9, 1.4 Hz, 1H), 7.63 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 1H), 7.44 (d, <i>J</i> = 4.3 Hz, 1H), 6.66 (s, 1H), 3.81–3.76 (m, 3H), 1.76–1.72 (m, 2H), 1.38 (dd, <i>J</i> = 8.1, 4.9 Hz, 2H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.14 min, <i>m</i>/<i>z</i> 271.6 [M + H]<sup>+</sup> (93%). Then methyl 1-(quinoline-4-carboxamido)cyclopropanecarboxylate (0,130 g, 0,481 mmol) was added to a solution of KOH (0.033 g, 0.495 mmol) in methanol (1 mL). The mixture was stirred for 2 h and evaporated till dryness. The resulting potassium 1-(quinoline-4-carboxamido)cyclopropanecarboxylate (0.140 g, 0.476 mmol, 99% yield) was used without further purification in the next step. Compound <b>14</b> was made according to general procedure A with cyanoproline tosylate and methyl 1-(quinoline-4-carboxamido)cyclopropanecarboxylate, giving a colorless oil. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.92 (d, <i>J</i> = 4.41 Hz, 1H), 8.17 (d, <i>J</i> = 7.27 Hz, 1H), 8.09 (d, <i>J</i> = 8.42 Hz, 1H), 7.83 (ddd, <i>J</i> = 1.42, 6.78, 8.37 Hz, 1H), 7.68 (ddd, <i>J</i> = 1.21, 6.92, 8.30 Hz, 1H), 7.59 (d, <i>J</i> = 4.51 Hz, 1H), 3.74 (dq, <i>J</i> = 6.88, 19.58 Hz, 2H), 3.35 (s, 1H), 2.38–2.15 (m, 2H), 2.11 (ddt, <i>J</i> = 6.08, 14.42, 17.60 Hz, 2H), 1.57 (s, 2H), 1.24 (d, <i>J</i> = 2.75 Hz, 2H); <sup>13</sup>C NMR (101 MHz, MeOD) δ 171.74, 170.51, 151.01, 149.19, 142.80, 131.61, 129.88, 129.18, 126.26, 125.85, 120.22, 119.89, 55.81, 43.79, 37.07, 30.80, 26.56, 15.48, 15.38; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.4 min, <i>m</i>/<i>z</i> 335.0 [M + H]<sup>+</sup> (96%); UPLC I (ESI) <i>t</i><sub>R</sub> 1.15 min, <i>m</i>/<i>z</i> 335.6 [M + H]<sup>+</sup> (96%); 76 mg, 47%.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile (<b>15</b>)</h3><div class="NLM_p last">The title compound was made as described by Singh et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-<i>N</i>-methylquinoline-4-carboxamide (<b>16</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans amide rotamer, 1/3) δ 8.98 (dd, <i>J</i> = 4.2, 2.5 Hz, 1H), 8.20–8.09 (m, 1.75H), 7.88 (dd, <i>J</i> = 8.2, 1.1 Hz, 0.25H), 7.78 (ddd, <i>J</i> = 8.5, 6.9, 1.5 Hz, 1H), 7.67 (ddd, <i>J</i> = 8.3, 6.9, 1.3 Hz, 0.75H), 7.60 (ddd, <i>J</i> = 8.3, 7.0, 1.3 Hz, 0.25H), 7.38 (d, <i>J</i> = 4.4 Hz, 0.75H), 7.33 (d, <i>J</i> = 4.3, 0.25H), 4.94–4.86 (m, 1H), 3.84–3.69 (m, 1H), 3.70–3.59 (m, 1H), 2.98 (d, <i>J</i> = 11.5 Hz, 1H), 2.95 (s, 3H), 2.94 (d, <i>J</i> = 11.4 Hz, 1H), 2.44–2.09 (m, 4H); UPLC (ESI) I <i>t</i><sub>R</sub> 1.05, <i>m</i>/<i>z</i> 323.50 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.4 min, <i>m</i>/<i>z</i> 323.1 [M + H]<sup>+</sup> (97%); yellowish oil, 0.022 g, 13%.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-<i>N</i>-cyclopropylquinoline-4-carboxamide (<b>17</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans amide rotamer, 1/9) δ 8.95 (d, <i>J</i> = 4.4 Hz, 1H), 8.25–8.09 (m, 2H), 7.74 (ddd, <i>J</i> = 8.4, 6.9, 1.4 Hz, 1H), 7.62 (ddd, <i>J</i> = 8.2, 6.9, 1.3 Hz, 1H), 7.44 (d, <i>J</i> = 4.7, 1H), 4.91–4.87 (m, 0.1H), 4.85 (dd, <i>J</i> = 7.6, 2.5 Hz, 0.9H), 4.66 (d, <i>J</i> = 16.1 Hz, 1H), 4.05 (d, <i>J</i> = 16.1 Hz, 1H), 3.74–3.65(m, 1H), 3.64–3.55 (m, 1H), 2.89–2.78 (m, 1H), 2.42–2.06 (m, 4H), 0.62–0.37 (m, 3H), 0.31–0.20 (m, 1H); UPLC (ESI) I <i>t</i><sub>R</sub> 1.26, <i>m</i>/<i>z</i> 349.40 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 11.7 min, <i>m</i>/<i>z</i> 349.1 [M + H]<sup>+</sup> (98%); yellowish oil, 0.050 g, 18%.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-(4-Chlorobenzyl)-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>18</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans amide rotamer, 1/4) δ 8.98–8.94 (m, 0.2H), 8.93 (d, <i>J</i> = 4.35, 0.8H), 8.35 (br s, 1H), 8.18 (dd, <i>J</i> = 16.44, 3.43 Hz, 0.2H), 8.13 (d, <i>J</i> = 8.36 Hz, 0.8H), 7.91–7.83 (m, 0.2H), 7.78 (ddd, <i>J</i> = 8.30, 6.69, 1.44 Hz, 0.8H), 7.69 (ddd, <i>J</i> = 8.23, 6.92, 1.29 Hz, 0.8H), 7.64–7.58 (m, 0.2H), 7.43 (d, <i>J</i> = 3.70, 0.8H), 7.41–7.36 (m, 0.2H), 7.34 (q, <i>J</i> = 6.69, 5.04 Hz, 1.6H), 7.33–7.27 (m, <i>J</i> = 6.69, 5.04 Hz, 0.4H), 7.13–7.03 (m, 2H), 4.94–4.72 (m, 2H), 5.37–5.33 (m, 0.8H), 5.47–5.43 (m, 0.2H), 4.43 (d, <i>J</i> = 3.14 Hz, 2H), 3.75 (dt, <i>J</i> = 11.03, 5.33 Hz, 0.4H), 3.67–3.43 (d, <i>J</i> = 26.63 Hz, 1.6H), 2.41–2.06 (m, 3.6H), 2.40–2.05 (m, 0.4H); UPLC(ESI) I <i>t</i><sub>R</sub> 1.69, <i>m</i>/<i>z</i> 433.30 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 15.6 min, <i>m</i>/<i>z</i> 433.3 [M + H]<sup>+</sup> (98%); yellowish oil, 0.030 g, 18%.</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-<i>N</i>-(2-methoxyethyl)quinoline-4-carboxamide (<b>19</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans mixture of amide rotamers) δ 8.96 (d, <i>J</i> = 4.4, 1H), 8.34–8.29 (m, 1H), 8.14 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (td, <i>J</i> = 7.9, 7.4, 1.6 Hz, 1H), 7.68 (s, 1H), 7.44–7.38 (m, 1H), 4.97–4.85 (m, 1H), 4.07 (m, 1H), 3.70 (m, 2H), 3.47–3.30 (m, 5H), 3.27 (s, 3H), 2.41–2.11 (m, 4H); UPLC (ESI) I <i>t</i><sub>R</sub> 1.21, <i>m</i>/<i>z</i> 367.30 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 11.2 min, <i>m</i>/<i>z</i> 367.1 [M + H]<sup>+</sup> (99%); yellowish oil, 0.049 g, 28%.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-<i>N</i>-isopentylquinoline-4-carboxamide (<b>20</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (cis/trans amide rotamer mixture) δ 8.94 (dd, <i>J</i> = 4.2, 2.5 Hz, 1H), 8.13 (dd, <i>J</i> = 8.6, 1.3 Hz, 1H), 8.25 (br s, 1H), 7.76 (ddd, <i>J</i> = 8.4, 6.8, 1.4 Hz, 1H), 7.66 (t, <i>J</i> = 7.6, 1H), 7.33 (br s, 1H), 4.92–4.68 (m, 1.5H), 4.50–4.10 (m, 0.5H), 3.84–3.54 (m, 3H), 3.21–3.06 (m, 2H), 2.42–2.05 (m, 4H), 1.45–1.15 (m, 3H), 0.55 (d, <i>J</i> = 6.3 Hz, 6H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 14.5 min, <i>m</i>/<i>z</i> 379.1 [M + H]<sup>+</sup> (99%); yellowish oil, 0.056 g, 33%.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-1-(2-((2-Methoxyethyl)(quinolin-4-ylmethyl)amino)acetyl)pyrrolidine-2-carbonitril (<b>21</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile <b>11</b> (0.272 g, 1.576 mmol) in 2.5 mL of THF was added dropwise over 0.5 h into an ice–water cooled mixture of the appropriate 2-methoxy-<i>N</i>-(quinolin-4-ylmethyl)ethanamine <b>S10</b> (0.150 g, 0.694 mmol) and potassium carbonate (0.392 g, 2.84 mmol) in 5 mL of THF. The resulting mixture was stirred at ice–water temperature for 2 h and then at room temperature for 1–3 days. The resulting mixture was then filtered to remove K<sub>2</sub>CO<sub>3</sub>, concentrated, and then partitioned between DCM and saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was then washed with DCM (2×), and the combined organic layers were washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification was done using column chromatography with a DCM–MeOH gradient to yield a yellowish oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans amide rotamer, 1/4) δ 8.84 (d, <i>J</i> = 4.4 Hz, 0.2H), 8.83 (d, <i>J</i> = 4.3 Hz, 0.8H), 8.26 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 0.7 Hz, 0.8H), 8.09 (dd, <i>J</i> = 8.5 Hz, <i>J</i>′ = 0.7 Hz, 0.8H), 8.1 (dd, <i>J</i> = 8.5 Hz, <i>J</i>′ = 0.7 Hz, 0.2H) 8.18 (dd, <i>J</i> = 8.7 Hz, <i>J</i>′ = 1.0 Hz, 0.2H), 7.68 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.4 Hz, 1H), 7.54 (ddd, <i>J</i> = 8.3 Hz, <i>J</i>″ = 6.8 Hz, <i>J</i>′ = 1.3 Hz, 1H), 7.45 (dd, <i>J</i> = 4.4 Hz, <i>J</i>′ = 0.9 Hz, 0.8H), 7.41 (d, <i>J</i> = 4.3 Hz, 0.2H), 5.20 (dd, <i>J</i> = 8.0 Hz, <i>J</i>′ = 1.6 Hz, 0.2H), 4.70–4.57 (m, 0.8H), 4.38 (d, <i>J</i> = 14.0 Hz, 0.8H), 4.30 (d, <i>J</i> = 14.2 Hz, 0.8H), 4.24 (d, <i>J</i> = 14.1 Hz, 0.2H), 4.16 (d, <i>J</i> = 14.2 Hz, 0.2H), 3.71 (d, <i>J</i> = 14.4 Hz, 0.4H), 3.66 (td, <i>J</i> = 7.7 Hz, <i>J</i>′ = 3.9 Hz, 0.4H), 3.53 (t, <i>J</i> = 5.2 Hz, 1.6H), 3.50–3.44 (m, 0.2H), 3.39 (d, <i>J</i> = 15.0 Hz, 1.6H), 3.32 (s, 3H), 3.38–3.31 (m, 0.8H), 3.27–3.11 (m, 1H), 2.99 (dt, <i>J</i> = 5.3 Hz, <i>J</i>′ = 2.4 Hz, 1.6H), 2.81 (ddd, <i>J</i> = 13.9 Hz, <i>J</i>′ = 5.5 Hz, <i>J</i>″ = 3.2 Hz, 0.4H), 2.25–1.89 (m, 4H); UPLC (ESI) I <i>t</i><sub>R</sub> 1.18, <i>m</i>/<i>z</i> 353.50 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 10.3 min, <i>m</i>/<i>z</i> 353.1 [M + H]<sup>+</sup> (97%); 0.055 g, 25%.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-1-(2-(Methyl(quinolin-4-ylmethyl)amino)acetyl)pyrrolidine-2-carbonitrile (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared in a similar manner as compound <b>21</b> starting from <i>N</i>-methyl-1-(quinolin-4-yl)methanamine (<b>S9</b>). Purification was done using column chromatography with a DCM–MeOH gradient with an ammonia additive to yield a yellowish oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) (cis/trans amide rotamer, 1/3) δ 8.79 (s, 0.25H), 8.77 (d, <i>J</i> = 4.3 Hz, 0.75H), 8.17 (dd, 0.75H), 8.13–8.09 (m, 0.25H), 8.06 (d, <i>J</i> = 8.5 Hz, 0.25H), 8.03 (d, <i>J</i> = 8,5 Hz, 0.75H), 7.62 (ddd, <i>J</i> = 8.4, 6.8, 1.4 Hz, 1H), 7.49 (ddd, <i>J</i> = 8.4, 6.9, 1.3 Hz, 1H), 7.32 (d, <i>J</i> = 4.4, 0.75H), 7.29 (d, <i>J</i> = 4.3, 0.25H), 4.78 (dd, <i>J</i> = 7.8, 1.8 Hz, 0.25H), 4.63–4.52 (m, 0.75H), 4.07 (d, <i>J</i> = 13.4 Hz, 0.75H), 3.98 (d, <i>J</i> = 11.4 Hz, 0.75H), 3.96 (d, <i>J</i> = 13.6 Hz, 0.25H), 3.92 (d, <i>J</i> = 13.6 Hz, 0.25H), 3.50–3.37 (m, 1H), 3.20 (d, <i>J</i> = 1.5 Hz, 2H), 3.24–3.09 (m, 1H), 2.38 (s, 0.75H), 2.35 (s, 2.25H), 2.22–1.59 (m, 4H); UPLC (ESI) I <i>t</i><sub>R</sub> 0.57, <i>m</i>/<i>z</i> 309.50 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 8.8 min, <i>m</i>/<i>z</i> 309.1 [M + H]<sup>+</sup> (97%); 0.131 g, 48.8%.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>,2′<i>S</i>)-1,1′-(2,2′-(Methylazanediyl)bis(acetyl))bis(pyrrolidine-2-carbonitrile) (<b>23</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure D, but only 0.5 equiv of 33% methylamine in EtOH was used as the primary amine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of trans/cis rotamers) δ 5.69 (d, <i>J</i> = 7.3 Hz, 0.4H), 4.80–4.62 (m, 1.6H), 3.72–3.66 (m, 1H), 3.62–3.56 (m, 1H), 3.53–3.44 (m, <i>J</i> = 13.7, 8.1 Hz, 3H), 3.43–3.36 (m, <i>J</i> = 14.6, 3.3 Hz, 3H), 2.54 (s, 1.5H), 2.42 (s, <i>J</i> = 7.7 Hz, 1.5H), 2.35–1.99 (m, 8H); UPLC (ESI) I <i>t</i><sub>R</sub> 0.29, <i>m</i>/<i>z</i> 304.50 [M + H]<sup>+</sup>; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 2.2 min, <i>m</i>/<i>z</i> 304.1 [M + H]<sup>+</sup> (98%); yellowish oil, 0.028 g, 13%.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-1-(2-(4-Phenyl-1<i>H</i>-1,2,3-triazol-1-yl)acetyl)pyrrolidine-2-carbonitrile (<b>24</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure E. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.1 (s, 1H), 7.85–7.74 (m, 2H), 7.53–7.40 (m, 3H), 5.35 (d, <i>J</i> = 16.5 Hz, 1H), 5.12 (d, <i>J</i> = 16.5 Hz, 1H), 4.79–4.73 (m, 1H), 3.81–3.72 (m, 1H), 3.66–3.58 (m, 1H), 2.40–2.13 (m, 4H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 12.8 min, <i>m</i>/<i>z</i> 282.3 [M + H]<sup>+</sup> (96%); white powder, 54 mg, 62%.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-1-(2-(4-(4-Fluorophenyl)-1<i>H</i>-1,2,3-triazol-1-yl)acetyl)pyrrolidine-2-carbonitrile (<b>25</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure E. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.84–7.75 (m, 2H), 7.09 (t, <i>J</i> = 8.84 Hz, 2H), 5.35 (d, <i>J</i> = 16.38 Hz, 1H), 5.14 (d, <i>J</i> = 16.40 Hz, 1H), 4.79–4.73 (m, 1H), 3.81–3.72 (m, 1H), 3.66–3.58 (m, 1H), 2.40–2.13 (m, 4H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 13.5 min, <i>m</i>/<i>z</i> 300.0 [M + H]<sup>+</sup> (97%); white powder, 39 mg, 37%.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>S</i>)-1-(2-(4-(3-(Isoindolin-2-yl)-3-oxopropyl)-1<i>H</i>-1,2,3-triazol-1-yl)acetyl)pyrrolidine-2-carbonitrile (<b>26</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure E. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.65 (s, 1H), 7.32–7.22 (m, 4H), 5.22 (d, <i>J</i> = 16.33 Hz, 1H), 5.08 (d, <i>J</i> = 16.33 Hz, 1H), 4.79 (d, <i>J</i> = 5.59 Hz, 4H), 4.74–4.70 (m, 1H), 3.76–3.68 (m, 1H), 3.62–3.53 (m, 1H), 3.16 (t, <i>J</i> = 7.19 Hz, 2H), 2.84 (t, <i>J</i> = 7.19 Hz, 2H), 2.36–2.16 (m, 4H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 12.9 min, <i>m</i>/<i>z</i> 379.1 [M + H]<sup>+</sup> (97%); white powder, 36 mg, 23%.</div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-1-(2-(4-(Naphthalen-1-yl)-1<i>H</i>-1,2,3-triazol-1-yl)acetyl)pyrrolidine-2-carbonitrile (<b>27</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure E. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43–8.34 (m, 1H), 8.10 (s, 1H), 7.94–7.87 (m, 2H), 7.76 (dd, <i>J</i> = 1.23, 7.14 Hz, 1H), 7.57–7.49 (m, 3H), 5.43 (d, <i>J</i> = 16.32 Hz, 1H), 5.23 (d, <i>J</i> = 16.30 Hz, 1H), 4.79 (dd, <i>J</i> = 2.60, 7.46 Hz, 1H), 3.84–3.74 (m, 1H), 3.72–3.61 (m, 1H), 2.40–2.14 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 164.05, 147.28, 133.89, 131.10, 129.05, 128.46, 127.76, 127.40, 126.77, 126.05,125.37, 125.35, 124.41, 117.74, 51.55, 46.97, 46.28, 29.87, 25.24; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 15.0 min, <i>m</i>/<i>z</i> 332.1 [M + H]<sup>+</sup> (95%); white powder, 140 mg, 63.1%.</div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(Quinoline-4-carboxamido)acetic Acid (<b>28</b>)</h3><div class="NLM_p last"><i>Ethyl 2-(Quinoline-4-carboxamido)acetate</i>. To a solution of quinoline-4-carbonyl chloride hydrochloride (5 g, 21.9 mmol) in DCM were added a solution of ethyl 2-aminoacetate hydrochloride (3.06 g, 21.92 mmol) and triethylamine (9.72 mL, 70.2 mmol) in DCM. The mixture was stirred for 4 h at room temperature. It was washed with 1 N citric acid. The precipitate that formed was the product (5.66 g, 90%). UPLC I (ESI) <i>t</i><sub>R</sub> 1.20 min, <i>m</i>/<i>z</i> 259.6 [M + H]<sup>+</sup> (96%). Then sodium hydroxide (21.30 mL, 21.30 mmol) was added to a mixture of ethyl 2-(quinoline-4-carboxamido)acetate (5.5 g, 21.30 mmol) in MeOH (10 mL) and water (10.00 mL). The mixture was stirred for 16 h, evaporated, redissolved in water, washed with DCM, acidified, and the precipitate was 2-(quinoline-4-carboxamido)acetic acid: white powder, 4g, 82%. <sup>1</sup>H NMR (sodium salt) (400 MHz, D<sub>2</sub>O) δ 8.94 (d, <i>J</i> = 4.5 Hz, 1H), 8.23 (d, <i>J</i> = 7.9 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 7.90 (t, <i>J</i> = 7.1 Hz, 1H), 7.75 (t, <i>J</i> = 7.2 Hz, 1H), 7.71 (d, <i>J</i> = 4.5 Hz, 1H), 4.07 (s, 2H).</div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)isonicotinamide (<b>29</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.63 (d, <i>J</i> = 6 Hz, 2H), 7.99 (br s, 1H), 7.61 (d, <i>J</i> = 6 Hz, 2H), 4.76–4.72 (m, 1H), 4.53–4.46 (m, 1H), 4.12–4.05 (m, 1H), 3.74–3.66 (m, 1H), 3.54–3.45 (m, 1H), 2.36–2.13 (m, 4H); MS (ESI) <i>m</i>/<i>z</i> 259.1 [M + H]<sup>+</sup>; LC–MS (A) <i>t</i><sub>R</sub> 3.7 min, <i>m</i>/<i>z</i> 259.1 [M + H]<sup>+</sup> (96%); yellowish oil, 24 mg, 16%.</div></div><div id="sec5_7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-2-Chloro-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)isonicotinamide (<b>30</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure F. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of cis/trans amide rotamers, 1/9) δ 8.51 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 7.72 (dd, <i>J</i> = 1.5, 0.7 Hz, 1H), 7.57 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.44 (s, 1H), 4.81–4.75 (m, 0.9H), 4.68 (d, <i>J</i> = 5.7 Hz, 0.1H), 4.44 (dd, <i>J</i> = 17.6, 5.0 Hz, 0.1H), 4.35 (dd, <i>J</i> = 17.9, 5.0 Hz, 0.9H), 4.30–4.22 (m, 0.1H), 4.16 (dd, <i>J</i> = 17.9, 3.7 Hz, 0.9H), 3.74–3.66 (m, 1H), 3.55–3.46 (m, 1H), 2.42–2.14 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.20 min, 293.3 <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (96%); white powder, 53 mg, 57%)</div></div><div id="sec5_7_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>S</i>)-2-Bromo-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)isonicotinamide (<b>31</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of cis/trans amide rotamers, 1/9) δ 8.50 (dd, <i>J</i> = 5.1, 0.6 Hz, 1H), 7.88 (dd, <i>J</i> = 1.4, 0.7 Hz, 1H), 7.62 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.36 (s, 1H), 4.80–4.76 (m, 0.9H), 4.68 (d, <i>J</i> = 6.2 Hz, 0.1H), 4.43 (dd, <i>J</i> = 17.6, 5.2 Hz, 0.1H), 4.33 (dd, <i>J</i> = 17.9, 4.8 Hz, 0.9H), 4.29–4.23 (m, 0.1H), 4.17 (dd, <i>J</i> = 17.9, 3.7 Hz, 0.9H), 3.73–3.65 (m, 1H), 3.58–3.45 (m, 1H), 2.42–2.17 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.23 min, <i>m</i>/<i>z</i> 337.5, 339.6 [M + H]<sup>+</sup> (96%); colorless oil, 36 mg, 41%.</div></div><div id="sec5_7_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>)-2-Amino-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)isonicotinamide (<b>32</b>)</h3><div class="NLM_p last">(<i>S</i>)-<i>tert</i>-Butyl 4-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylcarbamoyl)pyridin-2-ylcarbamate was prepared using general procedure A using potassium 2-(<i>tert</i>-butoxycarbonylamino)isonicotinate to give a Boc-protected intermediate. Then TFA (0.827 mL, 10.74 mmol) was slowly added to a solution of (<i>S</i>)-<i>tert</i>-butyl 4-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylcarbamoyl)pyridin-2-ylcarbamate (0.537 mmol) in acetonitrile (2 mL) at 0 °C. After 1 h, the mixture was allowed to warm to room temperature and was stirred for 24 h. The volatiles were evaporated. The products were purified by reversed phase flash column using a acetonitrile–water gradient or converted into the HCl salt by stirring for 15 min in 1 N HCl in ether, followed by decantation of the ether and washing with cold ethyl acetate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (9/1 mixture of trans/cis amide rotamers) δ 9.13 (t, <i>J</i> = 5.87 Hz, 1H), 8.06 (d, <i>J</i> = 6.40 Hz, 1H), 7.95 (s, 2H), 7.26 (s, 1H), 7.10 (dd, <i>J</i> = 1.56, 6.44 Hz, 1H), 5.24 (dd, <i>J</i> = 2.26, 7.39 Hz, 0.1H) 4.76 (dd, <i>J</i> = 3.74, 7.38 Hz, 0.9H), 4.30 (dd, <i>J</i> = 5.74, 16.59 Hz, 0.2H), 4.20–4.02 (m, 1.8H), 3.70 (ddd, <i>J</i> = 3.88, 7.60, 9.51 Hz, 1H), 3.55–3.48 (m, 1H), 2.23–1.96 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.45 min, <i>m</i>/<i>z</i> 274.6 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 2.2 min, <i>m</i>/<i>z</i> 274.0 [M + H]<sup>+</sup> (97%); yellowish oil, 40 mg, 60%.</div></div><div id="sec5_7_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-phenylisonicotinamide (<b>33</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-phenylisonicotinic acid <b>S11</b>. <sup>1</sup>H NMR (400 M Hz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 8.83–8.79 (dd, <i>J</i> = 5.0, 0.9 Hz, 1H), 8.13–8.10 (dd, <i>J</i> = 1.6, 0.9 Hz, 1H), 8.07–8.02 (m, 2H), 7.60–7.56 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 7.53–7.42 (m, 3H), 7.41–7.36 (s, 1H), 4.83–4.77 (dd, <i>J</i> = 8.0, 2.4 Hz, 0.9H), 4.75–4.71 (d, <i>J</i> = 8.3 Hz, 0.1H), 4.53–4.46 (dd, <i>J</i> = 17.6, 5.2 Hz, 0.1H), 4.40–4.31 (dd, <i>J</i> = 18.0, 4.7 Hz, 0.9H), 4.26–4.17 (dd, <i>J</i> = 18.0, 3.7 Hz, 1H), 3.75–3.67 (ddd, <i>J</i> = 14.9, 8.4, 4.0 Hz, 1H), 3.58–3.49 (td, <i>J</i> = 8.6, 7.6, 5.9 Hz, 1H), 2.43–2.15 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.45 min, <i>m</i>/<i>z</i> 335.6 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 1.32min, 335.6 <i>m</i>/<i>z</i> [M + H]<sup>+</sup> (99%); white powder, 0.037 g, 52%.</div></div><div id="sec5_7_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-(3,4-dimethoxyphenyl)isonicotinamide (<b>34</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-(3,4-dimethoxyphenyl)isonicotinic acid <b>S12</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 8.82–8.69 (dd, <i>J</i> = 5.0, 0.9 Hz, 1H), 8.11–8.00 (s, 1H), 7.73–7.66 (d, <i>J</i> = 2.1 Hz, 1H), 7.61–7.57 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 7.52–7.48 (dd, <i>J</i> = 5.1, 1.6 Hz, 1H), 7.40–7.33 (t, <i>J</i> = 3.9 Hz, 1H), 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 4.83–4.76 (dd, <i>J</i> = 8.1, 2.8 Hz, 0.9H), 4.74–4.72 (d, <i>J</i> = 8.1 Hz, 0.1H), 4.52–4.46 (dd, <i>J</i> = 17.3, 5.1 Hz, 0.1H), 4.36 (dd, <i>J</i> = 18.0, 4.7 Hz, 0.9H), 4.21 (dd, <i>J</i> = 18.0, 3.7 Hz, 1H), 4.03–3.99 (s, 3H), 3.97–3.92 (s, 3H), 3.78–3.68 (m, 1H), 3.60–3.50 (m, 1H), 2.42–2.16 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.34 min, <i>m</i>/<i>z</i> 395.5 [M + H]<sup>+</sup> (100%); LC–MS (A) <i>t</i><sub>R</sub> 12.6 min, <i>m</i>/<i>z</i> 395.1 [M + H]<sup>+</sup> (99%); white powder, 36 mg, 43%.</div></div><div id="sec5_7_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>S</i>)-2-(4-Cyanophenyl)-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)isonicotinamide (<b>35</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-(4-cyanophenyl)isonicotinic acid <b>S13</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): (9/1 mixture of trans/cis amide rotamers) δ 8.76 (d, <i>J</i> = 5.0 Hz, 1H), 8.16–8.05 (m, 3H), 7.81–7.72 (m, 3H), 7.61 (dd, <i>J</i> = 5.0, 1.5 Hz, 1H), 4.84–4.74 (m, 0.9H), 4.73–4.71 (dd, <i>J</i> = 9.6, 1.9 Hz, 0.1H), 4.53–4.43 (dd, <i>J</i> = 17.8, 5.7 Hz, 1H), 4.34–4.28 (dd, <i>J</i> = 17.4, 3.6 Hz, 0.1H), 4.23–4.13 (dd, <i>J</i> = 17.8, 3.5 Hz, 0.9H), 3.81–3.70 (m, 1H), 3.58–3.51 (m, 1H), 2.42–2.18 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.44 min, <i>m</i>/<i>z</i> 360.6 [M + H]<sup>+</sup> (100%); LC–MS (A) <i>t</i><sub>R</sub> 13.5 min, <i>m</i>/<i>z</i> 360.0 [M + H]<sup>+</sup> (99%); white powder, 45 mg, 52%.</div></div><div id="sec5_7_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-(pyridin-4-yl)acetamide (<b>36</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.49–8.44 (d, <i>J</i> = 4.5 Hz, <i>J</i>′ = 1.6 Hz, 2H), 7.46–7.41 (d, <i>J</i> = 4.5 Hz, <i>J</i>′ = 1.6 Hz, 2H), 5.05 −5.02 (m, 0.14H), 4.79–4.74 (t, <i>J</i> = 5.4 Hz, 0.86H), 4.26–4.16 (m, 0.2H), 4.12–4.00 (m, 1.8H), 3.73–3.66 (m, 3H), 3.57–3.49 (dt, <i>J</i> = 9.6, 7.6 Hz, 1H), 2.28–2.12 (m, 4H); <sup>13</sup>C NMR (101 MHz, MeOD) δ 172.54, 169.57, 150.0, 147.3, 126.35, 119.51, 47.99, 46.90, 42.90, 42.50, 30.97, 26.12; UPLC I (ESI) <i>t</i><sub>R</sub> 0.28 min, <i>m</i>/<i>z</i> 273.6 [M + H]<sup>+</sup> (97%); LC–MS (A) <i>t</i><sub>R</sub> 1.5 min, <i>m</i>/<i>z</i> 273.0 [M + H]<sup>+</sup> (97%); colorless oil, 72 mg, 66%.</div></div><div id="sec5_7_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)piperidine-4-carboxamide (<b>37</b>)</h3><div class="NLM_p"><i>Step 1<i>.</i> 1-(<i>tert</i>-Butoxycarbonyl)piperidine-4-carboxylic Acid.</i> The piperidine-4-carboxylic acid (1 g, 7.74 mmol) was added to a stirred solution of guanidine hydrochloride (0.111 g, 1.161 mmol) and di-<i>tert</i>-butyl dicarbonate (4.22 g, 19.36 mmol) in EtOH (7 mL) at 35–40 °C. The mixture was stirred overnight. Then the ethanol was evaporated and the residue was dissolved in DCM and filtered to separate the catalyst. The filtrate was evaporated and washed with hexane to yield a white powder (1.5g, 84%). <sup>1</sup>H NMR (400 MHz, MeOD) δ 4.02–3.94 (td, <i>J</i> = 4.0, 1.3 Hz, 2H), 2.96–2.83 (br s, 2H), 2.55–2.43 (tt, <i>J</i> = 11.0, 4.0 Hz, 1H), 1.94–1.83 (dq, <i>J</i> = 13.9, 3.6 Hz, 2H), 1.61–1.47 (m, 2H), 1.52–1.38 (s, 9H); MS (ESI) <i>m</i>/<i>z</i> 230.4 [M + H]<sup>+</sup></div><div class="NLM_p last"><i>Step 2: (<i>S</i>)-t<i>ert</i>-Butyl 4-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethylcarbamoyl)piperidine-1-carboxylate.</i> The title product was prepared using general procedure A using 1-(<i>tert</i>-butoxycarbonyl)piperidine-4-carboxylic acid to give the product (0.1 g, 63%). UPLC I (ESI) <i>t</i><sub>R</sub> 1.47 min, <i>m</i>/<i>z</i> 365.6 [M + H]<sup>+</sup> (90%). Then (<i>S</i>)-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)piperidine-4-carboxamide (<b>40</b>) was made using general procedure B. <sup>1</sup>H NMR (400 MHz, MeOD) (9/1 mixture of trans/cis amide rotamers) δ 5.07–5.03 (m, 0.1H), 4.80–4.72 (dd, <i>J</i> = 6.1, 4.6 Hz, 0.1H), 4.12–3.99 (d, <i>J</i> = 17.1 Hz, 1H), 4.04–3.92 (d, <i>J</i> = 17.1 Hz, 1H), 3.77–3.63 (m, 1H), 3.61–3.48 (dt, <i>J</i> = 9.5, 7.5 Hz, 1H), 3.15–3.09 (t, <i>J</i> = 3.4 Hz, 1H), 3.12–3.06 (t, <i>J</i> = 3.3 Hz, 1H), 2.73–2.58 (td, <i>J</i> = 12.5, 2.9 Hz, 2H), 2.54–2.39 (tt, <i>J</i> = 11.6, 3.8 Hz, 1H), 2.31–2.19 (m, 2H), 2.22–2.11 (m, 2H), 1.89–1.77 (m, 2H), 1.76–1.58 (m, 2H; <sup>13</sup>C NMR (101 MHz, MeOD) δ 178.10, 169.80, 119.55, 47.9, 46.90, 46.11, 43.66, 42.70, 42.48, 30.97, 29.85, 26.13, 23.76; UPLC I (ESI) <i>t</i><sub>R</sub> 0.26 min, <i>m</i>/<i>z</i> 265.5 [M + H]<sup>+</sup> (98%); yellowish oil, 40 mg, 70%.</div></div><div id="sec5_7_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)pyridazine-4-carboxamide (<b>38</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure F. Major conformer (4:1 mixture of trans/cis amide rotamers), <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.51 (dd, <i>J</i> = 1.24, 2.31 Hz, 1H), 9.24 (dd, <i>J</i> = 1.24, 5.31 Hz, 1H), 8.50 (dd, <i>J</i> = 3.60, 6.74 Hz, 1H), 7.81 (dd, <i>J</i> = 2.33, 5.30 Hz, 1H), 4.72 (dd, <i>J</i> = 3.04, 7.21 Hz, 1H), 4.54 (dd, <i>J</i> = 6.78, 17.41 Hz, 1H), 4.10 (dd, <i>J</i> = 3.62, 17.41 Hz, 1H), 3.71 (ddd, <i>J</i> = 3.41, 7.40, 10.39 Hz, 1H), 3.58–3.47 (m, 1H), 2.48–2.05 (m, 4H); minor conformer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.56 (dd, <i>J</i> = 1.26, 2.38 Hz, 1H), 9.34 (dd, <i>J</i> = 1.25, 5.28 Hz, 1H), 8.05 (t, <i>J</i> = 4.70 Hz, 1H), 7.87 (dd, <i>J</i> = 2.36, 5.28 Hz, 1H), 4.85 (dd, <i>J</i> = 2.12, 7.69 Hz, 1H), 4.47 (dd, <i>J</i> = 5.30, 17.11 Hz, 1H), 4.29 (dd, <i>J</i> = 4.40, 17.09 Hz, 1H), 3.71 (ddd, <i>J</i> = 3.41, 7.40, 10.39 Hz, 1H), 3.58–3.47 (m, 1H), 2.48–2.05 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.07, 163.44, 151.93, 148.47, 130.64, 123.93, 118.16, 46.98, 45.97, 42.34, 29.82, 25.22; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 5.0 min, <i>m</i>/<i>z</i> 259.9 [M + H]<sup>+</sup> (96%); white crystals, 134 mg, 65%.</div></div><div id="sec5_7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-1-methyl-1<i>H</i>-imidazole-5-carboxamide (<b>39</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 7.57–7.51 (s, 1H), 7.51–7.44 (s, 1H), 7.08–7.02 (d, <i>J</i> = 5.6 Hz, 1H), 4.81–4.75 (m, 0.9H), 4.72–4.68 (dd, <i>J</i> = 7.8, 1.9 Hz, 0.1H), 4.43–4.34 (dd, <i>J</i> = 17.3, 5.2 Hz, 0.1H), 4.33–4.24 (dd, <i>J</i> = 17.7, 5.2 Hz, 0.9H), 4.23–4.15 (m, 0.1H), 4.13–4.05 (dd, <i>J</i> = 17.7, 3.9 Hz, 0.9H), 3.97–3.84 (s, 3H), 3.71–3.64 (ddd, <i>J</i> = 9.4, 7.0, 3.0 Hz, 1H), 3.54–3.44 (td, <i>J</i> = 9.0, 8.4, 6.3 Hz, 1H), 2.40–2.12 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.29 min, <i>m</i>/<i>z</i> 262.6 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 1.5 min, <i>m</i>/<i>z</i> 262.0 [M + H]<sup>+</sup> (97%); colorless oil, 46 mg, 38%.</div></div><div id="sec5_7_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-1<i>H</i>-1,2,3-triazole-5-carboxamide (<b>40</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (9/1 mixture of trans/cis amide rotamers) δ 15.53 (s, 1H), 8.58–8.44 (s, 1H), 8.39 (s, 1H), 5.28–5.22 (m, 0.1H), 4.77 (dd, <i>J</i> = 3.76, 7.32 Hz, 1H), 4.30 (dd, <i>J</i> = 5.61, 16.77 Hz, 0.2H), 4.10 (d, <i>J</i> = 5.76 Hz, 2H), 3.68 (ddd, <i>J</i> = 4.04, 7.68, 9.39 Hz, 1H), 3.50 (td, <i>J</i> = 6.84, 9.09 Hz, 1H), 2.31–1.88 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.72 min, <i>m</i>/<i>z</i> 249.6 [M + H]<sup>+</sup> (96%); LC–MS (A) <i>t</i><sub>R</sub> 4.0 min, <i>m</i>/<i>z</i> 249.0 [M + H]<sup>+</sup> (96%); colorless oil, 34 mg, 40%.</div></div><div id="sec5_7_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-1<i>H</i>-1,2,4-triazole-3-carboxamide (<b>41</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) (9/1 mixture of trans/cis amide rotamers) δ 8.56 (s, 1H), 5.12 (dd, <i>J</i> = 2.05, 7.76 Hz, 0.1H), 4.85–4.81 (m, 0.9H), 4.43 (d, <i>J</i> = 2.63 Hz, 0.2H), 4.32 (s, 2H), 3.79 (ddd, <i>J</i> = 4.53, 7.02, 9.82 Hz, 1H), 3.63 (dt, <i>J</i> = 7.65, 9.63 Hz, 1H), 2.48–2.10 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.77 min, <i>m</i>/<i>z</i> 271.5 [M + Na]<sup>+</sup> (97%); LC–MS (A) <i>t</i><sub>R</sub> 2.8 min, <i>m</i>/<i>z</i> 249.0 [M + H]<sup>+</sup> (97%); yellowish oil, 90 mg, 55%.</div></div><div id="sec5_7_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-(1<i>H</i>-imidazol-4-yl)acetamide (<b>42</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, MeOD) δ 7.68–7.63 (s, 1H), 7.05–6.99 (s, 1H), 4.78–4.73 (t, <i>J</i> = 5.3 Hz, 1H), 4.10–3.98 (m, 2H), 3.71–3.64 (ddd, <i>J</i> = 9.7, 6.4, 4.7 Hz, 1H), 3.63–3.58 (s, 2H), 3.56–3.47 (dt, <i>J</i> = 9.5, 7.5 Hz, 1H), 2.36–2.06 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 0.29 min, <i>m</i>/<i>z</i> 262.6 [M + H]<sup>+</sup> (99%); LC–MS (A) <i>t</i><sub>R</sub> 1.2 min, <i>m</i>/<i>z</i> 262.0 [M + H]<sup>+</sup> (96%); yellowish oil, 72 mg, 66%.</div></div><div id="sec5_7_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-4-methylthiazole-5-carboxamide (<b>43</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 8.71–8.67 (s, 1H), 7.13–7.04 (d, <i>J</i> = 7.3 Hz, 1H), 4.79–4.74 (d, <i>J</i> = 7.7 Hz, 0.9H), 4.74–4.71 (d, <i>J</i> = 7.7 Hz, 0.1H), 4.47–4.40 (dd, <i>J</i> = 17.4, 5.1 Hz, 0.1H), 4.38–4.27 (dd, <i>J</i> = 17.8, 5.1 Hz, 0.9H), 4.26–4.18 (dd, <i>J</i> = 17.4, 3.5 Hz, 0.1H), 4.16–4.05 (dd, <i>J</i> = 18.0, 3.4 Hz, 0.9H), 3.71–3.64 (ddd, <i>J</i> = 9.3, 7.2, 3.3 Hz, 1H), 3.54–3.44 (m, 1H), 2.76–2.73 (s, 3H), 2.38–2.14 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.08 min, <i>m</i>/<i>z</i> 279.6 [M + H]<sup>+</sup> (100%); LC–MS (A) <i>t</i><sub>R</sub> 9.3 min, <i>m</i>/<i>z</i> 279.0 [M + H]<sup>+</sup> (99%); whitish powder, 57 mg, 39%.</div></div><div id="sec5_7_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-4-methyloxazole-5-carboxamide (<b>44</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 7.83–7.75 (s, 1H), 7.19–7.12 (s, 1H), 4.83–4.76 (dd, <i>J</i> = 8.0, 2.6 Hz, 0.9H), 4.83–4.74 (d, 8.0 Hz, 0.1H), 4.46–4.39 (dd, <i>J</i> = 17.3, 5.6 Hz, 0.1H), 4.31–4.22 (dd, <i>J</i> = 17.9, 4.9 Hz, 0.9H), 4.22–4.17 (m, 0.1H), 4.16–4.09 (dd, <i>J</i> = 17.9, 4.0 Hz, 0.9H), 3.72–3.64 (ddd, <i>J</i> = 9.5, 7.1, 2.8 Hz, 1H), 3.56–3.43 (m, 1H), 2.58–2.45 (s, 3H), 2.40–2.18 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.04 min, <i>m</i>/<i>z</i> 263.4 [M + H]<sup>+</sup> (96%); whitish powder, 34 mg, 36%.</div></div><div id="sec5_7_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-4-(2,2,2-trifluoroacetamido)benzamide (<b>46</b>) and (<i>S</i>)-4-Amino-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)benzamide 2,2,2-Trifluoroacetate (<b>45</b>)</h3><div class="NLM_p last">TFA (0.228 mL, 2.95 mmol) was added to a solution of (<i>S</i>)-<i>tert</i>-butyl 4-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethylcarbamoyl)phenylcarbamate <b>S22</b> (0.055 g, 0.148 mmol) in acetonitrile (2 mL) at 0 °C. The mixture was allowed to warm to room temperature slowly and was stirred for 24 h. The volatiles were evaporated and the products were purified by reversed phase flash column using a acetonitrile–water gradient to yield (<i>S</i>)-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)-4-(2,2,2-trifluoroacetamido)benzamide (whitish crystals, 0.02 g, 0.054 mmol, 36% yield) and (<i>S</i>)-4-amino-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)benzamide 2,2,2-trifluoroacetate (colorless oil, 0.03 g, 0.078 mmol, 52% yield).</div></div><div id="sec5_7_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-4-(2,2,2-trifluoroacetamido)benzamide (<b>45</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (t, <i>J</i> = 5.9 Hz, 1H), 7.59 (d, <i>J</i> = 8.6 Hz, 2H), 6.55 (d, <i>J</i> = 8.6 Hz, 2H), 5.64 (s, 2H), 4.75 (dd, <i>J</i> = 7.3, 3.7 Hz, 1H), 4.07 (dd, <i>J</i> = 16.8, 5.6 Hz, 1H), 3.98 (dd, <i>J</i> = 16.8, 5.5 Hz, 1H), 3.72–3.64 (m, 1H), 3.54–3.44 (m, 1H), 2.22–1.95 (m, 4H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 6.5 min, <i>m</i>/<i>z</i> 273.0 [M + H]<sup>+</sup> (97%).</div></div><div id="sec5_7_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>S</i>)-4-Amino-<i>N</i>-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)benzamide 2,2,2-Trifluoroacetate (<b>46</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of cis/trans amide rotamers, 1/5) δ 8.09 (s, 1H), 7.87 (d, <i>J</i> = 8.7 Hz, 2H), 7.64 (d, <i>J</i> = 8.7 Hz, 2H), 7.27 (s, 1H), 4.81–4.75 (m, 0.8H), 4.76–4.72 (m, 0.2H), 4.52–4.43 (m, 0.2H), 4.35 (dd, <i>J</i> = 17.9, 5.0 Hz, 0.8H), 4.27–4.21 (m, 0.2H), 4.16 (dd, <i>J</i> = 17.9, 3.7 Hz, 0.8H), 3.76–3.66 (m, 1H), 3.55–3.47 (m, 1H), 2.41–2.18 (m, 4H); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 12.4 min, <i>m</i>/<i>z</i> 369.0 [M + H]<sup>+</sup> (97%).</div></div><div id="sec5_7_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-carboxamide (<b>47</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (9/1 mixture of trans/cis amide rotamers) δ 11.88 (s, 1H), 8.68 (t, <i>J</i> = 5.69 Hz, 1H), 8.33 (d, <i>J</i> = 4.91 Hz, 1H), 7.61 (dd, <i>J</i> = 2.51, 3.44 Hz, 1H), 7.42 (d, <i>J</i> = 4.92 Hz, 1H), 6.86 (dd, <i>J</i> = 1.86, 3.43 Hz, 1H), 5.29 (d, <i>J</i> = 7.22 Hz, 0.1H), 4.80 (dd, <i>J</i> = 3.62, 7.39 Hz, 0.9H), 4.38 (dd, <i>J</i> = 5.71, 16.63 Hz, 0.1H), 4.22 (dd, <i>J</i> = 6.09, 16.95 Hz, 0.9H), 4.14 (dd, <i>J</i> = 5.47, 16.93 Hz, 1H), 3.73 (ddd, <i>J</i> = 3.72, 7.57, 9.60 Hz, 1H), 3.54 (td, <i>J</i> = 6.79, 8.95 Hz, 1H), 2.34–2.01 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.08 min, <i>m</i>/<i>z</i> 298.6 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 9.2 min, <i>m</i>/<i>z</i> 298.0 [M + H]<sup>+</sup> (97%); colorless oil, 50 mg, 35%.</div></div><div id="sec5_7_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-(4-fluorophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-7-carboxamide (<b>48</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-(4-fluorophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-7-carboxylic acid <b>S26</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (9/1 mixture of trans/cis amide rotamers) δ 14.02 (s, 1H), 10.09 (s, 1H), 8.55–8.41 (m, 3H), 7.75 (d, <i>J</i> = 5.13 Hz, 1H), 7.49 (t, <i>J</i> = 8.60 Hz, 2H), 5.29 (dd, <i>J</i> = 2.78, 7.47 Hz, 0.1H), 4.88 (dd, <i>J</i> = 3.96, 6.56 Hz, 0.9H), 4.56 (d, <i>J</i> = 4.53 Hz, 0.1H), 4.45 (dd, <i>J</i> = 5.16, 17.77 Hz, 0.9H), 4.36 (dd, <i>J</i> = 4.92, 17.84 Hz, 1H), 3.79–3.69 (m, 1H), 3.55 (q, <i>J</i> = 8.30 Hz, 1H), 2.36–1.94 (m, 4H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.34, 166.85, 163.21, 162.70, 152.85, 144.21, 129.72, 129.63, 127.99, 125.40, 119.28, 116.58, 116.42, 116.21, 46.36, 45.35, 42.40, 29.57, 24.80; UPLC I (ESI) <i>t</i><sub>R</sub> 1.52 min, <i>m</i>/<i>z</i> 393.5 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 14.7 min, <i>m</i>/<i>z</i> 393.0 [M + H]<sup>+</sup> (97%); white powder, 53 mg, 58%.</div></div><div id="sec5_7_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-2-(4-methoxyphenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-7-carboxamide (<b>49</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-(4-fluorophenyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-7-carboxylic acid <b>S28</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (9/1 mixture of trans/cis amide rotamers) δ 10.15 (s, 1H), 8.44 (d, <i>J</i> = 5.02 Hz, 1H), 8.37 (d, <i>J</i> = 8.74 Hz, 2H), 7.72 (d, <i>J</i> = 4.99 Hz, 1H), 7.17 (d, <i>J</i> = 8.78 Hz, 2H), 5.32–5.26 (m, 0.1H), 4.89 (dd, <i>J</i> = 4.13, 6.70 Hz, 0.9H), 4.58 (dd, <i>J</i> = 4.45, 17.77 Hz, 0.1H), 4.45 (dd, <i>J</i> = 4.92, 17.95 Hz, 0.9H), 4.36 (dd, <i>J</i> = 4.78, 17.81 Hz, 1H), 3.88 (s, 3H), 3.74 (ddd, <i>J</i> = 3.71, 7.64, 11.08 Hz, 1H), 3.55 (td, <i>J</i> = 6.92, 9.11 Hz, 1H), 2.23–1.96 (m, 4H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.68, 166.32, 162.77, 161.25, 153.30, 149.94, 142.98, 132.23, 128.45, 120.49, 118.63, 115.75, 114.05, 54.98, 45.82, 44.80, 41.88, 29.03, 24.26; UPLC I (ESI) <i>t</i><sub>R</sub> 1.50 min, <i>m</i>/<i>z</i> 405.6 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 14.6 min, <i>m</i>/<i>z</i> 405.0 [M + H]<sup>+</sup> (97%); white powder, 67 mg, 75%.</div></div><div id="sec5_7_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)[1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-7-carboxamide (<b>50</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.59 (d, <i>J</i> = 6.96 Hz, 1H), 9.28 (s, 1H), 8.86 (s, 1H), 7.87 (d, <i>J</i> = 6.95 Hz, 1H), 4.79 (dd, <i>J</i> = 3.72, 7.35 Hz, 1H), 4.18 (d, <i>J</i> = 5.11 Hz, 2H), 3.76–3.67 (m, 1H), 3.52 (q, <i>J</i> = 8.33 Hz, 1H), 2.36–1.97 (m, 4H); UPLC I (ESI) <i>t</i><sub>R</sub> 1.02 min, <i>m</i>/<i>z</i> 300.6 [M + H]<sup>+</sup> (96%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 9.0 min, <i>m</i>/<i>z</i> 300.0 [M + H]<sup>+</sup> (97%); white powder, 54 mg, 57%.</div></div><div id="sec5_7_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-1,7-naphthyridine-4-carboxamide (<b>51</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 1,7-naphthyridine-4-carboxylic acid <b>S23</b>. A 5:1 mixture of trans/cis amide rotamers, major rotamer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.44 (d, <i>J</i> = 1.02 Hz, 1H), 8.97 (d, <i>J</i> = 4.29 Hz, 1H), 8.59 (d, <i>J</i> = 5.90 Hz, 1H), 8.12 (dd, <i>J</i> = 0.98, 5.86 Hz, 1H), 7.72 (d, <i>J</i> = 4.34 Hz, 1H), 7.64–7.57 (m, 1H), 4.76–4.69 (m, 1H), 4.41 (dd, <i>J</i> = 5.58, 17.60 Hz, 1H), 4.19 (dd, <i>J</i> = 4.00, 17.59 Hz, 1H), 3.69 (ddd, <i>J</i> = 3.37, 6.58, 11.84 Hz, 1H), 3.58–3.46 (m, 1H), 2.39–2.07 (m, 4H); minor rotamer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.48 (d, <i>J</i> = 0.94 Hz, 1H), 9.02 (d, <i>J</i> = 4.29 Hz, 1H), 8.61 (d, <i>J</i> = 4.26 Hz, 1H), 8.10 (d, 5.86 Hz, 1H), 7.70 (d, <i>J</i> = 4.12 Hz, 1H), 7.44 (t, <i>J</i> = 4.78 Hz, 1H), 4.79 (dd, <i>J</i> = 2.04, 7.77 Hz, 1H), 4.54 (dd, <i>J</i> = 5.44, 17.23 Hz, 1H), 4.29 (dd, <i>J</i> = 3.98, 17.27 Hz, 1H), 3.69 (ddd, <i>J</i> = 3.37, 6.58, 11.84 Hz, 1H), 3.58–3.46 (m, 1H), 2.39–2.07 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.24, 166.00, 154.45, 151.46, 144.79, 143.45, 139.40, 127.89, 122.74, 118.00, 117.76, 46.82, 45.79, 42.45, 29.91, 25.16; UPLC I (ESI) <i>t</i><sub>R</sub> 1.03 min, <i>m</i>/<i>z</i> 310.7 [M + H]<sup>+</sup> (96%); LC–MS (A) <i>t</i><sub>R</sub> 9.0 min, <i>m</i>/<i>z</i> 309.9 [M + H]<sup>+</sup> (96%); white powder, 58 mg, 57%.</div></div><div id="sec5_7_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-7-methylquinoline-4-carboxamide (<b>52</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A, using 7-methylquinoline-4-carboxylic acid <b>S31</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.89 (d, <i>J</i> = 4.36 Hz, 1H), 8.17 (d, <i>J</i> = 8.64 Hz, 1H), 7.92–7.88 (m, 1H), 7.47–7.41 (m, 2H), 7.16 (t, <i>J</i> = 4.64 Hz, 1H), 4.79–4.73 (m, 1H), 4.58 (dd, <i>J</i> = 5.36, 17.37 Hz, 0.1H), 4.40 (dd, <i>J</i> = 5.05, 17.76 Hz, 0.9H), 4.31 (dd, <i>J</i> = 3.70, 17.23 Hz, 0.1H), 4.24 (dd, <i>J</i> = 3.98, 17.77 Hz, 0.9H), 3.70 (ddd, <i>J</i> = 2.85, 6.84, 10.97 Hz, 1H), 3.58–3.49 (m, 1H), 2.57 (s, 3H), 2.39–2.17 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.66, 167.14, 149.91, 149.10, 140.66, 140.60, 130.21, 128.98, 124.96, 122.52, 118.18, 117.96, 46.81, 45.75, 42.56, 30.03, 25.20, 21.93; UPLC I (ESI) <i>t</i><sub>R</sub> 1.14 min, <i>m</i>/<i>z</i> 323.5 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 10.1 min, <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup> (97%); white powder, 55 mg, 56%.</div></div><div id="sec5_7_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-5-methylquinoline-4-carboxamide (<b>53</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 5-methylquinoline-4-carboxylic acid <b>S30</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93–8.84 (m, 1H), 8.04–7.96 (m, 1H), 7.62 (dd, <i>J</i> = 7.06, 8.49 Hz, 1H), 7.38 (dt, <i>J</i> = 1.20, 7.04 Hz, 1H), 7.35 (d, <i>J</i> = 4.24 Hz, 1H), 7.06 (t, <i>J</i> = 4.50 Hz, 1H), 4.75 (dd, <i>J</i> = 1.99, 7.79 Hz, 0.1H), 4.72–4.67 (m, 0.9H), 4.56 (dd, <i>J</i> = 5.53, 17.38 Hz, 0.1H), 4.37 (dd, <i>J</i> = 4.95, 17.82 Hz, 0.9H), 4.32 (dd, <i>J</i> = 5.53, 17.38 Hz, 0.1H), 4.23 (dd, <i>J</i> = 3.95, 17.81 Hz, 0.9H), 3.70 (ddd, <i>J</i> = 2.77, 7.09, 11.25 Hz, 1H), 3.52 (dt, <i>J</i> = 7.63, 10.69 Hz, 1H), 2.65 (s, 3H), 2.42–2.09 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.38, 166.83, 149.68, 149.13, 141.90, 134.49, 130.19, 129.73, 128.76, 123.43, 119.96, 117.89, 46.78, 45.74, 42.61, 30.05, 25.19, 21.31; UPLC I (ESI) <i>t</i><sub>R</sub> 1.07 min, <i>m</i>/<i>z</i> 323.5 [M + H]<sup>+</sup> (99%); LC–MS (A) <i>t</i><sub>R</sub> 10.0 min, <i>m</i>/<i>z</i> 323.1 [M + H]<sup>+</sup> (98%); white powder, 72 mg, 47%.</div></div><div id="sec5_7_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-7-phenylquinoline-4-carboxamide (<b>54</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 7-phenylquinoline-4-carboxylic acid <b>S24</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (d, <i>J</i> = 4.35 Hz, 1H), 8.38–8.33 (m, 2H), 7.89 (dd, <i>J</i> = 2.01, 8.66 Hz, 1H), 7.79–7.71 (m, 2H), 7.55–7.46 (m, 3H), 7.47–7.37 (m, 1H), 7.22 (t, <i>J</i> = 4.58 Hz, 1H), 7.12 (t, <i>J</i> = 4.28 Hz, 0.1H), 4.77 (dd, <i>J</i> = 2.41, 7.67 Hz, 1H), 4.60 (dd, <i>J</i> = 5.54, 17.33 Hz, 0.1H), 4.43 (dd, <i>J</i> = 5.07, 17.75 Hz, 0.9H), 4.34 (dd, <i>J</i> = 3.51, 17.28 Hz, 0.1H), 4.26 (dd, <i>J</i> = 4.02, 17.77 Hz, 0.9H), 3.72 (ddd, <i>J</i> = 2.95, 7.09, 9.42 Hz, 1H), 3.59–3.50 (m, 1H), 2.51–2.12 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.35, 166.97, 150.32, 149.12, 142.68, 140.57, 139.78, 129.07, 128.16, 127.50, 127.47, 127.39, 125.73, 123.49, 118.69, 117.83, 46.72, 45.65, 42.48, 29.94, 25.10; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 14.6 min, <i>m</i>/<i>z</i> 385.1 [M + H]<sup>+</sup> (95%); white powder, 86 mg, 74%.</div></div><div id="sec5_7_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-7-(phenylamino)quinoline-4-carboxamide (<b>55</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 7-(phenylamino)quinoline-4-carboxylic acid <b>S25</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (d, <i>J</i> = 4.43 Hz, 1H), 8.07 (d, <i>J</i> = 9.10 Hz, 1H), 7.57 (d, <i>J</i> = 2.39 Hz, 1H), 7.42 (t, <i>J</i> = 4.78 Hz, 1H), 7.33–7.27 (m, 2H), 7.20 (ddd, <i>J</i> = 1.60, 2.58, 8.15 Hz, 4H), 7.02 (tt, <i>J</i> = 1.21, 7.35 Hz, 1H), 6.53 (s, 1H), 4.75 (dd, <i>J</i> = 1.94, 7.81 Hz, 0.1H), 4.72–4.66 (m, 0.9H), 4.50 (dd, <i>J</i> = 5.62, 17.21 Hz, 0.1H), 4.33 (dd, <i>J</i> = 5.36, 17.59 Hz, 0.9H), 4.24 (dd, <i>J</i> = 3.96, 17.21 Hz, 0.1H), 4.13 (dd, <i>J</i> = 4.18, 17.59 Hz, 0.9H), 3.62 (ddd, <i>J</i> = 3.23, 7.04, 9.02 Hz, 1H), 3.44 (td, <i>J</i> = 4.49, 8.52, 9.05 Hz, 1H), 2.32–2.08 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.88, 167.29, 150.41, 150.23, 145.40, 141.28, 140.57, 129.56, 126.41, 122.81, 120.71, 119.91, 119.07, 118.12, 115.97, 110.03, 46.77, 45.72, 42.42, 29.93, 25.16; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 11.8 min, <i>m</i>/<i>z</i> 400.0 [M + H]<sup>+</sup> (98%); white powder, 78 mg, 73%.</div></div><div id="sec5_7_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-5-phenylquinoline-4-carboxamide (<b>56</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 5-phenylquinoline-4-carboxylic acid <b>S32</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of 1:9 cis/trans amide rotamer) major rotamer, δ 8.98 (d, <i>J</i> = 4.21 Hz, 1H), 8.20 (dd, <i>J</i> = 1.30, 8.46 Hz, 1H), 7.80 (dd, <i>J</i> = 7.14, 8.47 Hz, 1H), 7.52 (dd, <i>J</i> = 1.35, 7.16 Hz, 1H), 7.49–7.46 (m, 1H), 7.43 (s, 1H), 7.33 (dd, <i>J</i> = 8.72, 11.73 Hz, 2H), 7.05 (s, 1H), 6.49–6.43 (m, 2H), 4.77–4.71 (m, 1H), 4.43 (dd, <i>J</i> = 4.80, 17.69 Hz, 1H), 4.29 (dd, <i>J</i> = 4.01, 17.76 Hz, 1H), 3.44 (ddd, <i>J</i> = 3.19, 7.76, 10.27 Hz, 1H), 3.32–3.10 (m, 1H), 2.44–2.10 (m, 4H); mionor rotamer, <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (d, <i>J</i> = 4.26 Hz, 1H), 8.16 (dd, <i>J</i> = 1.24, 8.46 Hz, 1H), 7.60 (dd, <i>J</i> = 7.55, 8.47 Hz, 1H), 7.55 (d, <i>J</i> = 4.33 Hz, 1H), 7.49 (d, <i>J</i> = 4.27 Hz, 1H), 7.43 (s, 1H), 7.33 (dd, <i>J</i> = 8.72, 11.73 Hz, 2H), 6.94 (s, 1H), 6.49–6.43 (m, 2H), 4.79 (d, <i>J</i> = 5.81 Hz, 1H), 4.43 (dd, <i>J</i> = 4.80, 17.69 Hz, 1H), 4.29 (dd, <i>J</i> = 4.01, 17.76 Hz, 1H), 3.76–3.66 (m, 1H), 3.62–3.50 (m, 1H), 2.44–2.10 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.91, 166.54, 149.70, 141.36, 139.43, 133.70, 131.05, 129.81, 129.32, 128.11, 127.02, 122.45, 121.11, 118.86, 117.70, 100.00, 46.55, 45.37, 42.20, 29.98, 24.97; LC–MS (A) (ESI) <i>t</i><sub>R</sub> 13.3 min, <i>m</i>/<i>z</i> 385.1 [M + H]<sup>+</sup> (96%); colorless oil, 52 mg, 84%.</div></div><div id="sec5_7_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (<i>S</i>)-<i>N</i>-(2-(2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-5-methoxyquinoline-4-carboxamide (<b>57</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G, using 5-methoxyquinoline-4-carboxylic acid <b>S33</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9:1 mixture of trans/cis amide rotamers) δ 9.01 (d, <i>J</i> = 5.51 Hz, 1H), 8.70 (dd, <i>J</i> = 0.83, 8.64 Hz, 1H), 8.21 (d, <i>J</i> = 8.64 Hz, 1H), 7.74 (dt, <i>J</i> = 0.92, 8.66 Hz, 1H), 7.66 (dd, <i>J</i> = 7.62, 8.60 Hz, 1H), 6.92 (dd, <i>J</i> = 1.01, 7.73 Hz, 1H), 4.88 (d, <i>J</i> = 6.04 Hz, 0.1H), 4.85–4.81 (m, 0.9H), 4.58 (dd, <i>J</i> = 6.21, 17.03 Hz, 0.1H), 4.42 (dd, <i>J</i> = 5.53, 17.72 Hz, 0.9H), 4.34–4.27 (m, 0.1H), 4.25 (dd, <i>J</i> = 4.34, 17.75 Hz, 0.9H), 4.02 (s, 3H), 3.78–3.68 (m, 1H), 3.63–3.49 (m, 1H), 2.41–2.17 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.50, 164.82, 155.19, 149.17, 147.28, 132.81, 130.53, 122.20, 121.83, 118.15, 118.00, 105.71, 56.01, 46.80, 45.81, 42.34, 30.08, 25.29; UPLC I (ESI) <i>t</i><sub>R</sub> 1.61 min, <i>m</i>/<i>z</i> 339.6 [M + H]<sup>+</sup> (97%); LC–MS (A) <i>t</i><sub>R</sub> 14.0 min, <i>m</i>/<i>z</i> 339.1 [M + H]<sup>+</sup> (97%); white crystals, 63 mg, 64%.</div></div><div id="sec5_7_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-(2-((2<i>S</i>,4<i>S</i>)-2-Cyano-4-fluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>58</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G with 2-(quinoline-4-carboxamido)acetic acid and <b>S16</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (1:9 mixture of cis/trans amide rotamers) δ 8.87 (d, <i>J</i> = 4.45 Hz, 1H), 8.23 (ddd, <i>J</i> = 0.66, 1.36, 8.60 Hz, 1H), 8.13–8.09 (m, 1H), 7.76–7.69 (m, 1H), 7.60–7.54 (m, 1H), 7.48 (d, <i>J</i> = 4.33 Hz, 1H), 7.41–7.35 (m, 1H), 5.43 (dt, <i>J</i> = 3.29, 51.00 Hz, 0.9H), 5.34 (dt, <i>J</i> = 3.38, 51.11 Hz, 0.1H), 5.04 (d, <i>J</i> = 8.96 Hz, 0.1H), 4.92 (d, <i>J</i> = 9.29 Hz, 0.9H), 4.62 (dd, <i>J</i> = 5.79, 17.21 Hz, 0.1H), 4.37 (dd, <i>J</i> = 5.64, 17.48 Hz, 0.9H), 4.29 (dd, <i>J</i> = 4.02, 17.22 Hz, 0.1H), 4.17 (dd, <i>J</i> = 4.19, 17.49 Hz, 0.9H), 3.96 (ddd, <i>J</i> = 1.21, 11.79, 22.38 Hz, 1H), 3.76 (ddd, <i>J</i> = 3.62, 12.05, 36.05 Hz, 1H), 2.66 (t, <i>J</i> = 14.69 Hz, 1H), 2.35 (dddd, <i>J</i> = 3.51, 9.44, 14.83, 40.62 Hz, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.53, 167.30, 149.58, 148.15, 141.17, 130.28, 129.49, 127.94, 125.24, 124.35, 118.90, 117.24, 92.83, 91.03, 52.46, 52.22, 45.09, 42.34, 36.09, 35.88; UPLC I (ESI) <i>t</i><sub>R</sub> 1.11min, <i>m</i>/<i>z</i> 327.6 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 9.5 min, <i>m</i>/<i>z</i> 327.0 [M + H]<sup>+</sup> (98%); white crystals, 95 mg, 60%.</div></div><div id="sec5_7_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>-(2-((2<i>S</i>,4<i>R</i>)-2-Cyano-4-fluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>59</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure G with 2-(quinoline-4-carboxamido)acetic acid and <b>S15</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (1:9 mixture of cis/trans amide rotamers) δ 8.94 (d, <i>J</i> = 4.39 Hz, 1H), 8.31–8.24 (m, 1H), 8.17 (dd, <i>J</i> = 1.16, 8.63 Hz, 1H), 7.77 (ddd, <i>J</i> = 1.41, 6.87, 8.45 Hz, 1H), 7.62 (ddd, <i>J</i> = 1.24, 6.92, 8.32 Hz, 1H), 7.56 (d, <i>J</i> = 4.33 Hz, 1H), 7.35 (s, 0.9H), 7.12 (s, 0.1H), 5.41–5.25 (m, 1H), 4.93 (t, <i>J</i> = 8.15 Hz, 0.1H), 4.80 (dd, <i>J</i> = 7.86, 9.23 Hz, 0.9H), 4.63 (dd, <i>J</i> = 5.23, 17.31 Hz, 0.1H), 4.43 (dd, <i>J</i> = 4.62, 17.54 Hz, 0.9H), 4.28 (dd, <i>J</i> = 4.24, 17.50 Hz, 1H), 3.96 (dd, <i>J</i> = 12.24, 20.03 Hz, 1H), 3.82 (ddd, <i>J</i> = 3.13, 12.30, 34.74 Hz, 0.9H), 3.60 (dd, <i>J</i> = 12.96, 33.60 Hz, 0.1H), 2.91–2.76 (m, 1H), 2.49 (dddd, <i>J</i> = 3.91, 9.27, 14.76, 37.98 Hz, 1H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.44, 167.24, 149.32, 147.91, 141.58, 130.68, 129.38, 128.29, 125.45, 124.60, 119.03, 117.18, 91.70, 89.88, 52.52, 52.29, 45.29, 42.74, 36.63, 36.41. 3; UPLC I (ESI) <i>t</i><sub>R</sub> 1.09min, <i>m</i>/<i>z</i> 327.6 [M + H]<sup>+</sup> (99%); LC–MS (A) <i>t</i><sub>R</sub> 9.1 min, <i>m</i>/<i>z</i> 327.0 [M + H]<sup>+</sup> (98%); white crystals, 86 mg, 63%.</div></div><div id="sec5_7_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>S</i>)-<i>N</i>-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>60</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (8.5/1.5 mixture of trans/cis amide rotamers) δ 8.96–8.86 (m, 1H), 8.23 (t, <i>J</i> = 9.99 Hz, 1H), 8.12 (d, <i>J</i> = 8.42 Hz, 1H), 7.74 (t, <i>J</i> = 7.69 Hz, 1H), 7.60 (dd, <i>J</i> = 11.22, 4.11 Hz, 1H), 7.49 (dd, <i>J</i> = 10.11, 4.30 Hz, 1H), 7.30 (s, 1H), 5.15 (d, <i>J</i> = 9 Hz, 0.15H), 4.99–4.92 (m, 0.85H), 4.70 (dd, <i>J</i> = 17.4, 5.7 Hz, 0.15H), 4.39 (dd, <i>J</i> = 17.4, 5.6 Hz, 0.85H), 4.33 (dd, <i>J</i> = 17.4, 4.3 Hz, 0.15H), 4.21 (dd, <i>J</i> = 17.4, 4.2 Hz, 0.85H), 4.07–3.91 (m, 2H), 2.83–2.72 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.68, 167.40, 149.93, 148.82, 140.67, 130.30, 130.11, 128.08, 125.24, 124.41, 118.93, 116.09, 52.54, 52.22, 51.90, 44.44, 42.42, 37.78, 37.53, 37.28, 31.07; MS (ESI) <i>m</i>/<i>z</i> 345.0 [M + 1]<sup>+</sup>; LC–MS (A) <i>t</i><sub>R</sub> 10.8 min, <i>m</i>/<i>z</i> 345.0 [M + H]<sup>+</sup> (98%); HRMS calcd for C<sub>17</sub>H<sub>15</sub>N<sub>4</sub>O<sub>2</sub>F<sub>2</sub> [M + H]<sup>+</sup>, 345.1163; found, 345.1172; off-white powder, 350 mg, 67%.</div></div><div id="sec5_7_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>S</i>)-<i>N</i>-(2-(2-Cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)-6-methoxyquinoline-4-carboxamide (<b>61</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (9/1 mixture of trans/cis amide rotamers) δ 8.63 (d, <i>J</i> = 4.43 Hz, 1H), 7.90 (d, <i>J</i> = 9.19 Hz, 1H), 7.54 (d, <i>J</i> = 2.75 Hz, 1H), 7.47–7.40 (br s, 1H), 7.35 (d, <i>J</i> = 4.40 Hz, 1H), 7.31 (dd, <i>J</i> = 2.78, 9.24 Hz, 1H), 5.19–5.12 (m, 0.1H), 4.91 (dd, <i>J</i> = 4.58, 8.37 Hz, 0.9H), 4.52 (d, <i>J</i> = 5.77 Hz, 0.1H), 4.30 (dd, <i>J</i> = 5.71, 17.35 Hz, 0.9H), 4.12 (dd, <i>J</i> = 4.73, 17.33 Hz, 1H), 4.08–3.86 (m, 2H), 3.86 (s, 3H), 2.83–2.65 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.18, 167.71, 158.77, 147.05, 144.85, 139.04, 131.13, 127.88, 125.54, 123.14, 119.15, 116.40, 102.85, 55.83,52.05 (t, <i>J</i> = 32.25 Hz), 44.41, 42.20, 37.26 (t, <i>J</i> = 25.29 Hz); UPLC I (ESI) <i>t</i><sub>R</sub> 1.28 min, <i>m</i>/<i>z</i> 375.6 [M + H]<sup>+</sup> (99%); LC–MS (A) (ESI) <i>t</i><sub>R</sub> 11.6 min, <i>m</i>/<i>z</i> 374.9 [M + H]<sup>+</sup> (98%); white powder, 61 mg, 33%.</div></div><div id="sec5_7_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (<i>S</i>)-5-Bromo-<i>N</i>-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>62</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (cis/trans mixture of amide rotamers, 1:9) δ 9.10 (dd, <i>J</i> = 4.46, 6.43 Hz, 0.9H), 8.88 (s, 0.1H), 8.41 (d, <i>J</i> = 8.76 Hz, 1H), 8.05 (d, <i>J</i> = 8.73 Hz, 1H), 7.96 (d, <i>J</i> = 8.55 Hz, 1H), 7.84 (dd, <i>J</i> = 1.06, 7.58 Hz, 1H), 7.55 (dd, <i>J</i> = 7.47, 8.49 Hz, 1H), 5.34 (d, <i>J</i> = 8.83 Hz, 0.1H), 5.03 (dd, <i>J</i> = 5.05, 8.22 Hz, 0.9H), 4.64 (dd, <i>J</i> = 6.13, 17.08 Hz, 0.1H), 4.56 (dd, <i>J</i> = 6.74, 17.53 Hz, 0.9H), 4.30 (dd, <i>J</i> = 4.51, 17.10 Hz, 0.1H), 4.17 (dd, <i>J</i> = 4.17, 17.48 Hz, 0.9H), 4.14–4.05 (m, 1H), 4.04–3.95 (m, 1H), 2.84–2.73 (m, 2H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.40, 164.31, 149.25, 146.80, 136.27, 131.65, 130.18, 129.81, 128.24, 121.69, 119.40, 116.80, 53.55,51.98 (t, 32.1 Hz, 1C), 44.42, 41.96, 37.19 (t, 25.4 Hz, 1C); UPLC I (ESI) <i>t</i><sub>R</sub> 1.83 min, <i>m</i>/<i>z</i> 423.5, 425.3 [M + H]<sup>+</sup> (96%); LC–MS (A) <i>t</i><sub>R</sub> 15.8 min, <i>m</i>/<i>z</i> 265.9, 267.9 (95%); white powder, 89 mg, 54%.</div></div><div id="sec5_7_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (<i>S</i>)-5-Cyano-<i>N</i>-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>63</b>)</h3><div class="NLM_p last">To a round-bottom flask were added (<i>S</i>)-5-bromo-<i>N</i>-((2-cyano-4,4-difluoropyrrolidin-1-yl)methyl)quinoline-4-carboxamide 65 (0.085 g, 0.215 mmol), zinc cyanide (0.015 g, 0.129 mmol) (caution, highly toxic), 10% palladium on carbon (0.023 g, 0.022 mmol), 1,1′-bis(diphenylphosphino)ferrocene (4.82 mg, 8.60 μmol), and DMAC (volume, 2 mL). The resulting slurry was sparged with subsurface nitrogen for 10 min, and zinc(II) formate dihydrate (6.2 mg, 0.032 mmol) was added to the reaction mixture. The reaction mixture was again sparged with subsurface nitrogen for 10 min and was heated under nitrogen to 110 °C for 2 h. The reaction mixture was diluted with 10 mL of EtOAc. The resulting slurry was filtered, and the cake was rinsed with EtOAc (2 mL). The product was isolated by washing the filtrate with water (2 × 10 mL) and 5% NH<sub>4</sub>OH (1 × 10 mL). The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>. The volatile was removed in vacuo to give a residue, which was further purified by silica gel chromatography (heptanes/EtOAc) to provide the product (white powder, 40 mg, 50%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (t, <i>J</i> = 5.73 Hz, 1H), 8.73 (d, <i>J</i> = 8.75 Hz, 1H), 8.49 (d, <i>J</i> = 8.53 Hz, 1H), 8.44–8.37 (m, 2H), 8.05 (dd, <i>J</i> = 7.08, 8.62 Hz, 1H), 5.13 (dd, <i>J</i> = 2.65, 9.28 Hz, 1H), 4.37–4.27 (m, 1H), 4.27 (d, <i>J</i> = 5.92 Hz, 2H), 4.14 (dt, <i>J</i> = 10.32, 21.10 Hz, 1H), 3.00–2.73 (m, 2H); UPLC II (ESI) <i>t</i><sub>R</sub> 3.24 min, <i>m</i>/<i>z</i> 370.6 [M + H]<sup>+</sup> (95%).</div></div><div id="sec5_7_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>-(2-Oxo-2-(pyrrolidin-1-yl)ethyl)quinoline-4-carboxamide (<b>64</b>)</h3><div class="NLM_p last">The title product was prepared using general procedure A using 2-amino-1-(pyrrolidin-1-yl)ethanone hydrochloride S34. The product was purified using column chromatography with a DCM-MeOH gradient, followed by recrystallization from methanol. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 4.30 Hz, 1H), 8.92 (t, <i>J</i> = 5.90 Hz, 1H), 8.41 (d, 8.16 Hz, 1H), 8.09 (d, <i>J</i> = 8.32 Hz, 1H), 7.82 (ddd, <i>J</i> = 1.45, 6.88, 8.44 Hz, 1H), 7.68 (ddd, <i>J</i> = 1.31, 6.84, 8.25 Hz, 1H), 7.55 (d, <i>J</i> = 4.27 Hz, 1H), 4.17–4.07 (m, 2H), 3.51 (t, <i>J</i> = 6.75 Hz, 2H), 3.37 (t, <i>J</i> = 6.89 Hz, 2H), 1.94 (h, <i>J</i> = 6.12, 6.65 Hz, 2H), 1.87–1.75 (m, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.55, 166.67, 150.69, 148.38, 142.83, 130.28, 129.66, 127.63, 126.45, 124.74, 119.44, 46.16, 45.46, 42.13, 26.16, 24.22; UPLC I (ESI) <i>t</i><sub>R</sub> 1.11min, <i>m</i>/<i>z</i> 284.7 [M + H]<sup>+</sup> (98%); LC–MS (A) <i>t</i><sub>R</sub> 7.8 min, <i>m</i>/<i>z</i> 284.1 [M + H]<sup>+</sup> (98%); white powder, 0.187 g, 73%.</div></div><div id="sec5_7_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(2-Oxo-2-((2<i>R</i>)-2-((3a<i>S</i>,7a<i>R</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)pyrrolidin-1-yl)ethyl)quinoline-4-carboxamide (<b>65</b>)</h3><div class="NLM_p last">(2<i>R</i>)-2-((3a<i>S</i>,7a<i>R</i>)-3a,5,5-Trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)pyrrolidine hydrochloride<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (0.190 g, 0.665 mmol) was added to a mixture of 2-(quinoline-4-carboxamido)acetic acid (0.153 g, 0.665 mmol), HATU (0,253 g, 0,665 mmol), and DIPEA (0.360 mL, 2.062 mmol) in dichloromethane (5 mL). The mixture was stirred for 3 h and washed with 0.5 N citric acid, saturated sodium bicarbonate, and brine, followed by filtration and evaporation. Purification was done using column chromatography DCM–MeOH, 0–6% MeOH. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (d, <i>J</i> = 4.36 Hz, 1H), 8.30 (ddd, <i>J</i> = 0.72, 1.48, 8.50 Hz, 1H), 8.17 (dd, <i>J</i> = 1.25, 8.28 Hz, 1H), 7.77 (ddd, <i>J</i> = 1.44, 6.92, 8.47 Hz, 1H), 7.62 (ddd, <i>J</i> = 1.29, 6.94, 8.30 Hz, 1H), 7.53 (d, <i>J</i> = 4.34 Hz, 1H), 7.19 (t, <i>J</i> = 4.10 Hz, 1H), 4.32–4.27 (m, 3H), 3.61–3.39 (m, 2H), 3.21 (dd, <i>J</i> = 6.93, 10.00 Hz, 1H), 2.50–2.25(m, 1H), 2.25–1.95 (m, 5H), 1.94–1.78 (m, 3H), 1.41 (s, 3H), 1.28–1.24 (m, 4H), 0.82 (s, 3H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.01, 165.44, 149.56, 130.42, 129.57, 128.03, 125.63, 124.73, 119.02, 86.32, 78.05, 77.36, 53.57, 51.35, 45.86, 42.35, 39.61, 38.75, 38.35, 35.62, 28.59, 27.53, 27.34, 27.20, 26.41, 24.15; colorless oil, 0.270 g, 88%.</div></div><div id="sec5_7_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>R</i>)-1-(2-(Quinoline-4-carboxamido)acetyl)pyrrolidin-2-ylboronic Acid (<b>66</b>)</h3><div class="NLM_p last">To a stirred solution of the <i>N</i>-(2-oxo-2-((2<i>R</i>)-2-((3aS,7a<i>R</i>)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[<i>d</i>][1,3,2]dioxaborol-2-yl)pyrrolidin-1-yl)ethyl)quinoline-4-carboxamide <b>69</b> (0.27 g, 0.585 mmol) in water (8 mL) at pH 3 (adjusting as necessary with 2 N aqueous HCl) were added phenylboronic acid (0.143 g, 1.17 mmol) and methyl <i>tert</i>-butyl ether (7 mL). The mixture was stirred for 2 days (pH 4). Water and the organic layer were separated. The water layer was adjusted to pH 3, and the water layer was extracted with a mixture 4:1 of DCM–isopropanol. The DCM layer was dried over sodium sulfate, filtered, evaporated, and further purified using column chromatography (DCM–MeOH, 0–10% MeOH) to yield a clear oil of 0.119 g (79%) of (<i>R</i>)-1-(2-(quinoline-4-carboxamido)acetyl)pyrrolidin-2-ylboronic acid. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.92–8.84 (m, 1H), 8.15 (ddd, <i>J</i> = 0.64, 1.43, 8.58 Hz, 1H), 8.09–8.00 (m, 1H), 7.84 (ddd, <i>J</i> = 1.41, 6.92, 8.47 Hz, 1H), 7.70 (ddd, <i>J</i> = 1.18, 6.94, 8.29 Hz, 1H), 7.64 (d, <i>J</i> = 4.46 Hz, 1H), 4.32–4.27 (m, 2H), 3.67 (ddd, <i>J</i> = 3.33, 8.37, 10.14 Hz, 1H), 3.55 (ddd, <i>J</i> = 6.54, 8.44, 10.90 Hz, 1H), 3.12 (dd, <i>J</i> = 7.01, 10.34 Hz, 1H), 2.13 (tdd, <i>J</i> = 3.42, 7.02, 9.03 Hz, 2H), 2.08–1.87 (m, 1H), 1.82–1.68 (m, 1H); <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 170.63, 168.11, 150.41, 147.54, 142.15, 131.50, 128.92, 128.64, 125.66, 124.61, 119.99, 48.94 (<sup>13</sup>C-B splitting), 47.22, 42.32, 27.48, 27.43; UPLC I (ESI) <i>t</i><sub>R</sub> 1.01 min, <i>m</i>/<i>z</i> 328.6 [M + H]<sup>+</sup> (99%); LC–MS (A) <i>t</i><sub>R</sub> 9.3min, <i>m</i>/<i>z</i> 328.0 [M + H]<sup>+</sup> (98%); HRMS calcd for C<sub>16</sub>H<sub>19</sub>BN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 328.1469; found, 328.1469.</div></div><div id="sec5_7_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>S</i>)-<i>N</i>-(2-(2-(2-Chloroacetyl)pyrrolidin-1-yl)-2-oxoethyl)quinoline-4-carboxamide (<b>67</b>)</h3><div class="NLM_p">4 M HCl (10.90 mL, 43.6 mmol) in dioxane was added to (<i>S</i>)-<i>tert</i>-butyl 2-(2-chloroacetyl)pyrrolidine-1-carboxylate (1.2 g, 4.84 mmol) <b>S35</b> and stirred for 1 h. Then the volatiles were evaporated and the residue was washed with ether to give 0.9 g of (<i>S</i>)-2-chloro-1-(pyrrolidin-2-yl)ethanone hydrochloride. The product was used in the next reaction without further purification.</div><div class="NLM_p last">To a solution containing 2-(quinoline-4-carboxamido)acetic acid (0.180 g, 0.782 mmol) and HOBT (0.132 g, 0.860 mmol) in 1,4-dioxane (5 mL) was added a solution of EDC (0.165 g, 0.860 mmol) in DCM (5 mL). The mixture was stirred for 30 min at 0 °C. To the resulting solution was added the appropriate amine (<i>S</i>)-2-chloro-1-(pyrrolidin-2-yl)ethanone hydrochloride (0.144 g, 0.782 mmol) and DIPEA (0.150 mL, 0.860 mmol) in DCM (4 mL), with stirring. After 2 h (on completion of the reaction), the reaction mixture was diluted with DCM and washed with saturated aqueous NaHCO<sub>3</sub> solution (10 mL), 0.1 N aqueous citric acid solution (10 mL), and brine (10 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, concentrated, and purified with flash chromatography using DCM–MeOH with 0–5% methanol (slightly yellowish oil, 0.120 g, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (d, <i>J</i> = 4.38 Hz, 1H), 8.29 (dd, <i>J</i> = 1.36, 8.17 Hz, 1H), 8.19 (d, <i>J</i> = 8.17 Hz, 1H), 7.78 (ddd, <i>J</i> = 1.41, 6.99, 8.50 Hz, 1H), 7.64 (ddd, <i>J</i> = 1.22, 6.91, 8.30 Hz, 1H), 7.54 (d, <i>J</i> = 4.32 Hz, 1H), 7.02 (s, 1H), 4.83 (dd, <i>J</i> = 5.10, 8.35 Hz, 1H), 4.43 (dd, <i>J</i> = 4.78, 17.74 Hz, 1H), 4.33 (d, <i>J</i> = 15.29 Hz, 1H), 4.35–4.25 (m, 1H), 4.23 (d, <i>J</i> = 15.33 Hz, 1H), 3.71 (ddd, <i>J</i> = 5.79, 7.27, 9.78 Hz, 1H), 3.63 (dt, <i>J</i> = 6.68, 9.75 Hz, 1H), 2.35–1.97 (m, 4H); <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 200.81, 167.32, 166.61, 149.78, 148.58, 141.31, 130.25, 129.78, 127.98, 125.42, 124.54, 118.95, 62.52, 47.19, 46.54, 42.41, 28.81, 25.16; UPLC I (ESI) <i>t</i><sub>R</sub> 1.25min, <i>m</i>/<i>z</i> 360.6 [M + H]<sup>+</sup> (95%); LC–MS (A) <i>t</i><sub>R</sub> 11.0 min, <i>m</i>/<i>z</i> 360.1 [M + H]<sup>+</sup> (98%).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/jm500031w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthetic procedures and analytical data for intermediates, protocols of the enzymatic assays used, and procedures and extended data series for in vitro and in vivo pharmacokinetic analyses. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500031w/suppl_file/jm500031w_si_001.pdf">jm500031w_si_001.pdf (531.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500031w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pieter Van der Veken</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmaceutical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f0809995849582de86919e94958286959b959eb085919e8487958280959ede9295"><span class="__cf_email__" data-cfemail="b9c9d0dccddccb97cfd8d7dddccbcfdcd2dcd7f9ccd8d7cdcedccbc9dcd797dbdc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Jansen</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmaceutical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leen Heirbaut</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmaceutical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Verkerk</span> - <span class="hlFld-Affiliation affiliation">Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Cheng</span> - <span class="hlFld-Affiliation affiliation">Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jurgen Joossens</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmaceutical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Cos</span> - <span class="hlFld-Affiliation affiliation">Laboratory of Microbiology, Parasitology,
and Hygiene, Departments of Pharmaceutical Sciences and Biomedical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis Maes</span> - <span class="hlFld-Affiliation affiliation">Laboratory of Microbiology, Parasitology,
and Hygiene, Departments of Pharmaceutical Sciences and Biomedical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Marie Lambeir</span> - <span class="hlFld-Affiliation affiliation">Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrid De Meester</span> - <span class="hlFld-Affiliation affiliation">Medical Biochemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Koen Augustyns</span> - <span class="hlFld-Affiliation affiliation">Medicinal Chemistry, Department of Pharmaceutical
Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1884e7191-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Nicole Lamoen, Sophie Lyssens, and Ann Mattheussen for excellent technical assistance with the enzymatic assays and the determination of in vitro and in vivo pharmacokinetic parameters.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i88" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i88"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i89" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i89"> Abbreviations Used</h2><tr><td class="NLM_term">FAP</td><td class="NLM_def"><p class="first last">fibroblast activation protein</p></td></tr><tr><td class="NLM_term">PREP</td><td class="NLM_def"><p class="first last">prolyl oligopeptidase</p></td></tr><tr><td class="NLM_term">DPPIV</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase IV</p></td></tr><tr><td class="NLM_term">DPPII</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase II</p></td></tr><tr><td class="NLM_term">DPP8</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 8</p></td></tr><tr><td class="NLM_term">DPP9</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase 9</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salakian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span> </span><span class="NLM_article-title">Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19441</span><span class="NLM_x">–</span> <span class="NLM_lpage">19444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19441-19444&author=K.+Aertgeertsauthor=I.+Levinauthor=L.+Shiauthor=G.+P.+Snellauthor=A.+Jenningsauthor=G.+S.+Prasadauthor=Y.+Zhangauthor=M.+L.+Krausauthor=S.+Salakianauthor=V.+Sridharauthor=R.+Wijnandsauthor=M.+G.+Tennant&title=Structural+and+kinetic+analysis+of+the+substrate+specificity+of+human+fibroblast+activation+protein+alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DI.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DSalakian%26aufirst%3DS.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DWijnands%26aufirst%3DR.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26atitle%3DStructural%2520and%2520kinetic%2520analysis%2520of%2520the%2520substrate%2520specificity%2520of%2520human%2520fibroblast%2520activation%2520protein%2520alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19441%26epage%3D19444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Acharya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.humpath.2005.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=16613331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=352-360&author=P.+S.+Acharyaauthor=A.+Zukasauthor=V.+Chandanauthor=A.+L.+Katzensteinauthor=E.+Pure&title=Fibroblast+activation+protein%3A+a+serine+protease+expressed+at+the+remodeling+interface+in+idiopathic+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Acharya, Pinak S.; Zukas, Alicia; Chandan, Vishal; Katzenstein, Anna-Luise A.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAPα) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases.  In its dimer form, FAPα exhibits gelatinase, collagenase, and DPP activity in vitro.  Reactive fibroblasts in healing wounds and stromal fibroblasts assocd. with epithelial tumors express FAPα.  Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiol. or mol. marker for disease activity.  Recently, it has been shown that fibroblast FAPα expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (α-SMA).  In this study, we det. whether FAPα expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF.  Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung.  Immunohistochem. studies were performed using anti-FAPα antibody and antibodies against α-SMA and CD26 (DPPIV), another member of the DPP family.  We found that FAPα was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and with a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium.  Specifically, FAPα was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung.  Alveolar/airway epithelium and vascular smooth muscle did not express FAPα.  This is the first report of FAPα expression in IPF and our results suggest that FAPα is selectively induced in fibrotic foci, but not in normal or emphysematous lung.  Future studies will address whether FAPα may be used as a marker for disease activity in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUc6hzUMix7Vg90H21EOLACvtfcHk0lgrSIHxPioDiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D&md5=ba036bf957422a280e73e40081daae30</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2005.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2005.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DP.%2BS.%26aulast%3DZukas%26aufirst%3DA.%26aulast%3DChandan%26aufirst%3DV.%26aulast%3DKatzenstein%26aufirst%3DA.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520serine%2520protease%2520expressed%2520at%2520the%2520remodeling%2520interface%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DHum.%2520Pathol.%26date%3D2006%26volume%3D37%26spage%3D352%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadvi, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein and chronic liver disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3168</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.2741%2F2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=17981786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=3168-3180&author=X.+M.+Wangauthor=T.-W.+Yaoauthor=N.+A.+Nadviauthor=B.+Osborneauthor=G.+W.+McCaughanauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein+and+chronic+liver+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein and chronic liver disease</span></div><div class="casAuthors">Wang, Xin Maggie; Yao, Tsun-Wen; Nadvi, Naveed A.; Osborne, Brenna; McCaughan, Geoffrey W.; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3168-3180</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Fibroblast activation protein (FAP) is the member of Dipeptidyl Peptidase IV (DPIV) gene family that is most similar to DPIV.  Four members of this family, DPIV, FAP, DP8 and DP9 possess a rare catalytic activity, hydrolysis of a prolyl bond two residues from the substrate N terminus.  Crystal structures show that the sol. form of FAP comprises two domains, an alpha/beta-hydrolase domain and an 8-blade beta-propeller domain.  The interface between these two domains forms the catalytic pocket, and an opening for substrate access to the internal active site.  The FAP homodimer is structurally very similar to DPIV but FAP glycoprotein expression is largely confined to mesenchymal cells in diseased and damaged tissue, notably the tissue remodelling region in chronically injured liver.  FAP peptide substrates include denatured collagen and alpha2-antiplasmin.  The functional roles of FAP in tumors and fibrotic tissue are not fully understood.  This review places FAP in the context of chronic liver injury pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Sjq8tkR9ibVg90H21EOLACvtfcHk0lgrSIHxPioDiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cnt7o%253D&md5=0528a1f19ab337f0d303951d96613f83</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2741%2F2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2918%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYao%26aufirst%3DT.-W.%26aulast%3DNadvi%26aufirst%3DN.%2BA.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%2520and%2520chronic%2520liver%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D3168%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keene, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadvi, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=1316-1332&issue=8&author=F.+M.+Keeneauthor=N.+A.+Nadviauthor=T.+W.+Yaoauthor=M.+D.+Gorrell&title=Neuropeptide+Y%2C+B-type+natriuretic+peptide%2C+substance+P+and+peptide+YY+are+novel+substrates+of+fibroblast+activation+protein-%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeene%26aufirst%3DF.%2BM.%26aulast%3DNadvi%26aufirst%3DN.%2BA.%26aulast%3DYao%26aufirst%3DT.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DNeuropeptide%2520Y%252C%2520B-type%2520natriuretic%2520peptide%252C%2520substance%2520P%2520and%2520peptide%2520YY%2520are%2520novel%2520substrates%2520of%2520fibroblast%2520activation%2520protein-%25CE%25B1%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26issue%3D8%26spage%3D1316%26epage%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodelling+interface+in+human+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodelling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dienus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, O.</span><span> </span><span class="NLM_article-title">Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option</span> <span class="citation_source-journal">Arch. Dermatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1007%2Fs00403-010-1084-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=20872224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOrtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2010&pages=725-731&author=K.+Dienusauthor=A.+Bayatauthor=B.+F.+Gilmoreauthor=O.+Seifert&title=Increased+expression+of+fibroblast+activation+protein-alpha+in+keloid+fibroblasts%3A+implications+for+development+of+a+novel+treatment+option"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option</span></div><div class="casAuthors">Dienus, Kirstin; Bayat, Ardeshir; Gilmore, Brendan F.; Seifert, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">725-731</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Keloid scars are common benign fibroproliferative reticular dermal lesions with unknown etiol. and ill-defined management with high rate of recurrence post surgery.  The progression of keloids is characterized by increased deposition of extracellular matrix proteins, invasion into the surrounding healthy skin and inflammation.  Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars.  Fibroblast activation protein alpha (FAP-α) and dipeptidyl peptidase IV (DPPIV) are proteases located at the plasma membrane promoting cell invasiveness and tumor growth and have been previously assocd. with keloid scars.  Therefore, in this study we analyzed in further detail the expression of FAP-α in keloid fibroblasts compared to control skin fibroblasts.  Dermal fibroblasts were obtained from punch-biopsies from the active margin of four keloids and four control skin samples.  Flow cytometry was used to analyze FAP-α expression and the CytoSelect 24-Well Collagen I Cell Invasion Assay was applied to study fibroblast invasion.  Secretion of extracellular matrix (ECM) proteins was investigated by multiplexed particle-based flow cytometric assay and ELISA.  We found an increased expression of FAP-α in keloid fibroblasts compared to control skin fibroblasts (p < 0.001).  Inhibition of FAP-α/DPPIV activity using the irreversible inhibitor H2N-Gly-Pro diphenylphosphonate reduced the increased invasiveness of keloid fibroblasts (p < 0.001) indicating that keloid invasion may be partly FAP-α/DPPIV mediated.  FAP-α/DPPIV inhibition had no effect, (a) on the synthesis of the ECM proteins procollagen type I C-terminal peptide and fibronectin, (b) on the prodn. of fibroblast growth factor or vascular endothelial growth factor, (c) on the expression of the proinflammatory cytokines interleukin-6 (IL-6), interleukin 8 (IL-8) or monocyte chemotactic protein-1.  These results suggest a potential role for FAP-α and DPPIV in the invasive behavior of keloids.  FAP-α and DPPIV may increase the invasive capacity of keloid fibroblasts rather than by modulating inflammation or ECM prodn.  Since FAP-α expression is restricted to reactive fibroblasts in wound healing and normal adult tissues are generally FAP-α neg., inhibiting FAP-α/DPPIV activity may be a novel treatment option to prevent keloid progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWDsa4lmY6LVg90H21EOLACvtfcHk0ljXEIl69Wrs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOrtLrL&md5=1466bf234d10c2acfda9f9964d22df94</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00403-010-1084-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-010-1084-x%26sid%3Dliteratum%253Aachs%26aulast%3DDienus%26aufirst%3DK.%26aulast%3DBayat%26aufirst%3DA.%26aulast%3DGilmore%26aufirst%3DB.%2BF.%26aulast%3DSeifert%26aufirst%3DO.%26atitle%3DIncreased%2520expression%2520of%2520fibroblast%2520activation%2520protein-alpha%2520in%2520keloid%2520fibroblasts%253A%2520implications%2520for%2520development%2520of%2520a%2520novel%2520treatment%2520option%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D2010%26volume%3D302%26spage%3D725%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Milner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kevorkian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wait, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donell, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barksby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawston, T. E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=R23&author=J.+M.+Milnerauthor=L.+Kevorkianauthor=D.+A.+Youngauthor=D.+Jonesauthor=R.+Waitauthor=S.+T.+Donellauthor=E.+Barksbyauthor=A.+M.+Pattersonauthor=J.+Middletonauthor=B.+F.+Cravattauthor=I.+M.+Clarkauthor=A.+D.+Rowanauthor=T.+E.+Cawston&title=Fibroblast+activation+protein+alpha+is+expressed+by+chondrocytes+following+a+pro-inflammatory+stimulus+and+is+elevated+in+osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilner%26aufirst%3DJ.%2BM.%26aulast%3DKevorkian%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DWait%26aufirst%3DR.%26aulast%3DDonell%26aufirst%3DS.%2BT.%26aulast%3DBarksby%26aufirst%3DE.%26aulast%3DPatterson%26aufirst%3DA.%2BM.%26aulast%3DMiddleton%26aufirst%3DJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DClark%26aufirst%3DI.%2BM.%26aulast%3DRowan%26aufirst%3DA.%2BD.%26aulast%3DCawston%26aufirst%3DT.%2BE.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520is%2520expressed%2520by%2520chondrocytes%2520following%2520a%2520pro-inflammatory%2520stimulus%2520and%2520is%2520elevated%2520in%2520osteoarthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Milner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A. D.</span><span> </span><span class="NLM_article-title">Emerging roles of serine proteinases in tissue turnover in arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1002%2Fart.24046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19035508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3644-3656&author=J.+M.+Milnerauthor=A.+Patelauthor=A.+D.+Rowan&title=Emerging+roles+of+serine+proteinases+in+tissue+turnover+in+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of serine proteinases in tissue turnover in arthritis</span></div><div class="casAuthors">Milner, J. M.; Patel, A.; Rowan, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3644-3656</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review on the traditional roles of serine proteinases (coagulation, complement, and fibrinolysis) and the new emerging roles of these and novel serine proteinases in relation to the tissue turnover assocd. with joint destruction in rheumatoid arthritis and osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnPTwcQH2_k7Vg90H21EOLACvtfcHk0ljXEIl69Wrs5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1yntA%253D%253D&md5=c2ef997659a70930a14b4a654b39d62e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.24046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24046%26sid%3Dliteratum%253Aachs%26aulast%3DMilner%26aufirst%3DJ.%2BM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DRowan%26aufirst%3DA.%2BD.%26atitle%3DEmerging%2520roles%2520of%2520serine%2520proteinases%2520in%2520tissue%2520turnover%2520in%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3644%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brokopp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüscher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerstrup, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, C. M.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1093%2Feurheartj%2Fehq519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=21292680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2713-2722&author=C.+E.+Brokoppauthor=R.+Schoenauerauthor=P.+Richardsauthor=S.+Bauerauthor=C.+Lohmannauthor=M.+Y.+Emmertauthor=B.+Weberauthor=S.+Winnikauthor=E.+Aikawaauthor=K.+Gravesauthor=M.+Genoniauthor=P.+Vogtauthor=T.+F.+L%C3%BCscherauthor=C.+Rennerauthor=S.+P.+Hoerstrupauthor=C.+M.+Matter&title=Fibroblast+activation+protein+is+induced+by+inflammation+and+degrades+type+I+collagen+in+thin-cap+fibroatheromata"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span></div><div class="casAuthors">Brokopp, Chad E.; Schoenauer, Roman; Richards, Peter; Bauer, Stefan; Lohmann, Christine; Emmert, Maximilian Y.; Weber, Benedikt; Winnik, Stephan; Aikawa, Elena; Graves, Kirk; Genoni, Michele; Vogt, Peter; Luescher, Thomas F.; Renner, Christoph; Hoerstrup, Simon P.; Matter, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Collagen degrdn. in atherosclerotic plaques with thin fibrous caps renders them more prone to rupture.  Fibroblast activation protein (FAP) plays a role in arthritis and tumor formation through its collagenase activity.  However, the significance of FAP in thin-cap human fibroatheromata remains unknown.  Methods and results We detected enhanced FAP expression in type IV-V human aortic atheromata (n = 12), compared with type II-III lesions (n = 9; P < 0.01) and healthy aortae (n = 8; P < 0.01) by immunostaining and western blot analyses.  Fibroblast activation protein was also increased in thin-cap (<65 μm) vs. thick-cap (≥65 μm) human coronary fibroatheromata (n = 12; P < 0.01).  Fibroblast activation protein was expressed by human aortic smooth muscle cells (HASMC) as shown by colocalization on immunofluorescent aortic plaque stainings (n = 10; P < 0.01) and by flow cytometry in cell culture.  Although macrophages did not express FAP, macrophage burden in human aortic plaques correlated with FAP expression (n = 12; R2= 0.763; P < 0.05).  Enzyme-linked immunosorbent assays showed a time- and dose-dependent up-regulation of FAP in response to human tumor necrosis factor α (TNFα) in HASMC (n = 6; P < 0.01).  Moreover, supernatants from peripheral blood-derived macrophages induced FAP expression in cultured HASMC (n = 6; P < 0.01), an effect abolished by blocking TNFα (n = 6; P < 0.01).  Fibroblast activation protein assocd. with collagen-poor regions in human coronary fibrous caps and digested type I collagen and gelatin in vitro (n = 6; P < 0.01).  Zymog. revealed that FAP-mediated collagenase activity was neutralized by an antibody directed against the FAP catalytic domain both in HASMC (n = 6; P < 0.01) and in fibrous caps of atherosclerotic plaques (n = 10; P < 0.01).  Conclusion Fibroblast activation protein expression in HASMC is induced by macrophage-derived TNFα.  Fibroblast activation protein assocs. with thin-cap human coronary fibroatheromata and contributes to type I collagen breakdown in fibrous caps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4eDr7Cnj1c7Vg90H21EOLACvtfcHk0lhsIO85HsTuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO&md5=585eb7eb395d15ac6c5bb83f625da5b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq519%26sid%3Dliteratum%253Aachs%26aulast%3DBrokopp%26aufirst%3DC.%2BE.%26aulast%3DSchoenauer%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLohmann%26aufirst%3DC.%26aulast%3DEmmert%26aufirst%3DM.%2BY.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DWinnik%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DGraves%26aufirst%3DK.%26aulast%3DGenoni%26aufirst%3DM.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DL%25C3%25BCscher%26aufirst%3DT.%2BF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHoerstrup%26aufirst%3DS.%2BP.%26aulast%3DMatter%26aufirst%3DC.%2BM.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520induced%2520by%2520inflammation%2520and%2520degrades%2520type%2520I%2520collagen%2520in%2520thin-cap%2520fibroatheromata%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2713%26epage%3D2722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Moncasi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5657</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5657-5661&author=M.+J.+Scanlanauthor=B.+K.+Rajauthor=B.+Calvoauthor=P.+Garin-Chesaauthor=M.+P.+Sanz-Moncasiauthor=J.+H.+Healeyauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Molecular+cloning+of+fibroblast+activation+protein+alpha%2C+a+member+of+the+serine+protease+family+selectively+expressed+in+stromal+fibroblasts+of+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DCalvo%26aufirst%3DB.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DSanz-Moncasi%26aufirst%3DM.%2BP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DMolecular%2520cloning%2520of%2520fibroblast%2520activation%2520protein%2520alpha%252C%2520a%2520member%2520of%2520the%2520serine%2520protease%2520family%2520selectively%2520expressed%2520in%2520stromal%2520fibroblasts%2520of%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D5657%26epage%3D5661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19920354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pur%C3%A9&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span></div><div class="casAuthors">Santos, Angelica M.; Jung, Jason; Aziz, Nazneen; Kissil, Joseph L.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3613-3625</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Membrane-bound proteases have recently emerged as crit. mediators of tumorigenesis, angiogenesis, and metastasis.  However, the mechanisms by which they regulate these processes remain unknown.  As the cell surface serine protease fibroblast activation protein (FAP) is selectively expressed on tumor-assocd. fibroblasts and pericytes in epithelial tumors, we set out to investigate the role of FAP in mouse models of epithelial-derived solid tumors.  In this study, we demonstrate that genetic deletion and pharmacol. inhibition of FAP inhibited tumor growth in both an endogenous mouse model of lung cancer driven by the K-rasG12D mutant and a mouse model of colon cancer, in which CT26 mouse colon cancer cells were transplanted into immune competent syngeneic mice.  Interestingly, growth of only the K-rasG12D-driven lung tumors was also attenuated by inhibition of the closely related protease dipeptidyl peptidase IV (DPPIV).  Our results indicate that FAP depletion inhibits tumor cell proliferation indirectly, increases accumulation of collagen, decreases myofibroblast content, and decreases blood vessel d. in tumors.  These data provide proof of principle that targeting stromal cell-mediated modifications of the tumor microenvironment may be an effective approach to treating epithelial-derived solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1-xywXMGHrVg90H21EOLACvtfcHk0lhsIO85HsTuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK&md5=20f20b9dbbcbe1f72a06d37f6ee19cde</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canutescu, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1158%2F1535-7163.MCT-05-0128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=15767544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=351-360&author=J.+D.+Chengauthor=M.+Valianouauthor=A.+A.+Canutescuauthor=E.+K.+Jaffeauthor=H.-O.+Leeauthor=H.+Wangauthor=J.+H.+Laiauthor=W.+W.+Bachovchinauthor=L.+M.+Weiner&title=Abrogation+of+fibroblast+activation+protein+enzymatic+activity+attenuates+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span></div><div class="casAuthors">Cheng, Jonathan D.; Valianou, Matthildi; Canutescu, Adrian A.; Jaffe, Eileen K.; Lee, Hyung-Ok; Wang, Hao; Lai, Jack H.; Bachovchin, William W.; Weiner, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor-assocd. fibroblasts are functionally and phenotypically distinct from normal fibroblasts that are not in the tumor microenvironment.  Fibroblast activation protein is a 95 kDa cell surface glycoprotein expressed by tumor stromal fibroblasts, and has been shown to have dipeptidyl peptidase and collagenase activity.  Site-directed mutagenesis at the catalytic site of fibroblast activation protein, Ser624 Ala624, resulted in an ∼100,000-fold loss of fibroblast activation protein dipeptidyl peptidase (DPP) activity.  HEK293 cells transfected with wild-type fibroblast activation protein, enzymic mutant (S624A) fibroblast activation protein, or vector alone, were inoculated s.c. into immunodeficient mouse to assess the contribution of fibroblast activation protein enzymic activity to tumor growth.  Overexpression of wild-type fibroblast activation protein showed growth potentiation and enhanced tumorigenicity compared with both fibroblast activation protein S624A and vector-transfected HEK293 xenografts.  HEK293 cells transfected with fibroblast activation protein S624A showed tumor growth rates and tumorigenicity potential similar only to vector-transfected HEK293.  In vivo assessment of fibroblast activation protein DPP activity of these tumors showed enhanced enzymic activity of wild-type fibroblast activation protein, with only baseline levels of fibroblast activation protein DPP activity in either fibroblast activation protein S624A or vector-only xenografts.  These results indicate that the enzymic activity of fibroblast activation protein is necessary for fibroblast activation protein-driven tumor growth in the HEK293 xenograft model system.  This establishes the proof-of-principle that the enzymic activity of fibroblast activation protein plays an important role in the promotion of tumor growth, and provides an attractive target for therapeutics designed to alter fibroblast activation protein-induced tumor growth by targeting its enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQ7ekEjT-O7Vg90H21EOLACvtfcHk0lhsIO85HsTuVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D&md5=9ef5725b966bd47692ad130aecf56ba9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0128%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCanutescu%26aufirst%3DA.%2BA.%26aulast%3DJaffe%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DAbrogation%2520of%2520fibroblast%2520activation%2520protein%2520enzymatic%2520activity%2520attenuates%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2712</span><span class="NLM_x">–</span> <span class="NLM_lpage">2716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2712-2716&author=Y.+Huangauthor=S.+Wangauthor=T.+Kelly&title=Seprase+promotes+rapid+tumor+growth+and+increased+microvessel+density+in+a+mouse+model+of+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DSeprase%2520promotes%2520rapid%2520tumor%2520growth%2520and%2520increased%2520microvessel%2520density%2520in%2520a%2520mouse%2520model%2520of%2520human%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D2712%26epage%3D2716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B. F.</span><span> </span><span class="NLM_article-title">Seprase: an overview of an important matrix serine protease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=1130-1145&author=P.+O%E2%80%99Brienauthor=B.+F.+O%E2%80%99Connor&title=Seprase%3A+an+overview+of+an+important+matrix+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BF.%26atitle%3DSeprase%253A%2520an%2520overview%2520of%2520an%2520important%2520matrix%2520serine%2520protease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D1130%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlank, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerenyi, T. D.</span><span> </span><span class="NLM_article-title">Leucylglycinamide released from oxytocin by human uterine enzyme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1971&pages=827-829&author=R.+Walterauthor=H.+Shlankauthor=J.+D.+Glassauthor=I.+L.+Schwartzauthor=T.+D.+Kerenyi&title=Leucylglycinamide+released+from+oxytocin+by+human+uterine+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DShlank%26aufirst%3DH.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DSchwartz%26aufirst%3DI.%2BL.%26aulast%3DKerenyi%26aufirst%3DT.%2BD.%26atitle%3DLeucylglycinamide%2520released%2520from%2520oxytocin%2520by%2520human%2520uterine%2520enzyme%26jtitle%3DScience%26date%3D1971%26volume%3D173%26spage%3D827%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span> </span><span class="NLM_article-title">On the role of prolyl oligopeptidase in health and disease</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=1-24&author=J.+A.+Garc%C3%ADa-Horsmanauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+I.+Ven%C3%A4l%C3%A4inen&title=On+the+role+of+prolyl+oligopeptidase+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26atitle%3DOn%2520the%2520role%2520of%2520prolyl%2520oligopeptidase%2520in%2520health%2520and%2520disease%26jtitle%3DNeuropeptides%26date%3D2007%26volume%3D41%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jambunathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endsley, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodukula, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galande, A. K.</span><span> </span><span class="NLM_article-title">Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">586</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.febslet.2012.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=22750443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFCksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2012&pages=2507-2512&author=K.+Jambunathanauthor=D.+S.+Watsonauthor=A.+N.+Endsleyauthor=K.+Kodukulaauthor=A.+K.+Galande&title=Comparative+analysis+of+the+substrate+preferences+of+two+post-proline+cleaving+endopeptidases%2C+prolyl+oligopeptidase+and+fibroblast+activation+protein+%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α</span></div><div class="casAuthors">Jambunathan, Kalyani; Watson, Douglas S.; Endsley, Aaron N.; Kodukula, Krishna; Galande, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2507-2512</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Post-proline cleaving peptidases are promising therapeutic targets for neurodegenerative diseases, psychiatric conditions, metabolic disorders, and many cancers.  Prolyl oligopeptidase (POP; E.C. 3.4.21.26) and fibroblast activation protein α (FAP; E.C. 3.4.24.B28) are two post-proline cleaving endopeptidases with very similar substrate specificities.  Both enzymes are implicated in numerous human diseases, but their study is impeded by the lack of specific substrate probes.  We interrogated a combinatorial library of proteolytic substrates and identified novel and selective substrates of POP and FAP.  These new sequences will be useful as probes for fundamental biochem. study, scaffolds for inhibitor design, and triggers for controlled drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgLjBZTsaIE7Vg90H21EOLACvtfcHk0liR5VKm_jb6ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFCksrw%253D&md5=29fe45e4ea2eaf8c4c59cae587cb5c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DJambunathan%26aufirst%3DK.%26aulast%3DWatson%26aufirst%3DD.%2BS.%26aulast%3DEndsley%26aufirst%3DA.%2BN.%26aulast%3DKodukula%26aufirst%3DK.%26aulast%3DGalande%26aufirst%3DA.%2BK.%26atitle%3DComparative%2520analysis%2520of%2520the%2520substrate%2520preferences%2520of%2520two%2520post-proline%2520cleaving%2520endopeptidases%252C%2520prolyl%2520oligopeptidase%2520and%2520fibroblast%2520activation%2520protein%2520%25CE%25B1%26jtitle%3DFEBS%2520Lett.%26date%3D2012%26volume%3D586%26spage%3D2507%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Christiansen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Targeting inhibition of fibroblast activation protein-alpha and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=348-358&author=V.+Christiansenauthor=K.+Jacksonauthor=K.+N.+Leeauthor=T.+D.+Downsauthor=P.+A.+McKee&title=Targeting+inhibition+of+fibroblast+activation+protein-alpha+and+prolyl+oligopeptidase+activities+on+cells+common+to+metastatic+tumor+microenvironments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DV.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DDowns%26aufirst%3DT.%2BD.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DTargeting%2520inhibition%2520of%2520fibroblast%2520activation%2520protein-alpha%2520and%2520prolyl%2520oligopeptidase%2520activities%2520on%2520cells%2520common%2520to%2520metastatic%2520tumor%2520microenvironments%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D348%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">D’Agostino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diano, S.</span><span> </span><span class="NLM_article-title">Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1093%2Fcercor%2Fbhs199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=22767632" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=2007-2014&author=G.+D%E2%80%99Agostinoauthor=J.+D.+Kimauthor=Z.-W.+Liuauthor=J.+K.+Jeongauthor=S.+Suyamaauthor=A.+Calignanoauthor=X.-B.+Gaoauthor=M.+Schwartzauthor=S.+Diano&title=Prolyl+endopeptidase-deficient+mice+have+reduced+synaptic+spine+density+in+the+CA1+region+of+the+hippocampus%2C+impaired+LTP%2C+and+spatial+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2Fbhs199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252Fbhs199%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DZ.-W.%26aulast%3DJeong%26aufirst%3DJ.%2BK.%26aulast%3DSuyama%26aufirst%3DS.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DDiano%26aufirst%3DS.%26atitle%3DProlyl%2520endopeptidase-deficient%2520mice%2520have%2520reduced%2520synaptic%2520spine%2520density%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%252C%2520impaired%2520LTP%252C%2520and%2520spatial%2520learning%2520and%2520memory%26jtitle%3DCereb.%2520Cortex%26date%3D2012%26volume%3D23%26spage%3D2007%26epage%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Eager, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senzer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uprichard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemunaitis, J.</span><span> </span><span class="NLM_article-title">Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.clon.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A280%3ADC%252BD1MvnslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=464-472&author=R.+M.+Eagerauthor=C.+C.+Cunninghamauthor=N.+Senzerauthor=D.+A.+Richardsauthor=R.+N.+Rajuauthor=B.+Jonesauthor=M.+Uprichardauthor=J.+Nemunaitis&title=Phase+II+trial+of+talabostat+and+docetaxel+in+advanced+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer</span></div><div class="casAuthors">Eager R M; Cunningham C C; Senzer N; Richards D A; Raju R N; Jones B; Uprichard M; Nemunaitis J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Currently available therapies do improve survival in advanced stage non-small cell lung cancer (NSCLC), but only to a limited degree.  Talabostat mesilate (PT-100) is an orally available amino boronic dipeptide that specifically inhibits dipeptidyl peptidases (including fibroblast activation protein) and enhances an immune response.  The aim of this study was to determine the efficacy and safety of talabostat in NSCLC patients.  MATERIALS AND METHODS:  A phase II trial was conducted to evaluate talabostat in combination with docetaxel in patients with advanced NSCLC after failure of previous platinum-based chemotherapy.  In total, 42 patients were enrolled.  RESULTS:  Talabostat was well tolerated.  Two patients achieved a partial response and one achieved a complete response.  CONCLUSION:  There was no evidence that talabostat enhanced the clinical activity of docetaxel in patients with NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTzMVo_b7EzHWEEzDrymxmfW6udTcc2eYp4UkPQN_0B7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvnslCjtw%253D%253D&md5=ad5ab6406f54c4a919563b02f0e0ac76</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26aulast%3DSenzer%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DD.%2BA.%26aulast%3DRaju%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DUprichard%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520trial%2520of%2520talabostat%2520and%2520docetaxel%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Oncol.%26date%3D2009%26volume%3D21%26spage%3D464%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Narra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzemkowski-Brun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meropol, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.-O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+McKeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 μg p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0lhyeUAlC5uymA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1691%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Eager, R. M.; Cunningham, C. C.; Senzer, N. N.; Stephenson, J.; Anthony, S. P.; O’Day, S. J.; Frenette, G.; Pavlick, A. C.; Jones, B.; Uprichard, M.; Nemunaitis, J.</span><span> </span><span class="NLM_article-title">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span>.  <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span>, DOI: <span class="refDoi"> DOI: 10.1186/1471-2407-9-263</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1186%2F1471-2407-9-263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&author=R.+M.+Eager&author=C.+C.+Cunningham&author=N.+N.+Senzer&author=J.+Stephenson&author=S.+P.+Anthony&author=S.+J.+O%E2%80%99Day&author=G.+Frenette&author=A.+C.+Pavlick&author=B.+Jones&author=M.+Uprichard&author=J.+Nemunaitis&title=Phase+II+assessment+of+talabostat+and+cisplatin+in+second-line+stage+IV+melanoma&doi=10.1186%2F1471-2407-9-263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-9-263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-9-263%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520II%2520assessment%2520of%2520talabostat%2520and%2520cisplatin%2520in%2520second-line%2520stage%2520IV%2520melanoma%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26doi%3D10.1186%2F1471-2407-9-263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langkopf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 iinhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1124%2Fjpet.107.135723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18223196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=175-182&author=L.+Thomasauthor=M.+Eckhardtauthor=E.+Langkopfauthor=M.+Tadayyonauthor=F.+Himmelsbachauthor=M.+Mark&title=%28R%29-8-%283-Amino-piperidin-1-yl%29-7-but-2-ynyl-3-methyl-1-%284-methyl-quinazolin-2-ylmethyl%29-3%2C7-dihydro-purine-2%2C6-dione+%28BI+1356%29%2C+a+novel+xanthine-based+dipeptidyl+peptidase+4+iinhibitor%2C+has+a+superior+potency+and+longer+duration+of+action+compared+with+other+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2 -ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Thomas, Leo; Eckhardt, Matthias; Langkopf, Elke; Tadayyon, Moh; Himmelsbach, Frank; Mark, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">BI 1356 [proposed trade name ONDERO; (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2 -ylmethyl)-3,7-dihydro-purine-2,6-dione] is a novel dipeptidyl peptidase (DPP)-4 inhibitor under clin. development for the treatment of type 2 diabetes.  In this study, we investigated the potency, selectivity, mechanism, and duration of action of BI 1356 in vitro and in vivo and compared it with other DPP-4 inhibitors.  BI 1356 inhibited DPP-4 activity in vitro with an IC50 of approx. 1 nM, compared with sitagliptin (19 nM), alogliptin (24 nM), saxagliptin (50 nM), and vildagliptin (62 nM).  BI 1356 was a competitive inhibitor, with a Ki of 1 nM.  The calcd. koff rate for BI 1356 was 3.0 × 10-5/s (vs. 2.1 × 10-4/s for vildagliptin).  BI 1356 was ≥10,000-fold more selective for DPP-4 than DPP-8, DPP-9, aminopeptidases N and P, prolyloligopeptidase, trypsin, plasmin, and thrombin and was 90-fold more selective than for fibroblast activation protein in vitro.  In HanWistar rats, the DPP-4 inhibition 24 h after administration of BI 1356 was more profound than with any of the other DPP-4 inhibitors.  In C57BL/6J mice and Zucker fatty (fa/fa) rats, the duration of action on glucose tolerance decreased in the order BI 1356 > (sitagliptin/saxagliptin) > vildagliptin.  These effects were mediated through control of glucagon-like peptide-1 and insulin.  BI 1356 inhibited DPP-4 more effectively than vildagliptin, sitagliptin, saxagliptin, and alogliptin and has the potential to become the first truly once-a-day DPP-4 inhibitor for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCDp95uMTVH7Vg90H21EOLACvtfcHk0lgCbidcCcpOmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtLk%253D&md5=c66d67f9eb83ae3587457878a32a3452</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.135723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.135723%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DLangkopf%26aufirst%3DE.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DMark%26aufirst%3DM.%26atitle%3D%2528R%2529-8-%25283-Amino-piperidin-1-yl%2529-7-but-2-ynyl-3-methyl-1-%25284-methyl-quinazolin-2-ylmethyl%2529-3%252C7-dihydro-purine-2%252C6-dione%2520%2528BI%25201356%2529%252C%2520a%2520novel%2520xanthine-based%2520dipeptidyl%2520peptidase%25204%2520iinhibitor%252C%2520has%2520a%2520superior%2520potency%2520and%2520longer%2520duration%2520of%2520action%2520compared%2520with%2520other%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tsai, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W.-T.</span><span> </span><span class="NLM_article-title">Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6572-6583&author=T.-Y.+Tsaiauthor=T.-K.+Yehauthor=X.+Chenauthor=T.+Hsuauthor=Y.-C.+Jaoauthor=C.-H.+Huangauthor=J.-S.+Songauthor=Y.-C.+Huangauthor=C.-H.+Chienauthor=J.-H.+Chiuauthor=S.-C.+Yenauthor=H.-K.+Tangauthor=Y.-S.+Chaoauthor=W.-T.+Jiaang&title=Substituted+4-carboxymethylpyroglutamic+acid+diamides+as+potent+and+selective+inhibitors+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm1002556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002556%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.-Y.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DJao%26aufirst%3DY.-C.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DHuang%26aufirst%3DY.-C.%26aulast%3DChien%26aufirst%3DC.-H.%26aulast%3DChiu%26aufirst%3DJ.-H.%26aulast%3DYen%26aufirst%3DS.-C.%26aulast%3DTang%26aufirst%3DH.-K.%26aulast%3DChao%26aufirst%3DY.-S.%26aulast%3DJiaang%26aufirst%3DW.-T.%26atitle%3DSubstituted%25204-carboxymethylpyroglutamic%2520acid%2520diamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6572%26epage%3D6583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300410d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=491-496&author=K.+Jansenauthor=L.+Heirbautauthor=J.+D.+Chengauthor=J.+Joossensauthor=O.+Ryabtsovaauthor=P.+Cosauthor=L.+Maesauthor=A.-M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Selective+inhibitors+of+fibroblast+activation+protein+%28FAP%29+with+a+%284-quinolinoyl%29-glycyl-2-cyanopyrrolidine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300410d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300410d%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.-M.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSelective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520with%2520a%2520%25284-quinolinoyl%2529-glycyl-2-cyanopyrrolidine%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D491%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolence, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor A2-antiplasmin</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1111%2Fj.1538-7836.2011.04195.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=21251197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=987-996&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=E.+K.+Dolenceauthor=P.+A.+McKee&title=Enhancement+of+fibrinolysis+by+inhibiting+enzymatic+cleavage+of+precursor+A2-antiplasmin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin</span></div><div class="casAuthors">Lee, K. N.; Jackson, K. W.; Christiansen, V. J.; Dolence, E. K.; McKee, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-996</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Resistance of thrombi to plasmin digestion depends primarily on the amt. of α2-antiplasmin (α2AP) incorporated within fibrin.  Circulating prolyl-specific serine proteinase, antiplasmin-cleaving enzyme (APCE), a homolog of fibroblast activation protein (FAP), cleaves precursor Met-α2AP between -Pro12-Asn13- to yield Asn-α2AP, which is crosslinked to fibrin approx. 13× more rapidly than Met-α2AP and confers resistance to plasmin.  We reasoned that an APCE inhibitor might decrease conversion of Met-α2AP to Asn-α2AP and thereby enhance endogenous fibrinolysis.  We designed and synthesized several APCE inhibitors and assessed each vs. plasma dipeptidyl peptidase IV (DPPIV) and prolyl oligopeptidase (POP), which have amino acid sequence similarity with APCE.  Acetyl-Arg-(8-amino-3,6-dioxaoctanoic acid)-D-Ala-L-boroPro selectively inhibited APCE vs. DPPIV, with an apparent Ki of 5.7 nM vs. 6.1 μM, indicating that an approx. 1000-fold greater inhibitor concn. is required for DPPIV than for APCE.  An apparent Ki of 7.4 nM was found for POP inhibition, which is similar to 5.7 nM for APCE; however, the potential problem of overlapping FAP/APCE and POP inhibition was negated by our finding that normal human plasma lacks POP activity.  The inhibitor construct caused a dose-dependent decrease of APCE-mediated Met-α2AP cleavage, which ultimately shortened plasminogen activator-induced plasma clot lysis times.  Incubation of the inhibitor with human plasma for 22 h did not lessen its APCE inhibitory activity, with its IC50 value in plasma remaining comparable to that in phosphate buffer.  These data establish that inhibition of APCE might represent a therapeutic approach for enhancing thrombolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNDs9DkEyXZbVg90H21EOLACvtfcHk0ljtne2vLAZnAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFymtb8%253D&md5=f045cb95788182a837ba9a75228d111b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2011.04195.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2011.04195.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DDolence%26aufirst%3DE.%2BK.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DEnhancement%2520of%2520fibrinolysis%2520by%2520inhibiting%2520enzymatic%2520cleavage%2520of%2520precursor%2520A2-antiplasmin%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2011%26volume%3D9%26spage%3D987%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Poplawski, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Identification of selective and potent inhibitors of fibroblast activation protein and prolyl ooligopeptidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400351a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3467-3477&author=S.+E.+Poplawskiauthor=J.+H.+Laiauthor=Y.+Liauthor=Z.+Jinauthor=Y.+Liuauthor=W.+Wuauthor=Y.+Wuauthor=Y.+Zhouauthor=J.+L.+Sudmeierauthor=D.+G.+Sanfordauthor=W.+W.+Bachovchin&title=Identification+of+selective+and+potent+inhibitors+of+fibroblast+activation+protein+and+prolyl+ooligopeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm400351a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400351a%26sid%3Dliteratum%253Aachs%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520and%2520potent%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520and%2520prolyl%2520ooligopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3467%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.-M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issue+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.-M.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issue%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4159-4162&author=S.+Van+Goethemauthor=P.+Van+der+Vekenauthor=V.+Duboisauthor=A.+Sorokaauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=I.+De+Meesterauthor=K.+Augustyns&title=Inhibitors+of+dipeptidyl+peptidase+8+and+dipeptidyl+peptidase+9.+Part+2%3A+Isoindoline+containing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DDubois%26aufirst%3DV.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%25208%2520and%2520dipeptidyl%2520peptidase%25209.%2520Part%25202%253A%2520Isoindoline%2520containing%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4159%26epage%3D4162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5568</span><span class="NLM_x">–</span> <span class="NLM_lpage">5570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701005a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5568-5570&author=P.+Van+der+Vekenauthor=A.+Sorokaauthor=I.+Brandtauthor=Y.+S.+Chenauthor=M.+B.+Maesauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=K.+Augustynsauthor=I.+De+Meester&title=Irreversible+inhibition+of+dipeptidyl+peptidase+8+by+dipeptide-derived+diaryl+phosphonates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Fjm701005a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701005a%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DY.%2BS.%26aulast%3DMaes%26aufirst%3DM.%2BB.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DIrreversible%2520inhibition%2520of%2520dipeptidyl%2520peptidase%25208%2520by%2520dipeptide-derived%2520diaryl%2520phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5568%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Singh, S. K.; Manne, N.; Pal, M.</span><span> </span><span class="NLM_article-title">Synthesis of (<i>S</i>)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: a key intermediate for dipeptidyl peptidase IV inhibitors</span>.  <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span>, DOI: <span class="refDoi"> DOI: 10.3762/bjoc.4.20</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.3762%2Fbjoc.4.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18941490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=20&author=S.+K.+Singh&author=N.+Manne&author=M.+Pal&title=Synthesis+of+%28S%29-1-%282-chloroacetyl%29pyrrolidine-2-carbonitrile%3A+a+key+intermediate+for+dipeptidyl+peptidase+IV+inhibitors&doi=10.3762%2Fbjoc.4.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: A key intermediate for dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Singh, Santosh Kumar; Manne, Narendra; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">No. 20, No pp. given</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">An alternative and practical synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile was achieved.  Reaction of L-proline with chloroacetyl chloride was followed by conversion of the carboxylic acid moiety of the resulting N-acylated product into the carbonitrile via the corresponding amide intermediate.  The synthesized pyrrolidine deriv. was utilized to prep. DPP-IV inhibitor Vildagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvAWVRF6xot7Vg90H21EOLACvtfcHk0lh_MCyOLWo3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVaktrg%253D&md5=580782da81b6f0cd36bdc3055ec588e4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.4.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.4.20%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520of%2520%2528S%2529-1-%25282-chloroacetyl%2529pyrrolidine-2-carbonitrile%253A%2520a%2520key%2520intermediate%2520for%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D4%26spage%3D20%26doi%3D10.3762%2Fbjoc.4.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: Identification of dipeptide derived leads</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4154</span><span class="NLM_x">–</span> <span class="NLM_lpage">4158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4154-4158&author=P.+Van+der+Vekenauthor=I.+De+Meesterauthor=V.+Duboisauthor=A.+Sorokaauthor=S.+Van+Goethemauthor=M.+B.+Maesauthor=I.+Brandtauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=K.+Augustyns&title=Inhibitors+of+dipeptidyl+peptidase+8+and+dipeptidyl+peptidase+9.+Part+1%3A+Identification+of+dipeptide+derived+leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DDubois%26aufirst%3DV.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DM.%2BB.%26aulast%3DBrandt%26aufirst%3DI.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%25208%2520and%2520dipeptidyl%2520peptidase%25209.%2520Part%25201%253A%2520Identification%2520of%2520dipeptide%2520derived%2520leads%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4154%26epage%3D4158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito-Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munetomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of potent 1-(2-substituted-aminoacetyl)-4-fluoro-2-cyanopyrrolidine dipeptidyl-peptidase IV inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1110-1117&author=H.+Fukushimaauthor=A.+Hiratateauthor=M.+Takahishiauthor=M.+Saito-Horiauthor=E.+Munetomoauthor=K.+Kitanoauthor=H.+Saitoauthor=Y.+Takaokaauthor=K.+Yamamoto&title=Synthesis+and+structure%E2%80%93activity+relationships+of+potent+1-%282-substituted-aminoacetyl%29-4-fluoro-2-cyanopyrrolidine+dipeptidyl-peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DHiratate%26aufirst%3DA.%26aulast%3DTakahishi%26aufirst%3DM.%26aulast%3DSaito-Hori%26aufirst%3DM.%26aulast%3DMunetomo%26aufirst%3DE.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520potent%25201-%25282-substituted-aminoacetyl%2529-4-fluoro-2-cyanopyrrolidine%2520dipeptidyl-peptidase%2520IV%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D1110%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBernardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, D. H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young-Sciame, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=21-39&author=N.+Kailaauthor=K.+Janzauthor=S.+DeBernardoauthor=P.+W.+Bedardauthor=R.+T.+Camphausenauthor=S.+Tamauthor=D.+H.+H.+Tsaoauthor=J.+C.+Keithauthor=C.+Nickerson-Nutterauthor=A.+Shillingauthor=R.+Young-Sciameauthor=Q.+Wang&title=Synthesis+and+biological+evaluation+of+quinoline+salicylic+acids+as+P-selectin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0602256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602256%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DDeBernardo%26aufirst%3DS.%26aulast%3DBedard%26aufirst%3DP.%2BW.%26aulast%3DCamphausen%26aufirst%3DR.%2BT.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2BH.%2BH.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%26aulast%3DShilling%26aufirst%3DA.%26aulast%3DYoung-Sciame%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520quinoline%2520salicylic%2520acids%2520as%2520P-selectin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Facile and efficient synthesis of quinoline-4-carboxylic acids under microwave irradiation</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.cclet.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=35-38&author=H.+Zhuauthor=R.+F.+Yangauthor=L.+H.+Yunauthor=J.+Li&title=Facile+and+efficient+synthesis+of+quinoline-4-carboxylic+acids+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Facile and efficient synthesis of quinoline-4-carboxylic acids under microwave irradiation</span></div><div class="casAuthors">Zhu, Hui; Yang, Ri Fang; Yun, Liu Hong; Li, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A facile and efficient method for the prepn. of 2-non-substituted quinoline-4-carboxylic acids was described via the Pfitzinger reaction of isatins with sodium pyruvate following consequent decarboxylation under microwave irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ1nY29NGr3LVg90H21EOLACvtfcHk0lh_MCyOLWo3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFeqsLs%253D&md5=e0c608e98502645f881df2ee67fd203c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DYun%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DFacile%2520and%2520efficient%2520synthesis%2520of%2520quinoline-4-carboxylic%2520acids%2520under%2520microwave%2520irradiation%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D21%26spage%3D35%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, P. T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thottathil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polniaszek, R. P.</span><span> </span><span class="NLM_article-title">A practical method for the preparation of A′-chloroketones of <i>N</i>-carbamate protected-α-aminoacids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=3175-3178&author=P.+Chenauthor=P.+T.+W.+Chengauthor=S.+H.+Spergelauthor=R.+Zahlerauthor=X.+Wangauthor=J.+Thottathilauthor=J.+C.+Barrishauthor=R.+P.+Polniaszek&title=A+practical+method+for+the+preparation+of+A%E2%80%B2-chloroketones+of+N-carbamate+protected-%CE%B1-aminoacids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DP.%2BT.%2BW.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DThottathil%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPolniaszek%26aufirst%3DR.%2BP.%26atitle%3DA%2520practical%2520method%2520for%2520the%2520preparation%2520of%2520A%25E2%2580%25B2-chloroketones%2520of%2520N-carbamate%2520protected-%25CE%25B1-aminoacids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D3175%26epage%3D3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">The efficient synthesis and simple resolution of a prolineboronate ester suitable for enzyme-inhibition studies</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=1009-1016&author=T.+Kelly&title=The+efficient+synthesis+and+simple+resolution+of+a+prolineboronate+ester+suitable+for+enzyme-inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DThe%2520efficient%2520synthesis%2520and%2520simple%2520resolution%2520of%2520a%2520prolineboronate%2520ester%2520suitable%2520for%2520enzyme-inhibition%2520studies%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D1009%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Pandey, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naduthambi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zondlo, N. J.</span><span> </span><span class="NLM_article-title">Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">4333</span><span class="NLM_x">–</span> <span class="NLM_lpage">4363</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja3109664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=4333-4363&author=A.+K.+Pandeyauthor=D.+Naduthambiauthor=K.+M.+Thomasauthor=N.+J.+Zondlo&title=Proline+editing%3A+a+general+and+practical+approach+to+the+synthesis+of+functionally+and+structurally+diverse+peptides.+Analysis+of+steric+versus+stereoelectronic+effects+of+4-substituted+prolines+on+conformation+within+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Proline Editing: A General and Practical Approach to the Synthesis of Functionally and Structurally Diverse Peptides. Analysis of Steric versus Stereoelectronic Effects of 4-Substituted Prolines on Conformation within Peptides</span></div><div class="casAuthors">Pandey, Anil K.; Naduthambi, Devan; Thomas, Krista M.; Zondlo, Neal J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4333-4363</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functionalized proline residues have diverse applications.  Herein, the authors describe a practical approach, proline editing, for the synthesis of peptides with stereospecifically modified proline residues.  Peptides are synthesized by std. solid-phase peptide synthesis to incorporate Fmoc-hydroxyproline (4R-Hyp).  In an automated manner, the Hyp hydroxyl is protected and the remainder of the peptide synthesized.  After peptide synthesis, the Hyp protecting group is orthogonally removed and Hyp selectively modified to generate substituted proline amino acids, with the peptide main chain functioning to "protect" the proline amino and carboxyl groups.  In a model tetrapeptide (Ac-TYPN-NH2), 4R-Hyp was stereospecifically converted to 122 different 4-substituted prolyl amino acids, with 4R or 4S stereochem., via Mitsunobu, oxidn., redn., acylation, and substitution reactions.  4-Substituted prolines synthesized via proline editing include incorporated structured amino acid mimetics (Cys, Asp/Glu, Phe, Lys, Arg, pSer/pThr), recognition motifs (biotin, RGD), electron-withdrawing groups to induce stereoelectronic effects (fluoro, nitrobenzoate), handles for heteronuclear NMR (19F:fluoro; pentafluorophenyl or perfluoro-tert-Bu ether; 4,4-difluoro; 77SePh) and other spectroscopies (fluorescence, IR: cyanophenyl ether), leaving groups (sulfonate, halide, NHS, bromoacetate), and other reactive handles (amine, thiol, thioester, ketone, hydroxylamine, maleimide, acrylate, azide, alkene, alkyne, aryl halide, tetrazine, 1,2-aminothiol).  Proline editing provides access to these proline derivs. with no soln.-phase synthesis.  All peptides were analyzed by NMR to identify stereoelectronic and steric effects on conformation.  Proline derivs. were synthesized to permit bioorthogonal conjugation reactions, including azide-alkyne, tetrazine-trans-cyclooctene, oxime, reductive amination, native chem. ligation, Suzuki, Sonogashira, cross-metathesis, and Diels-Alder reactions.  These proline derivs. allowed three parallel bioorthogonal reactions to be conducted in one soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvheFC_32tnbVg90H21EOLACvtfcHk0lhz1NwDwaww5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsL8%253D&md5=f9102ce8cda0f0b4900006b90252ccdb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja3109664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3109664%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%2BK.%26aulast%3DNaduthambi%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DK.%2BM.%26aulast%3DZondlo%26aufirst%3DN.%2BJ.%26atitle%3DProline%2520editing%253A%2520a%2520general%2520and%2520practical%2520approach%2520to%2520the%2520synthesis%2520of%2520functionally%2520and%2520structurally%2520diverse%2520peptides.%2520Analysis%2520of%2520steric%2520versus%2520stereoelectronic%2520effects%2520of%25204-substituted%2520prolines%2520on%2520conformation%2520within%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D4333%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shoulders, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, R. T.</span><span> </span><span class="NLM_article-title">Origin of the stability conferred upon collagen by fluorination</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3859</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.bmcl.2009.03.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19423349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3859-3862&author=M.+D.+Shouldersauthor=K.+J.+Kamerauthor=R.+T.+Raines&title=Origin+of+the+stability+conferred+upon+collagen+by+fluorination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of the stability conferred upon collagen by fluorination</span></div><div class="casAuthors">Shoulders, Matthew D.; Kamer, Kimberli J.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3859-3862</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">According to a prevailing theory, (2S,4R)-4-hydroxyproline (Hyp) residues stabilize the collagen triple helix via a stereoelectronic effect that preorganizes appropriate backbone torsion angles for triple-helix formation.  This theory is consistent with the marked stability that results from replacing the hydroxyl group with the more electron-withdrawing fluoro group, as in (2S,4R)-4-fluoroproline (Flp).  Nonetheless, the hyperstability of triple helixes contg. Flp has been attributed by others to the hydrophobic effect rather than a stereoelectronic effect.  We tested this hypothesis by replacing Hyp with 4,4-difluoroproline (Dfp) in collagen-related peptides.  Dfp retains the hydrophobicity of Flp, but lacks the ability of Flp to preorganize backbone torsion angles.  Unlike Flp, Dfp does not endow triple helixes with elevated stability, indicating that the hyperstability conferred by Flp is not due to the hydrophobic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqor9GAQnbIsbVg90H21EOLACvtfcHk0lhz1NwDwaww5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGnsb8%253D&md5=8ae527760e72313f474dbccf58136757</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.168%26sid%3Dliteratum%253Aachs%26aulast%3DShoulders%26aufirst%3DM.%2BD.%26aulast%3DKamer%26aufirst%3DK.%2BJ.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DOrigin%2520of%2520the%2520stability%2520conferred%2520upon%2520collagen%2520by%2520fluorination%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3859%26epage%3D3862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Mattheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungraithmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEntee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Method comparison of DPP IV activity assays and their application in biological samples containing reversible inhibitors</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.cca.2011.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2012&pages=456-462&author=V.+Mattheeussenauthor=A.+M.+Lambeirauthor=W.+Jungraithmayrauthor=N.+Gomezauthor=K.+McEnteeauthor=P.+Van+der+Vekenauthor=S.+Scharp%C3%A9author=I.+De+Meester&title=Method+comparison+of+DPP+IV+activity+assays+and+their+application+in+biological+samples+containing+reversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2011.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2011.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DMattheeussen%26aufirst%3DV.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DJungraithmayr%26aufirst%3DW.%26aulast%3DGomez%26aufirst%3DN.%26aulast%3DMcEntee%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DMethod%2520comparison%2520of%2520DPP%2520IV%2520activity%2520assays%2520and%2520their%2520application%2520in%2520biological%2520samples%2520containing%2520reversible%2520inhibitors%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D412%26spage%3D456%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 8 (DPP8, DPP9): Is DPP8-selectivity attainable?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5737</span><span class="NLM_x">–</span> <span class="NLM_lpage">5746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200383j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5737-5746&author=S.+Van+Goethemauthor=V.+Mateeussenauthor=J.+Joossensauthor=A.+M.+Lambeirauthor=X.+Chenauthor=I.+De+Meesterauthor=A.+Haemersauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Structure%E2%80%93activity+relationship+studies+on+isoindoline+inhibitors+of+dipeptidyl+peptidases+8+and+8+%28DPP8%2C+DPP9%29%3A+Is+DPP8-selectivity+attainable%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm200383j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200383j%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DMateeussen%26aufirst%3DV.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520on%2520isoindoline%2520inhibitors%2520of%2520dipeptidyl%2520peptidases%25208%2520and%25208%2520%2528DPP8%252C%2520DPP9%2529%253A%2520Is%2520DPP8-selectivity%2520attainable%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5737%26epage%3D5746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 76 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tilmann Grus, Hanane Lahnif, Benedikt Klasen, Euy-Sung Moon, Lukas Greifenstein, <span class="NLM_string-name hlFld-ContribAuthor">Frank Roesch</span>. </span><span class="cited-content_cbyCitation_article-title">Squaric Acid-Based Radiopharmaceuticals for Tumor Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 1223-1231. <a href="https://doi.org/10.1021/acs.bioconjchem.1c00305" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.1c00305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.1c00305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.1c00305%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DSquaric%252BAcid-Based%252BRadiopharmaceuticals%252Bfor%252BTumor%252BImaging%252Band%252BTherapy%26aulast%3DGrus%26aufirst%3DTilmann%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09062021%26date%3D15062021%26date%3D25062021%26volume%3D32%26issue%3D7%26spage%3D1223%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anchen Fu, Hongbo Wang, Taotao Huo, Xinwei Li, Wei Fu, Rongqin Huang, <span class="NLM_string-name hlFld-ContribAuthor">Zhijuan Cao</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (16)
                                     , 6501-6507. <a href="https://doi.org/10.1021/acs.analchem.1c00413" title="DOI URL">https://doi.org/10.1021/acs.analchem.1c00413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.1c00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.1c00413%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DA%252BNovel%252BChemiluminescence%252BProbe%252Bfor%252BSensitive%252BDetection%252Bof%252BFibroblast%252BActivation%252BProtein-Alpha%252BIn%252BVitro%252Band%252Bin%252BLiving%252BSystems%26aulast%3DFu%26aufirst%3DAnchen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28012021%26date%3D09042021%26date%3D19042021%26volume%3D93%26issue%3D16%26spage%3D6501%26epage%3D6507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephanie L. Slania, Deepankar Das, Ala Lisok, Yong Du, Zirui Jiang, Ronnie C. Mease, Steven P. Rowe, Sridhar Nimmagadda, Xing Yang, <span class="NLM_string-name hlFld-ContribAuthor">Martin G. Pomper</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 4059-4070. <a href="https://doi.org/10.1021/acs.jmedchem.0c02171" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImaging%252Bof%252BFibroblast%252BActivation%252BProtein%252Bin%252BCancer%252BXenografts%252BUsing%252BNovel%252B%2525284-Quinolinoyl%252529-glycyl-2-cyanopyrrolidine-Based%252BSmall%252BMolecules%26aulast%3DSlania%26aufirst%3DStephanie%2BL.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D16122020%26date%3D17032021%26volume%3D64%26issue%3D7%26spage%3D4059%26epage%3D4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yibo Zhou, Keyi Yin, Hao Dong, Sheng Yang, JunBin Li, Jinqiu Luo, Yi Li, <span class="NLM_string-name hlFld-ContribAuthor">Ronghua Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (8)
                                     , 3726-3732. <a href="https://doi.org/10.1021/acs.analchem.0c03638" title="DOI URL">https://doi.org/10.1021/acs.analchem.0c03638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.0c03638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.0c03638%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DLong-Lasting%252BBioluminescence%252BImaging%252Bof%252Bthe%252BFibroblast%252BActivation%252BProtein%252Bby%252Ban%252BAmphiphilic%252BBlock%252BCopolymer-Based%252BProbe%26aulast%3DZhou%26aufirst%3DYibo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26082020%26date%3D04022021%26date%3D18022021%26volume%3D93%26issue%3D8%26spage%3D3726%26epage%3D3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuxing Lin, Zhao Ma, Zhenzhen Li, Yuqi Gao, Xiaojun Qin, Zheng Zhang, Guankai Wang, Lupei Du, <span class="NLM_string-name hlFld-ContribAuthor">Minyong Li</span>. </span><span class="cited-content_cbyCitation_article-title">Bioluminescent Probe for Monitoring Endogenous Fibroblast Activation Protein-Alpha. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2019,</strong> <em>91 </em>
                                    (23)
                                     , 14873-14878. <a href="https://doi.org/10.1021/acs.analchem.9b02117" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b02117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b02117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b02117%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DBioluminescent%252BProbe%252Bfor%252BMonitoring%252BEndogenous%252BFibroblast%252BActivation%252BProtein-Alpha%26aulast%3DLin%26aufirst%3DYuxing%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05052019%26date%3D31102019%26date%3D11112019%26date%3D31102019%26volume%3D91%26issue%3D23%26spage%3D14873%26epage%3D14878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jessica Plescia, Stéphane De Cesco, Mihai Burai Patrascu, Jerry Kurian, Justin Di Trani, Caroline Dufresne, Alexander S. Wahba, Naëla Janmamode, Anthony K. Mittermaier, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7874-7884. <a href="https://doi.org/10.1021/acs.jmedchem.9b00642" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BSynthetic%25252C%252BBiophysical%25252C%252Band%252BComputational%252BInvestigations%252Bof%252BCovalent%252BInhibitors%252Bof%252BProlyl%252BOligopeptidase%252Band%252BFibroblast%252BActivation%252BProtein%252B%2525CE%2525B1%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D22082019%26date%3D08082019%26volume%3D62%26issue%3D17%26spage%3D7874%26epage%3D7884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">An De Decker, Gwendolyn Vliegen, Dries Van Rompaey, Anke Peeraer, An Bracke, Line Verckist, Koen Jansen, Ruth Geiss-Friedlander, Koen Augustyns, Hans De Winter, Ingrid De Meester, Anne-Marie Lambeir, <span class="NLM_string-name hlFld-ContribAuthor">Pieter Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1173-1179. <a href="https://doi.org/10.1021/acsmedchemlett.9b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BSmall%252BMolecule-Derived%25252C%252BHighly%252BSelective%252BSubstrates%252Bfor%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DDe%2BDecker%26aufirst%3DAn%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25042019%26date%3D09072019%26date%3D10072019%26date%3D09072019%26volume%3D10%26issue%3D8%26spage%3D1173%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrea Testa, Xavier Lucas, Guilherme V. Castro, Kwok-Ho Chan, Jane E. Wright, Andrew C. Runcie, Morgan S. Gadd, William T. A. Harrison, Eun-Jung Ko, Daniel Fletcher, <span class="NLM_string-name hlFld-ContribAuthor">Alessio Ciulli</span>. </span><span class="cited-content_cbyCitation_article-title">3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (29)
                                     , 9299-9313. <a href="https://doi.org/10.1021/jacs.8b05807" title="DOI URL">https://doi.org/10.1021/jacs.8b05807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b05807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b05807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3D3-Fluoro-4-hydroxyprolines%25253A%252BSynthesis%25252C%252BConformational%252BAnalysis%25252C%252Band%252BStereoselective%252BRecognition%252Bby%252Bthe%252BVHL%252BE3%252BUbiquitin%252BLigase%252Bfor%252BTargeted%252BProtein%252BDegradation%26aulast%3DTesta%26aufirst%3DAndrea%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08062018%26date%3D12072018%26date%3D27062018%26volume%3D140%26issue%3D29%26spage%3D9299%26epage%3D9313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petra  Dvořáková</span>, <span class="hlFld-ContribAuthor ">Petr  Bušek</span>, <span class="hlFld-ContribAuthor ">Tomáš  Knedlík</span>, <span class="hlFld-ContribAuthor ">Jiří  Schimer</span>, <span class="hlFld-ContribAuthor ">Tomáš  Etrych</span>, <span class="hlFld-ContribAuthor ">Libor  Kostka</span>, <span class="hlFld-ContribAuthor ">Lucie  Stollinová Šromová</span>, <span class="hlFld-ContribAuthor ">Vladimír  Šubr</span>, <span class="hlFld-ContribAuthor ">Pavel  Šácha</span>, <span class="hlFld-ContribAuthor ">Aleksi  Šedo</span>, and <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8385-8393. <a href="https://doi.org/10.1021/acs.jmedchem.7b00767" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00767%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitor-Decorated%252BPolymer%252BConjugates%252BTargeting%252BFibroblast%252BActivation%252BProtein%26aulast%3DDvo%25C5%2599%25C3%25A1kov%25C3%25A1%26aufirst%3DPetra%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30052017%26date%3D16102017%26date%3D26102017%26date%3D27092017%26volume%3D60%26issue%3D20%26spage%3D8385%26epage%3D8393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Okugawa</span>, <span class="hlFld-ContribAuthor ">Katsuhiko  Moriyama</span>, and <span class="hlFld-ContribAuthor ">Hideo  Togo</span>  . </span><span class="cited-content_cbyCitation_article-title">Introduction of Quinolines and Isoquinolines onto Nonactivated α-C–H Bond of Tertiary Amides through a Radical Pathway. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (1)
                                     , 170-178. <a href="https://doi.org/10.1021/acs.joc.6b02303" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02303%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIntroduction%252Bof%252BQuinolines%252Band%252BIsoquinolines%252Bonto%252BNonactivated%252B%2525CE%2525B1-C%2525E2%252580%252593H%252BBond%252Bof%252BTertiary%252BAmides%252Bthrough%252Ba%252BRadical%252BPathway%26aulast%3DOkugawa%26aufirst%3DNaoki%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D22092016%26date%3D15122016%26date%3D06012017%26date%3D07122016%26volume%3D82%26issue%3D1%26spage%3D170%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chong  Si</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Fales</span>, <span class="hlFld-ContribAuthor ">Alicia  Torrado</span>, <span class="hlFld-ContribAuthor ">Kwame  Frimpong</span>, <span class="hlFld-ContribAuthor ">Talbi  Kaoudi</span>, <span class="hlFld-ContribAuthor ">Harold George  Vandeveer</span>, and <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>  . </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of 3,3-Difluoropyrrolidin-4-ol, a Valuable Building Block in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (10)
                                     , 4359-4363. <a href="https://doi.org/10.1021/acs.joc.6b00305" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00305%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DEnantioselective%252BSynthesis%252Bof%252B3%25252C3-Difluoropyrrolidin-4-ol%25252C%252Ba%252BValuable%252BBuilding%252BBlock%252Bin%252BMedicinal%252BChemistry%26aulast%3DSi%26aufirst%3DChong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10022016%26date%3D10052016%26date%3D20052016%26date%3D03052016%26volume%3D81%26issue%3D10%26spage%3D4359%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sam  Hofmans</span>, <span class="hlFld-ContribAuthor ">Tom Vanden  Berghe</span>, <span class="hlFld-ContribAuthor ">Lars  Devisscher</span>, <span class="hlFld-ContribAuthor ">Behrouz  Hassannia</span>, <span class="hlFld-ContribAuthor ">Sophie  Lyssens</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Peter  Vandenabeele</span>, and <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 2041-2053. <a href="https://doi.org/10.1021/acs.jmedchem.5b01641" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01641%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BFerroptosis%252BInhibitors%252Bwith%252BImproved%252BPotency%252Band%252BADME%252BProperties%26aulast%3DHofmans%26aufirst%3DSam%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20102015%26date%3D08022016%26date%3D10032016%26date%3D22122015%26volume%3D59%26issue%3D5%26spage%3D2041%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric P.  Gillis</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">David J.  Donnelly</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8315-8359. <a href="https://doi.org/10.1021/acs.jmedchem.5b00258" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DGillis%26aufirst%3DEric%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D22072015%26date%3D12112015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Siikanen</span>, <span class="hlFld-ContribAuthor ">Emma  Jussing</span>, <span class="hlFld-ContribAuthor ">Stefan  Milton</span>, <span class="hlFld-ContribAuthor ">Carsten  Steiger</span>, <span class="hlFld-ContribAuthor ">Johan  Ulin</span>, <span class="hlFld-ContribAuthor ">Cathrine  Jonsson</span>, <span class="hlFld-ContribAuthor ">Erik  Samén</span>, <span class="hlFld-ContribAuthor ">Thuy A.  Tran</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclotron-produced 68Ga from enriched 68Zn foils. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2021,</strong> <em>176 </em>, 109825. <a href="https://doi.org/10.1016/j.apradiso.2021.109825" title="DOI URL">https://doi.org/10.1016/j.apradiso.2021.109825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2021.109825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2021.109825%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DCyclotron-produced%252B68Ga%252Bfrom%252Benriched%252B68Zn%252Bfoils%26aulast%3DSiikanen%26aufirst%3DJonathan%26date%3D2021%26volume%3D176%26spage%3D109825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Tereza  Ormsby</span>, <span class="hlFld-ContribAuthor ">Natan  Sidej</span>, <span class="hlFld-ContribAuthor ">Lenka Poštová  Slavětínská</span>, <span class="hlFld-ContribAuthor ">Jiří  Brynda</span>, <span class="hlFld-ContribAuthor ">Jana  Beranová</span>, <span class="hlFld-ContribAuthor ">Pavel  Šácha</span>, <span class="hlFld-ContribAuthor ">Pavel  Majer</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship and biochemical evaluation of novel fibroblast activation protein and prolyl endopeptidase inhibitors with α-ketoamide warheads. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>23 </em>, 113717. <a href="https://doi.org/10.1016/j.ejmech.2021.113717" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113717%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Band%252Bbiochemical%252Bevaluation%252Bof%252Bnovel%252Bfibroblast%252Bactivation%252Bprotein%252Band%252Bprolyl%252Bendopeptidase%252Binhibitors%252Bwith%252B%2525CE%2525B1-ketoamide%252Bwarheads%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2021%26volume%3D23%26spage%3D113717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuailiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Xu</span>, <span class="hlFld-ContribAuthor ">Jin  Ding</span>, <span class="hlFld-ContribAuthor ">Song  Liu</span>, <span class="hlFld-ContribAuthor ">Xingguo  Hou</span>, <span class="hlFld-ContribAuthor ">Nan  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhi  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1007/s00259-021-05470-5" title="DOI URL">https://doi.org/10.1007/s00259-021-05470-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-021-05470-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-021-05470-5%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DClinical%252Btranslational%252Bevaluation%252Bof%252BAl18F-NOTA-FAPI%252Bfor%252Bfibroblast%252Bactivation%252Bprotein-targeted%252Btumour%252Bimaging%26aulast%3DWang%26aufirst%3DShuailiang%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjana  Ballal</span>, <span class="hlFld-ContribAuthor ">Madhav Prasad  Yadav</span>, <span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Vasko S.  Kramer</span>, <span class="hlFld-ContribAuthor ">Frank  Roesch</span>, <span class="hlFld-ContribAuthor ">Samta  Kumari</span>, <span class="hlFld-ContribAuthor ">Madhavi  Tripathi</span>, <span class="hlFld-ContribAuthor ">Sreedharan Thankarajan  ArunRaj</span>, <span class="hlFld-ContribAuthor ">Sulochana  Sarswat</span>, <span class="hlFld-ContribAuthor ">Chandrasekhar  Bal</span>. </span><span class="cited-content_cbyCitation_article-title">Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (6)
                                     , 1915-1931. <a href="https://doi.org/10.1007/s00259-020-05132-y" title="DOI URL">https://doi.org/10.1007/s00259-020-05132-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-05132-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-05132-y%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DBiodistribution%25252C%252Bpharmacokinetics%25252C%252Bdosimetry%252Bof%252B%25255B68Ga%25255DGa-DOTA.SA.FAPi%25252C%252Band%252Bthe%252Bhead-to-head%252Bcomparison%252Bwith%252B%25255B18F%25255DF-FDG%252BPET%25252FCT%252Bin%252Bpatients%252Bwith%252Bvarious%252Bcancers%26aulast%3DBallal%26aufirst%3DSanjana%26date%3D2021%26date%3D2020%26volume%3D48%26issue%3D6%26spage%3D1915%26epage%3D1931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nasim  Vahidfar</span>, <span class="hlFld-ContribAuthor ">Ayuob  Aghanejad</span>, <span class="hlFld-ContribAuthor ">Hojjat  Ahmadzadehfar</span>, <span class="hlFld-ContribAuthor ">Saeed  Farzanehfar</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Eppard</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic Advances in Breast Cancer in Nuclear Medicine. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (9)
                                     , 4597. <a href="https://doi.org/10.3390/ijms22094597" title="DOI URL">https://doi.org/10.3390/ijms22094597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22094597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22094597%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTheranostic%252BAdvances%252Bin%252BBreast%252BCancer%252Bin%252BNuclear%252BMedicine%26aulast%3DVahidfar%26aufirst%3DNasim%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D9%26spage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narges  Jokar</span>, <span class="hlFld-ContribAuthor ">Irina  Velikyan</span>, <span class="hlFld-ContribAuthor ">Hojjat  Ahmadzadehfar</span>, <span class="hlFld-ContribAuthor ">Seyed Javad  Rekabpour</span>, <span class="hlFld-ContribAuthor ">Esmail  Jafari</span>, <span class="hlFld-ContribAuthor ">Hong Hoi  Ting</span>, <span class="hlFld-ContribAuthor ">Hans-Jürgen  Biersack</span>, <span class="hlFld-ContribAuthor ">Majid  Assadi</span>. </span><span class="cited-content_cbyCitation_article-title">Theranostic Approach in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Nuclear Medicine</span><span> <strong>2021,</strong> <em>Publish Ahead of Print </em><a href="https://doi.org/10.1097/RLU.0000000000003678" title="DOI URL">https://doi.org/10.1097/RLU.0000000000003678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/RLU.0000000000003678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FRLU.0000000000003678%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Nuclear%2520Medicine%26atitle%3DTheranostic%252BApproach%252Bin%252BBreast%252BCancer%26aulast%3DJokar%26aufirst%3DNarges%26date%3D2021%26volume%3DPublish%2520Ahead%2520of%2520Print" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yentl  Van Rymenant</span>, <span class="hlFld-ContribAuthor ">Muhammet  Tanc</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Olivier  De Wever</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Mark  Kockx</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.640566" title="DOI URL">https://doi.org/10.3389/fchem.2021.640566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.640566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.640566%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252BIn%252BSitu%252BActivity-Based%252BLabeling%252Bof%252BFibroblast%252BActivation%252BProtein%252Bwith%252BUAMC1110-Derived%252BProbes%26aulast%3DVan%2BRymenant%26aufirst%3DYentl%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Jin  Jung</span>, <span class="hlFld-ContribAuthor ">Eun Hye  Nam</span>, <span class="hlFld-ContribAuthor ">Jin Young  Park</span>, <span class="hlFld-ContribAuthor ">Prithwish  Ghosh</span>, <span class="hlFld-ContribAuthor ">In Su  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>37 </em>, 127846. <a href="https://doi.org/10.1016/j.bmcl.2021.127846" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127846%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BBR102910%252Bas%252Ba%252Bselective%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Binhibitor%26aulast%3DJung%26aufirst%3DHui%2BJin%26date%3D2021%26volume%3D37%26spage%3D127846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajarshi  Mondal</span>, <span class="hlFld-ContribAuthor ">Mohamed  Agbaria</span>, <span class="hlFld-ContribAuthor ">Zackaria  Nairoukh</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated Rings: Conformation and Application. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1002/chem.202005425" title="DOI URL">https://doi.org/10.1002/chem.202005425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202005425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202005425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFluorinated%252BRings%25253A%252BConformation%252Band%252BApplication%26aulast%3DMondal%26aufirst%3DRajarshi%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James M.  Kelly</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Jeitner</span>, <span class="hlFld-ContribAuthor ">Shashikanth  Ponnala</span>, <span class="hlFld-ContribAuthor ">Clarence  Williams</span>, <span class="hlFld-ContribAuthor ">Anastasia  Nikolopoulou</span>, <span class="hlFld-ContribAuthor ">Stephen G.  DiMagno</span>, <span class="hlFld-ContribAuthor ">John W.  Babich</span>. </span><span class="cited-content_cbyCitation_article-title">A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα). </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.1007/s11307-021-01593-1" title="DOI URL">https://doi.org/10.1007/s11307-021-01593-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-021-01593-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-021-01593-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DA%252BTrifunctional%252BTheranostic%252BLigand%252BTargeting%252BFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252B%252528FAP%2525CE%2525B1%252529%26aulast%3DKelly%26aufirst%3DJames%2BM.%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuailiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Xu</span>, <span class="hlFld-ContribAuthor ">Jin  Ding</span>, <span class="hlFld-ContribAuthor ">Teli  Liu</span>, <span class="hlFld-ContribAuthor ">Jinquan  Jiang</span>, <span class="hlFld-ContribAuthor ">Nan  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhi  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic PET/CT Imaging of 68Ga-FAPI-04 in Chinese Subjects. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.651005" title="DOI URL">https://doi.org/10.3389/fonc.2021.651005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.651005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.651005%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DDynamic%252BPET%25252FCT%252BImaging%252Bof%252B68Ga-FAPI-04%252Bin%252BChinese%252BSubjects%26aulast%3DWang%26aufirst%3DShuailiang%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Koustoulidou</span>, <span class="hlFld-ContribAuthor ">Mark W. H.  Hoorens</span>, <span class="hlFld-ContribAuthor ">Simone U.  Dalm</span>, <span class="hlFld-ContribAuthor ">Shweta  Mahajan</span>, <span class="hlFld-ContribAuthor ">Reno  Debets</span>, <span class="hlFld-ContribAuthor ">Yann  Seimbille</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (5)
                                     , 1100. <a href="https://doi.org/10.3390/cancers13051100" title="DOI URL">https://doi.org/10.3390/cancers13051100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13051100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13051100%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCancer-Associated%252BFibroblasts%252Bas%252BPlayers%252Bin%252BCancer%252BDevelopment%252Band%252BProgression%252Band%252BTheir%252BRole%252Bin%252BTargeted%252BRadionuclide%252BImaging%252Band%252BTherapy%26aulast%3DKoustoulidou%26aufirst%3DSofia%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D5%26spage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjana  Ballal</span>, <span class="hlFld-ContribAuthor ">Madhav Prasad  Yadav</span>, <span class="hlFld-ContribAuthor ">Vasko  Kramer</span>, <span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Frank  Roesch</span>, <span class="hlFld-ContribAuthor ">Madhav  Tripathi</span>, <span class="hlFld-ContribAuthor ">Soumyaranjan  Mallick</span>, <span class="hlFld-ContribAuthor ">Sreedharan Thankarajan  ArunRaj</span>, <span class="hlFld-ContribAuthor ">Chandrasekhar  Bal</span>. </span><span class="cited-content_cbyCitation_article-title">A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (3)
                                     , 942-944. <a href="https://doi.org/10.1007/s00259-020-04990-w" title="DOI URL">https://doi.org/10.1007/s00259-020-04990-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-04990-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-04990-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DA%252Btheranostic%252Bapproach%252Bof%252B%25255B68Ga%25255DGa-DOTA.SA.FAPi%252BPET%25252FCT-guided%252B%25255B177Lu%25255DLu-DOTA.SA.FAPi%252Bradionuclide%252Btherapy%252Bin%252Ban%252Bend-stage%252Bbreast%252Bcancer%252Bpatient%25253A%252Bnew%252Bfrontier%252Bin%252Btargeted%252Bradionuclide%252Btherapy%26aulast%3DBallal%26aufirst%3DSanjana%26date%3D2021%26date%3D2020%26volume%3D48%26issue%3D3%26spage%3D942%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gisela  Schnapp</span>, <span class="hlFld-ContribAuthor ">Yvette  Hoevels</span>, <span class="hlFld-ContribAuthor ">Remko A.  Bakker</span>, <span class="hlFld-ContribAuthor ">Patrick  Schreiner</span>, <span class="hlFld-ContribAuthor ">Thomas  Klein</span>, <span class="hlFld-ContribAuthor ">Herbert  Nar</span>. </span><span class="cited-content_cbyCitation_article-title">A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 630-639. <a href="https://doi.org/10.1002/cmdc.202000591" title="DOI URL">https://doi.org/10.1002/cmdc.202000591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000591%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BSingle%252BSecond%252BShell%252BAmino%252BAcid%252BDetermines%252BAffinity%252Band%252BKinetics%252Bof%252BLinagliptin%252BBinding%252Bto%252BType%252B4%252BDipeptidyl%252BPeptidase%252Band%252BFibroblast%252BActivation%252BProtein%26aulast%3DSchnapp%26aufirst%3DGisela%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D630%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">W Nathaniel  Brennen</span>, <span class="hlFld-ContribAuthor ">Daniel L  J Thorek</span>, <span class="hlFld-ContribAuthor ">Wen  Jiang</span>, <span class="hlFld-ContribAuthor ">Timothy E  Krueger</span>, <span class="hlFld-ContribAuthor ">Lizamma  Antony</span>, <span class="hlFld-ContribAuthor ">Samuel R  Denmeade</span>, <span class="hlFld-ContribAuthor ">John T  Isaacs</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Immunotherapy</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 155-175. <a href="https://doi.org/10.2217/imt-2020-0066" title="DOI URL">https://doi.org/10.2217/imt-2020-0066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/imt-2020-0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fimt-2020-0066%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunotherapy%26atitle%3DOvercoming%252Bstromal%252Bbarriers%252Bto%252Bimmuno-oncological%252Bresponses%252Bvia%252Bfibroblast%252Bactivation%252Bprotein-targeted%252Btherapy%26aulast%3DBrennen%26aufirst%3DW%25C2%25A0Nathaniel%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D155%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Jens  Siveke</span>. </span><span class="cited-content_cbyCitation_article-title">The Latest Developments in Imaging of Fibroblast Activation Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2021,</strong> <em>62 </em>
                                    (2)
                                     , 160-167. <a href="https://doi.org/10.2967/jnumed.120.244806" title="DOI URL">https://doi.org/10.2967/jnumed.120.244806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.120.244806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.120.244806%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DThe%252BLatest%252BDevelopments%252Bin%252BImaging%252Bof%252BFibroblast%252BActivation%252BProtein%26aulast%3DAltmann%26aufirst%3DAnnette%26date%3D2021%26date%3D2020%26volume%3D62%26issue%3D2%26spage%3D160%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Toms</span>, <span class="hlFld-ContribAuthor ">Jürgen  Kogler</span>, <span class="hlFld-ContribAuthor ">Simone  Maschauer</span>, <span class="hlFld-ContribAuthor ">Christoph  Daniel</span>, <span class="hlFld-ContribAuthor ">Christian  Schmidkonz</span>, <span class="hlFld-ContribAuthor ">Torsten  Kuwert</span>, <span class="hlFld-ContribAuthor ">Olaf  Prante</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
              18
              F-Labeled FAP Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2020,</strong> <em>61 </em>
                                    (12)
                                     , 1806-1813. <a href="https://doi.org/10.2967/jnumed.120.242958" title="DOI URL">https://doi.org/10.2967/jnumed.120.242958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.120.242958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.120.242958%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DTargeting%252BFibroblast%252BActivation%252BProtein%25253A%252BRadiosynthesis%252Band%252BPreclinical%252BEvaluation%252Bof%252Ban%252B18%252BF-Labeled%252BFAP%252BInhibitor%26aulast%3DToms%26aufirst%3DJohannes%26date%3D2020%26date%3D2020%26volume%3D61%26issue%3D12%26spage%3D1806%26epage%3D1813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Filipe  Elvas</span>, <span class="hlFld-ContribAuthor ">Gwendolyn  Vliegen</span>, <span class="hlFld-ContribAuthor ">Stef  De Lombaerde</span>, <span class="hlFld-ContribAuthor ">Christel  Vangestel</span>, <span class="hlFld-ContribAuthor ">Sven  De Bruycker</span>, <span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Eppard</span>, <span class="hlFld-ContribAuthor ">Lukas  Greifenstein</span>, <span class="hlFld-ContribAuthor ">Benedikt  Klasen</span>, <span class="hlFld-ContribAuthor ">Vasko  Kramer</span>, <span class="hlFld-ContribAuthor ">Steven  Staelens</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-020-00102-z" title="DOI URL">https://doi.org/10.1186/s41181-020-00102-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-020-00102-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-020-00102-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DTargeting%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%25253A%252Bnext%252Bgeneration%252BPET%252Bradiotracers%252Busing%252Bsquaramide%252Bcoupled%252Bbifunctional%252BDOTA%252Band%252BDATA5m%252Bchelators%26aulast%3DMoon%26aufirst%3DEuy%2BSung%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Susanne  Krämer</span>, <span class="hlFld-ContribAuthor ">Christian  Kleist</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Frederik  Giesel</span>, <span class="hlFld-ContribAuthor ">Walter  Mier</span>, <span class="hlFld-ContribAuthor ">Frederik  Marme</span>, <span class="hlFld-ContribAuthor ">Jürgen  Debus</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Development of
              99m
              Tc-Labeled FAPI Tracers for SPECT Imaging and
              188
              Re Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2020,</strong> <em>61 </em>
                                    (10)
                                     , 1507-1513. <a href="https://doi.org/10.2967/jnumed.119.239731" title="DOI URL">https://doi.org/10.2967/jnumed.119.239731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.119.239731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.119.239731%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DDesign%252Band%252BDevelopment%252Bof%252B99m%252BTc-Labeled%252BFAPI%252BTracers%252Bfor%252BSPECT%252BImaging%252Band%252B188%252BRe%252BTherapy%26aulast%3DLindner%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26volume%3D61%26issue%3D10%26spage%3D1507%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Kreppel</span>, <span class="hlFld-ContribAuthor ">Florian C.  Gärtner</span>, <span class="hlFld-ContribAuthor ">Milka  Marinova</span>, <span class="hlFld-ContribAuthor ">Ulrike  Attenberger</span>, <span class="hlFld-ContribAuthor ">Michael  Meisenheimer</span>, <span class="hlFld-ContribAuthor ">Marieta  Toma</span>, <span class="hlFld-ContribAuthor ">Glen  Kristiansen</span>, <span class="hlFld-ContribAuthor ">Georg  Feldmann</span>, <span class="hlFld-ContribAuthor ">Euy Sung  Moon</span>, <span class="hlFld-ContribAuthor ">Frank  Roesch</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Markus  Essler</span>. </span><span class="cited-content_cbyCitation_article-title">[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging. </span><span class="cited-content_cbyCitation_journal-name">Nuklearmedizin</span><span> <strong>2020,</strong> <em>59 </em>
                                    (05)
                                     , 387-389. <a href="https://doi.org/10.1055/a-1164-5667" title="DOI URL">https://doi.org/10.1055/a-1164-5667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1164-5667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1164-5667%26sid%3Dliteratum%253Aachs%26jtitle%3DNuklearmedizin%26atitle%3D%25255B68Ga%25255DGa-DATA5m.SA.FAPi%252BPET%25252FCT%25253A%252BSpecific%252BTracer-uptake%252Bin%252BFocal%252BNodular%252BHyperplasia%252Band%252Bpotential%252BRole%252Bin%252BLiver%252BTumor%252BImaging%26aulast%3DKreppel%26aufirst%3DBarbara%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D05%26spage%3D387%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allison A.  Fitzgerald</span>, <span class="hlFld-ContribAuthor ">Louis M.  Weiner</span>. </span><span class="cited-content_cbyCitation_article-title">The role of fibroblast activation protein in health and malignancy. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2020,</strong> <em>39 </em>
                                    (3)
                                     , 783-803. <a href="https://doi.org/10.1007/s10555-020-09909-3" title="DOI URL">https://doi.org/10.1007/s10555-020-09909-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-020-09909-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-020-09909-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DThe%252Brole%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bin%252Bhealth%252Band%252Bmalignancy%26aulast%3DFitzgerald%26aufirst%3DAllison%2BA.%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D3%26spage%3D783%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adéla  Šimková</span>, <span class="hlFld-ContribAuthor ">Petr  Bušek</span>, <span class="hlFld-ContribAuthor ">Aleksi  Šedo</span>, <span class="hlFld-ContribAuthor ">Jan  Konvalinka</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (7)
                                     , 140409. <a href="https://doi.org/10.1016/j.bbapap.2020.140409" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140409%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DMolecular%252Brecognition%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bfor%252Bdiagnostic%252Band%252Btherapeutic%252Bapplications%26aulast%3D%25C5%25A0imkov%25C3%25A1%26aufirst%3DAd%25C3%25A9la%26date%3D2020%26volume%3D1868%26issue%3D7%26spage%3D140409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingye  Zhang</span>, <span class="hlFld-ContribAuthor ">Futao  Liu</span>, <span class="hlFld-ContribAuthor ">Min-Fu  Yang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Rongfu  Wang</span>, <span class="hlFld-ContribAuthor ">Xing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A cell-based fluorescent assay for FAP inhibitor discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127253. <a href="https://doi.org/10.1016/j.bmcl.2020.127253" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bcell-based%252Bfluorescent%252Bassay%252Bfor%252BFAP%252Binhibitor%252Bdiscovery%26aulast%3DZhang%26aufirst%3DBingye%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of boronic acid drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112270. <a href="https://doi.org/10.1016/j.ejmech.2020.112270" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112270%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252Bboronic%252Bacid%252Bdrugs%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D195%26spage%3D112270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Röhrich</span>, <span class="hlFld-ContribAuthor ">Ralf  Floca</span>, <span class="hlFld-ContribAuthor ">Lisa  Loi</span>, <span class="hlFld-ContribAuthor ">Sebastian  Adeberg</span>, <span class="hlFld-ContribAuthor ">Paul  Windisch</span>, <span class="hlFld-ContribAuthor ">Frederik L.  Giesel</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Paul  Flechsig</span>, <span class="hlFld-ContribAuthor ">Hendrik  Rathke</span>, <span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Heinz Peter  Schlemmer</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Daniel  Paech</span>. </span><span class="cited-content_cbyCitation_article-title">FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Radiology</span><span> <strong>2020,</strong> <em>127 </em>, 109021. <a href="https://doi.org/10.1016/j.ejrad.2020.109021" title="DOI URL">https://doi.org/10.1016/j.ejrad.2020.109021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejrad.2020.109021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejrad.2020.109021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Radiology%26atitle%3DFAP-specific%252BPET%252Bsignaling%252Bshows%252Ba%252Bmoderately%252Bpositive%252Bcorrelation%252Bwith%252Brelative%252BCBV%252Band%252Bno%252Bcorrelation%252Bwith%252BADC%252Bin%252B13%252BIDH%252Bwildtype%252Bglioblastomas%26aulast%3DR%25C3%25B6hrich%26aufirst%3DManuel%26date%3D2020%26volume%3D127%26spage%3D109021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Palano</span>, <span class="hlFld-ContribAuthor ">M.  Jansson</span>, <span class="hlFld-ContribAuthor ">A.  Backmark</span>, <span class="hlFld-ContribAuthor ">S.  Martinsson</span>, <span class="hlFld-ContribAuthor ">A.  Sabirsh</span>, <span class="hlFld-ContribAuthor ">K.  Hultenby</span>, <span class="hlFld-ContribAuthor ">P.  Åkerblad</span>, <span class="hlFld-ContribAuthor ">K.L.  Granberg</span>, <span class="hlFld-ContribAuthor ">K.  Jennbacken</span>, <span class="hlFld-ContribAuthor ">E.  Müllers</span>, <span class="hlFld-ContribAuthor ">E.M.  Hansson</span>. </span><span class="cited-content_cbyCitation_article-title">A high-content, in vitro cardiac fibrosis assay for high-throughput, phenotypic identification of compounds with anti-fibrotic activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular and Cellular Cardiology</span><span> <strong>2020,</strong> <em>142 </em>, 105-117. <a href="https://doi.org/10.1016/j.yjmcc.2020.04.002" title="DOI URL">https://doi.org/10.1016/j.yjmcc.2020.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yjmcc.2020.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yjmcc.2020.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520and%2520Cellular%2520Cardiology%26atitle%3DA%252Bhigh-content%25252C%252Bin%252Bvitro%252Bcardiac%252Bfibrosis%252Bassay%252Bfor%252Bhigh-throughput%25252C%252Bphenotypic%252Bidentification%252Bof%252Bcompounds%252Bwith%252Banti-fibrotic%252Bactivity%26aulast%3DPalano%26aufirst%3DG.%26date%3D2020%26volume%3D142%26spage%3D105%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Kawano</span>, <span class="hlFld-ContribAuthor ">Carlos H. T.  de Paula da Silva</span>, <span class="hlFld-ContribAuthor ">Carlton A.  Taft</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Inhibitors of the Human Fibroblast Activation Protein α as a Strategy to Hinder Metastasis and Angiogenesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 277-303. <a href="https://doi.org/10.1007/978-3-030-31403-3_11" title="DOI URL">https://doi.org/10.1007/978-3-030-31403-3_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-31403-3_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-31403-3_11%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BInhibitors%252Bof%252Bthe%252BHuman%252BFibroblast%252BActivation%252BProtein%252B%2525CE%2525B1%252Bas%252Ba%252BStrategy%252Bto%252BHinder%252BMetastasis%252Band%252BAngiogenesis%26aulast%3DKawano%26aufirst%3DDaniel%2BF.%26date%3D2020%26date%3D2020%26spage%3D277%26epage%3D303%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEmerging%252BResearch%252Bin%252BScience%252Band%252BEngineering%252BBased%252Bon%252BAdvanced%252BExperimental%252Band%252BComputational%252BStrategies%26aulast%3DLa%2BPorta%26aufirst%3DFelipe%2Bde%2BAlmeida%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. Prakash  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic reactions in the synthesis of organofluorine compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-42. <a href="https://doi.org/10.1016/B978-0-12-813286-9.00001-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-813286-9.00001-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813286-9.00001-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813286-9.00001-8%26sid%3Dliteratum%253Aachs%26atitle%3DNucleophilic%252Breactions%252Bin%252Bthe%252Bsynthesis%252Bof%252Borganofluorine%252Bcompounds%26aulast%3DReddy%26aufirst%3DV.%2BPrakash%26date%3D2020%26spage%3D1%26epage%3D42%26pub%3DElsevier%26atitle%3DOrganofluorine%252BChemistry%26date%3D2020%26volume%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Caroline  Dufresne</span>, <span class="hlFld-ContribAuthor ">Naëla  Janmamode</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Wahba</span>, <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of covalent prolyl oligopeptidase boronic ester inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111783. <a href="https://doi.org/10.1016/j.ejmech.2019.111783" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111783%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcovalent%252Bprolyl%252Boligopeptidase%252Bboronic%252Bester%252Binhibitors%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D185%26spage%3D111783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Wu</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Sun</span>, <span class="hlFld-ContribAuthor ">Peng  Cai</span>, <span class="hlFld-ContribAuthor ">Ligao  Wu</span>, <span class="hlFld-ContribAuthor ">Duojie  Li</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Fibroblast Activation Protein-α Expressing Fibroblasts Promote Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma</p>. </span><span class="cited-content_cbyCitation_journal-name">OncoTargets and Therapy</span><span> <strong>2020,</strong> <em>Volume 13 </em>, 8141-8148. <a href="https://doi.org/10.2147/OTT.S257529" title="DOI URL">https://doi.org/10.2147/OTT.S257529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/OTT.S257529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FOTT.S257529%26sid%3Dliteratum%253Aachs%26jtitle%3DOncoTargets%2520and%2520Therapy%26atitle%3D%25253Cp%25253EFibroblast%252BActivation%252BProtein-%2525CE%2525B1%252BExpressing%252BFibroblasts%252BPromote%252BLymph%252BNode%252BMetastasis%252Bin%252BEsophageal%252BSquamous%252BCell%252BCarcinoma%25253C%25252Fp%25253E%26aulast%3DLi%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26volume%3DVolume%252013%26spage%3D8141%26epage%3D8148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peihua  Guo</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Wang</span>, <span class="hlFld-ContribAuthor ">Kuiling  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chiral Tertiary α,α‐Difluoromethyl Carbinols by Cu‐Catalyzed Asymmetric Propargylation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (71)
                                     , 16425-16434. <a href="https://doi.org/10.1002/chem.201904543" title="DOI URL">https://doi.org/10.1002/chem.201904543</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201904543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201904543%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSynthesis%252Bof%252BChiral%252BTertiary%252B%2525CE%2525B1%25252C%2525CE%2525B1%2525E2%252580%252590Difluoromethyl%252BCarbinols%252Bby%252BCu%2525E2%252580%252590Catalyzed%252BAsymmetric%252BPropargylation%26aulast%3DGuo%26aufirst%3DPeihua%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D71%26spage%3D16425%26epage%3D16434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Frederik  Giesel</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting of activated fibroblasts for imaging and therapy. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-019-0069-0" title="DOI URL">https://doi.org/10.1186/s41181-019-0069-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-019-0069-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-019-0069-0%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DTargeting%252Bof%252Bactivated%252Bfibroblasts%252Bfor%252Bimaging%252Band%252Btherapy%26aulast%3DLindner%26aufirst%3DThomas%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Johannes  Czernin</span>. </span><span class="cited-content_cbyCitation_article-title">A Conversation Between Uwe Haberkorn and Johannes Czernin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (11)
                                     , 1495-1498. <a href="https://doi.org/10.2967/jnumed.119.236760" title="DOI URL">https://doi.org/10.2967/jnumed.119.236760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.119.236760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.119.236760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DA%252BConversation%252BBetween%252BUwe%252BHaberkorn%252Band%252BJohannes%252BCzernin%26aulast%3DHaberkorn%26aufirst%3DUwe%26date%3D2019%26date%3D2019%26volume%3D60%26issue%3D11%26spage%3D1495%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An  Bracke</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>. </span><span class="cited-content_cbyCitation_article-title">The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma. </span><span class="cited-content_cbyCitation_journal-name">Clinica Chimica Acta</span><span> <strong>2019,</strong> <em>495 </em>, 154-160. <a href="https://doi.org/10.1016/j.cca.2019.04.063" title="DOI URL">https://doi.org/10.1016/j.cca.2019.04.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cca.2019.04.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cca.2019.04.063%26sid%3Dliteratum%253Aachs%26jtitle%3DClinica%2520Chimica%2520Acta%26atitle%3DThe%252Bdevelopment%252Band%252Bvalidation%252Bof%252Ba%252Bcombined%252Bkinetic%252Bfluorometric%252Bactivity%252Bassay%252Bfor%252Bfibroblast%252Bactivation%252Bprotein%252Balpha%252Band%252Bprolyl%252Boligopeptidase%252Bin%252Bplasma%26aulast%3DBracke%26aufirst%3DAn%26date%3D2019%26volume%3D495%26spage%3D154%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Saravanan  Parameswaran</span>, <span class="hlFld-ContribAuthor ">Rohit  Bavi</span>, <span class="hlFld-ContribAuthor ">Ayoung  Baek</span>, <span class="hlFld-ContribAuthor ">Minky  Son</span>, <span class="hlFld-ContribAuthor ">Shailima  Rampogu</span>, <span class="hlFld-ContribAuthor ">Chanin  Park</span>, <span class="hlFld-ContribAuthor ">Gihwan  Lee</span>, <span class="hlFld-ContribAuthor ">Amir  Zeb</span>, <span class="hlFld-ContribAuthor ">Shraddha  Parate</span>, <span class="hlFld-ContribAuthor ">Rabia Mukhtar  Rana</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>88 </em>, 92-103. <a href="https://doi.org/10.1016/j.jmgm.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DInvestigation%252Bof%252Bnovel%252Bchemical%252Bscaffolds%252Btargeting%252Bprolyl%252Boligopeptidase%252Bfor%252Bneurological%252Btherapeutics%26aulast%3DKumar%26aufirst%3DRaj%26date%3D2019%26volume%3D88%26spage%3D92%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Gunderson</span>, <span class="hlFld-ContribAuthor ">Tomoko  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Kayla  McCarty</span>, <span class="hlFld-ContribAuthor ">Michaela  Phillips</span>, <span class="hlFld-ContribAuthor ">Alejandro  Alice</span>, <span class="hlFld-ContribAuthor ">Shelly  Bambina</span>, <span class="hlFld-ContribAuthor ">Lauren  Zebertavage</span>, <span class="hlFld-ContribAuthor ">David  Friedman</span>, <span class="hlFld-ContribAuthor ">Benjamin  Cottam</span>, <span class="hlFld-ContribAuthor ">Pippa  Newell</span>, <span class="hlFld-ContribAuthor ">Michael J.  Gough</span>, <span class="hlFld-ContribAuthor ">Marka R.  Crittenden</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>, <span class="hlFld-ContribAuthor ">Kristina H.  Young</span>, . </span><span class="cited-content_cbyCitation_article-title">Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (2)
                                     , e0211117. <a href="https://doi.org/10.1371/journal.pone.0211117" title="DOI URL">https://doi.org/10.1371/journal.pone.0211117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0211117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0211117%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DBlockade%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bin%252Bcombination%252Bwith%252Bradiation%252Btreatment%252Bin%252Bmurine%252Bmodels%252Bof%252Bpancreatic%252Badenocarcinoma%26aulast%3DGunderson%26aufirst%3DAndrew%2BJ.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D2%26spage%3De0211117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalia M  de Vasconcelos</span>, <span class="hlFld-ContribAuthor ">Gwendolyn  Vliegen</span>, <span class="hlFld-ContribAuthor ">Amanda  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Emilie  De Hert</span>, <span class="hlFld-ContribAuthor ">Rosa  Martín-Pérez</span>, <span class="hlFld-ContribAuthor ">Nina  Van Opdenbosch</span>, <span class="hlFld-ContribAuthor ">Anvesh  Jallapally</span>, <span class="hlFld-ContribAuthor ">Ruth  Geiss-Friedlander</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Mohamed  Lamkanfi</span>. </span><span class="cited-content_cbyCitation_article-title">DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages. </span><span class="cited-content_cbyCitation_journal-name">Life Science Alliance</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , e201900313. <a href="https://doi.org/10.26508/lsa.201900313" title="DOI URL">https://doi.org/10.26508/lsa.201900313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.26508/lsa.201900313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.26508%2Flsa.201900313%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Science%2520Alliance%26atitle%3DDPP8%25252FDPP9%252Binhibition%252Belicits%252Bcanonical%252BNlrp1b%252Binflammasome%252Bhallmarks%252Bin%252Bmurine%252Bmacrophages%26aulast%3Dde%2BVasconcelos%26aufirst%3DNathalia%2BM%26date%3D2019%26date%3D2019%26volume%3D2%26issue%3D1%26spage%3De201900313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brandon L.  Panaro</span>, <span class="hlFld-ContribAuthor ">Andrew L.  Coppage</span>, <span class="hlFld-ContribAuthor ">Jacqueline L.  Beaudry</span>, <span class="hlFld-ContribAuthor ">Elodie M.  Varin</span>, <span class="hlFld-ContribAuthor ">Kirandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Jack H.  Lai</span>, <span class="hlFld-ContribAuthor ">Wengen  Wu</span>, <span class="hlFld-ContribAuthor ">Yuxin  Liu</span>, <span class="hlFld-ContribAuthor ">William W.  Bachovchin</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Drucker</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2019,</strong> <em>19 </em>, 65-74. <a href="https://doi.org/10.1016/j.molmet.2018.10.011" title="DOI URL">https://doi.org/10.1016/j.molmet.2018.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2018.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DFibroblast%252Bactivation%252Bprotein%252Bis%252Bdispensable%252Bfor%252Bcontrol%252Bof%252Bglucose%252Bhomeostasis%252Band%252Bbody%252Bweight%252Bin%252Bmice%26aulast%3DPanaro%26aufirst%3DBrandon%2BL.%26date%3D2019%26volume%3D19%26spage%3D65%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bastien  Michelet</span>, <span class="hlFld-ContribAuthor ">Hélène  Carreyre</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lecornué</span>, <span class="hlFld-ContribAuthor ">Agnès  Mingot</span>, <span class="hlFld-ContribAuthor ">Sébastien  Thibaudeau</span>. </span><span class="cited-content_cbyCitation_article-title">Superelectrophilic activation in superacid HF/SbF5: Expanding molecular diversity in nitrogen-containing compounds series by fluorination. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2018,</strong> <em>214 </em>, 68-79. <a href="https://doi.org/10.1016/j.jfluchem.2018.04.017" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2018.04.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2018.04.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSuperelectrophilic%252Bactivation%252Bin%252Bsuperacid%252BHF%25252FSbF5%25253A%252BExpanding%252Bmolecular%252Bdiversity%252Bin%252Bnitrogen-containing%252Bcompounds%252Bseries%252Bby%252Bfluorination%26aulast%3DMichelet%26aufirst%3DBastien%26date%3D2018%26volume%3D214%26spage%3D68%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanbing  Liang</span>, <span class="hlFld-ContribAuthor ">Long  Meng</span>, <span class="hlFld-ContribAuthor ">Xiaochen  Chi</span>, <span class="hlFld-ContribAuthor ">Shuzhi  Yao</span>, <span class="hlFld-ContribAuthor ">Hongshuai  Chen</span>, <span class="hlFld-ContribAuthor ">Luyang  Jiao</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Daopeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Yunhui  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium/Copper Co-Catalyzed Cascade Metallo-ene/Sonogashira Coupling Reaction of Allenamides. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (9)
                                     , 1793-1796. <a href="https://doi.org/10.1002/ajoc.201800377" title="DOI URL">https://doi.org/10.1002/ajoc.201800377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800377%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium%25252FCopper%252BCo-Catalyzed%252BCascade%252BMetallo-ene%25252FSonogashira%252BCoupling%252BReaction%252Bof%252BAllenamides%26aulast%3DLiang%26aufirst%3DHanbing%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D9%26spage%3D1793%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Lindner</span>, <span class="hlFld-ContribAuthor ">Anastasia  Loktev</span>, <span class="hlFld-ContribAuthor ">Annette  Altmann</span>, <span class="hlFld-ContribAuthor ">Frederik  Giesel</span>, <span class="hlFld-ContribAuthor ">Clemens  Kratochwil</span>, <span class="hlFld-ContribAuthor ">Jürgen  Debus</span>, <span class="hlFld-ContribAuthor ">Dirk  Jäger</span>, <span class="hlFld-ContribAuthor ">Walter  Mier</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (9)
                                     , 1415-1422. <a href="https://doi.org/10.2967/jnumed.118.210443" title="DOI URL">https://doi.org/10.2967/jnumed.118.210443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.210443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.210443%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DDevelopment%252Bof%252BQuinoline-Based%252BTheranostic%252BLigands%252Bfor%252Bthe%252BTargeting%252Bof%252BFibroblast%252BActivation%252BProtein%26aulast%3DLindner%26aufirst%3DThomas%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D9%26spage%3D1415%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens T.  Siveke</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (9)
                                     , 1412-1414. <a href="https://doi.org/10.2967/jnumed.118.214361" title="DOI URL">https://doi.org/10.2967/jnumed.118.214361</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.214361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.214361%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DFibroblast-Activating%252BProtein%25253A%252BTargeting%252Bthe%252BRoots%252Bof%252Bthe%252BTumor%252BMicroenvironment%26aulast%3DSiveke%26aufirst%3DJens%2BT.%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D9%26spage%3D1412%26epage%3D1414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  Puré</span>, <span class="hlFld-ContribAuthor ">Rachel  Blomberg</span>. </span><span class="cited-content_cbyCitation_article-title">Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2018,</strong> <em>37 </em>
                                    (32)
                                     , 4343-4357. <a href="https://doi.org/10.1038/s41388-018-0275-3" title="DOI URL">https://doi.org/10.1038/s41388-018-0275-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-018-0275-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-018-0275-3%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DPro-tumorigenic%252Broles%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252Bin%252Bcancer%25253A%252Bback%252Bto%252Bthe%252Bbasics%26aulast%3DPur%25C3%25A9%26aufirst%3DEllen%26date%3D2018%26date%3D2018%26volume%3D37%26issue%3D32%26spage%3D4343%26epage%3D4357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Rohit  Bavi</span>, <span class="hlFld-ContribAuthor ">Min Gi  Jo</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Arulalapperumal</span>, <span class="hlFld-ContribAuthor ">Ayoung  Baek</span>, <span class="hlFld-ContribAuthor ">Shailima  Rampogu</span>, <span class="hlFld-ContribAuthor ">Myeong Ok  Kim</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">New compounds identified through in silico approaches reduce the α-synuclein expression by inhibiting prolyl oligopeptidase in vitro. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-11302-0" title="DOI URL">https://doi.org/10.1038/s41598-017-11302-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-11302-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-11302-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DNew%252Bcompounds%252Bidentified%252Bthrough%252Bin%252Bsilico%252Bapproaches%252Breduce%252Bthe%252B%2525CE%2525B1-synuclein%252Bexpression%252Bby%252Binhibiting%252Bprolyl%252Boligopeptidase%252Bin%252Bvitro%26aulast%3DKumar%26aufirst%3DRaj%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis W.  Bainbridge</span>, <span class="hlFld-ContribAuthor ">Diana Ronai  Dunshee</span>, <span class="hlFld-ContribAuthor ">Noelyn M.  Kljavin</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Skelton</span>, <span class="hlFld-ContribAuthor ">Junichiro  Sonoda</span>, <span class="hlFld-ContribAuthor ">James A.  Ernst</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP). </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-12900-8" title="DOI URL">https://doi.org/10.1038/s41598-017-12900-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-12900-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-12900-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSelective%252BHomogeneous%252BAssay%252Bfor%252BCirculating%252BEndopeptidase%252BFibroblast%252BActivation%252BProtein%252B%252528FAP%252529%26aulast%3DBainbridge%26aufirst%3DTravis%2BW.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>, <span class="hlFld-ContribAuthor ">Petra  Tafelmeyer</span>, <span class="hlFld-ContribAuthor ">Dela  Golshayan</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (10)
                                     , 977-991. <a href="https://doi.org/10.1080/14728222.2017.1370455" title="DOI URL">https://doi.org/10.1080/14728222.2017.1370455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1370455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1370455%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DFibroblast%252Bactivation%252Bprotein-%2525CE%2525B1%252Bin%252Bfibrogenic%252Bdisorders%252Band%252Bcancer%25253A%252Bmore%252Bthan%252Ba%252Bprolyl-specific%252Bpeptidase%25253F%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D10%26spage%3D977%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean  Rea</span>, <span class="hlFld-ContribAuthor ">Roos  Van Elzen</span>, <span class="hlFld-ContribAuthor ">Hans  De Winter</span>, <span class="hlFld-ContribAuthor ">Sebastiaan  Van Goethem</span>, <span class="hlFld-ContribAuthor ">Bart  Landuyt</span>, <span class="hlFld-ContribAuthor ">Walter  Luyten</span>, <span class="hlFld-ContribAuthor ">Liliane  Schoofs</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Vilmos  Fülöp</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 482-491. <a href="https://doi.org/10.1016/j.ejmech.2017.08.024" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCrystal%252Bstructure%252Bof%252BPorphyromonas%252Bgingivalis%252Bdipeptidyl%252Bpeptidase%252B4%252Band%252Bstructure-activity%252Brelationships%252Bbased%252Bon%252Binhibitor%252Bprofiling%26aulast%3DRea%26aufirst%3DDean%26date%3D2017%26volume%3D139%26spage%3D482%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sunetra J.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Reshma B.  Patil</span>, <span class="hlFld-ContribAuthor ">Digambar R.  Kumbhar</span>, <span class="hlFld-ContribAuthor ">Ajinkya A.  Patravale</span>, <span class="hlFld-ContribAuthor ">Dattatraya R.  Chandam</span>, <span class="hlFld-ContribAuthor ">Madhukar B.  Deshmukh</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfamic acid-catalyzed multicomponent synthesis of 7-phenyl-7,12 dihydrobenzo(h)pyrido[2,3-b]naphthydrin-6(5H)-one derivatives: a green avenue. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (4)
                                     , 2529-2543. <a href="https://doi.org/10.1007/s11164-016-2778-2" title="DOI URL">https://doi.org/10.1007/s11164-016-2778-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2778-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2778-2%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DSulfamic%252Bacid-catalyzed%252Bmulticomponent%252Bsynthesis%252Bof%252B7-phenyl-7%25252C12%252Bdihydrobenzo%252528h%252529pyrido%25255B2%25252C3-b%25255Dnaphthydrin-6%2525285H%252529-one%252Bderivatives%25253A%252Ba%252Bgreen%252Bavenue%26aulast%3DJadhav%26aufirst%3DSunetra%2BJ.%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D4%26spage%3D2529%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Thibaudeau</span>, <span class="hlFld-ContribAuthor ">H.  Carreyre</span>, <span class="hlFld-ContribAuthor ">A.  Mingot</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Fluorinated Nitrogen-Containing Compounds Through Superelectrophilic Activation in Superacid HF/SbF5∗∗This work is dedicated to Pr Jean-Claude Jacquesy with great consideration.. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 349-388. <a href="https://doi.org/10.1016/B978-0-12-803740-9.00013-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-803740-9.00013-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803740-9.00013-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803740-9.00013-5%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BFluorinated%252BNitrogen-Containing%252BCompounds%252BThrough%252BSuperelectrophilic%252BActivation%252Bin%252BSuperacid%252BHF%25252FSbF5%2525E2%252588%252597%2525E2%252588%252597This%252Bwork%252Bis%252Bdedicated%252Bto%252BPr%252BJean-Claude%252BJacquesy%252Bwith%252Bgreat%252Bconsideration.%26aulast%3DThibaudeau%26aufirst%3DS.%26date%3D2017%26spage%3D349%26epage%3D388%26pub%3DElsevier%26atitle%3DModern%252BSynthesis%252BProcesses%252Band%252BReactivity%252Bof%252BFluorinated%252BCompounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christelle  Doebelin</span>, <span class="hlFld-ContribAuthor ">Yuanjun  He</span>, <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>. </span><span class="cited-content_cbyCitation_article-title">Multigram-scale synthesis of enantiopure 3,3-difluoroproline. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (50)
                                     , 5658-5660. <a href="https://doi.org/10.1016/j.tetlet.2016.11.012" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMultigram-scale%252Bsynthesis%252Bof%252Benantiopure%252B3%25252C3-difluoroproline%26aulast%3DDoebelin%26aufirst%3DChristelle%26date%3D2016%26volume%3D57%26issue%3D50%26spage%3D5658%26epage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph R.  Lizza</span>, <span class="hlFld-ContribAuthor ">Savan V.  Patel</span>, <span class="hlFld-ContribAuthor ">Catherine F.  Yang</span>, <span class="hlFld-ContribAuthor ">Gustavo  Moura-Letts</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of Cyanopyrrolidinyl β-Amino Alcohols for the Development of Diabetes Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (30)
                                     , 5160-5168. <a href="https://doi.org/10.1002/ejoc.201600969" title="DOI URL">https://doi.org/10.1002/ejoc.201600969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600969%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252BCyanopyrrolidinyl%252B%2525CE%2525B2-Amino%252BAlcohols%252Bfor%252Bthe%252BDevelopment%252Bof%252BDiabetes%252BTherapeutics%26aulast%3DLizza%26aufirst%3DJoseph%2BR.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D30%26spage%3D5160%26epage%3D5168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  Busek</span>, <span class="hlFld-ContribAuthor ">Zdislava  Vanickova</span>, <span class="hlFld-ContribAuthor ">Petr  Hrabal</span>, <span class="hlFld-ContribAuthor ">Marek  Brabec</span>, <span class="hlFld-ContribAuthor ">Premysl  Fric</span>, <span class="hlFld-ContribAuthor ">Miroslav  Zavoral</span>, <span class="hlFld-ContribAuthor ">Jan  Skrha</span>, <span class="hlFld-ContribAuthor ">Klara  Kmochova</span>, <span class="hlFld-ContribAuthor ">Martin  Laclav</span>, <span class="hlFld-ContribAuthor ">Bohus  Bunganic</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  Van Der Veken</span>, <span class="hlFld-ContribAuthor ">Aleksi  Sedo</span>. </span><span class="cited-content_cbyCitation_article-title">Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Pancreatology</span><span> <strong>2016,</strong> <em>16 </em>
                                    (5)
                                     , 829-838. <a href="https://doi.org/10.1016/j.pan.2016.06.001" title="DOI URL">https://doi.org/10.1016/j.pan.2016.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pan.2016.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pan.2016.06.001%26sid%3Dliteratum%253Aachs%26jtitle%3DPancreatology%26atitle%3DIncreased%252Btissue%252Band%252Bcirculating%252Blevels%252Bof%252Bdipeptidyl%252Bpeptidase-IV%252Benzymatic%252Bactivity%252Bin%252Bpatients%252Bwith%252Bpancreatic%252Bductal%252Badenocarcinoma%26aulast%3DBusek%26aufirst%3DPetr%26date%3D2016%26volume%3D16%26issue%3D5%26spage%3D829%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin-Bin  Feng</span>, <span class="hlFld-ContribAuthor ">Mei-Mei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Green Synthesis of Fused Polycyclic Pyrazolo[3,4-
              b
              ][1,6]naphthyridine Derivatives in Ionic Liquids via Three-Component Reaction. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2016,</strong> <em>36 </em>
                                    (4)
                                     , 478-489. <a href="https://doi.org/10.1080/10406638.2015.1014969" title="DOI URL">https://doi.org/10.1080/10406638.2015.1014969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2015.1014969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2015.1014969%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3DGreen%252BSynthesis%252Bof%252BFused%252BPolycyclic%252BPyrazolo%25255B3%25252C4-%252Bb%252B%25255D%25255B1%25252C6%25255Dnaphthyridine%252BDerivatives%252Bin%252BIonic%252BLiquids%252Bvia%252BThree-Component%252BReaction%26aulast%3DFeng%26aufirst%3DBin-Bin%26date%3D2016%26date%3D2015%26volume%3D36%26issue%3D4%26spage%3D478%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leen  Heirbaut</span>, <span class="hlFld-ContribAuthor ">Sebastiaan  van Goethem</span>, <span class="hlFld-ContribAuthor ">Koen  Jansen</span>, <span class="hlFld-ContribAuthor ">Hans  de Winter</span>, <span class="hlFld-ContribAuthor ">Nicole  Lamoen</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Jonathan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Ingrid  de Meester</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 433-438. <a href="https://doi.org/10.1039/C5MD00454C" title="DOI URL">https://doi.org/10.1039/C5MD00454C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00454C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00454C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DProbing%252Bfor%252Bimproved%252Bselectivity%252Bwith%252Bdipeptide-derived%252Binhibitors%252Bof%252Bdipeptidyl%252Bpeptidases%252B8%252Band%252B9%25253A%252Bthe%252Bimpact%252Bof%252BP1-variation%26aulast%3DHeirbaut%26aufirst%3DLeen%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D433%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana Ronai  Dunshee</span>, <span class="hlFld-ContribAuthor ">Travis W.  Bainbridge</span>, <span class="hlFld-ContribAuthor ">Noelyn M.  Kljavin</span>, <span class="hlFld-ContribAuthor ">Jose  Zavala-Solorio</span>, <span class="hlFld-ContribAuthor ">Amy C.  Schroeder</span>, <span class="hlFld-ContribAuthor ">Ruby  Chan</span>, <span class="hlFld-ContribAuthor ">Racquel  Corpuz</span>, <span class="hlFld-ContribAuthor ">Manda  Wong</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Sutherlin</span>, <span class="hlFld-ContribAuthor ">James A.  Ernst</span>, <span class="hlFld-ContribAuthor ">Junichiro  Sonoda</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2016,</strong> <em>291 </em>
                                    (11)
                                     , 5986-5996. <a href="https://doi.org/10.1074/jbc.M115.710582" title="DOI URL">https://doi.org/10.1074/jbc.M115.710582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M115.710582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M115.710582%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DFibroblast%252BActivation%252BProtein%252BCleaves%252Band%252BInactivates%252BFibroblast%252BGrowth%252BFactor%252B21%26aulast%3DDunshee%26aufirst%3DDiana%2BRonai%26date%3D2016%26volume%3D291%26issue%3D11%26spage%3D5986%26epage%3D5996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.M.  Koczorowska</span>, <span class="hlFld-ContribAuthor ">S.  Tholen</span>, <span class="hlFld-ContribAuthor ">F.  Bucher</span>, <span class="hlFld-ContribAuthor ">L.  Lutz</span>, <span class="hlFld-ContribAuthor ">J.N.  Kizhakkedathu</span>, <span class="hlFld-ContribAuthor ">O.  De Wever</span>, <span class="hlFld-ContribAuthor ">U.F.  Wellner</span>, <span class="hlFld-ContribAuthor ">M.L.  Biniossek</span>, <span class="hlFld-ContribAuthor ">A.  Stahl</span>, <span class="hlFld-ContribAuthor ">S.  Lassmann</span>, <span class="hlFld-ContribAuthor ">O.  Schilling</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. </span><span class="cited-content_cbyCitation_journal-name">Molecular Oncology</span><span> <strong>2016,</strong> <em>10 </em>
                                    (1)
                                     , 40-58. <a href="https://doi.org/10.1016/j.molonc.2015.08.001" title="DOI URL">https://doi.org/10.1016/j.molonc.2015.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molonc.2015.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molonc.2015.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Oncology%26atitle%3DFibroblast%252Bactivation%252Bprotein-%2525CE%2525B1%25252C%252Ba%252Bstromal%252Bcell%252Bsurface%252Bprotease%25252C%252Bshapes%252Bkey%252Bfeatures%252Bof%252Bcancer%252Bassociated%252Bfibroblasts%252Bthrough%252Bproteome%252Band%252Bdegradome%252Balterations%26aulast%3DKoczorowska%26aufirst%3DM.M.%26date%3D2016%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3D40%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romana  Meletta</span>, <span class="hlFld-ContribAuthor ">Adrienne  Müller Herde</span>, <span class="hlFld-ContribAuthor ">Aristeidis  Chiotellis</span>, <span class="hlFld-ContribAuthor ">Malsor  Isa</span>, <span class="hlFld-ContribAuthor ">Zoran  Rancic</span>, <span class="hlFld-ContribAuthor ">Nicole  Borel</span>, <span class="hlFld-ContribAuthor ">Simon  Ametamey</span>, <span class="hlFld-ContribAuthor ">Stefanie  Krämer</span>, <span class="hlFld-ContribAuthor ">Roger  Schibli</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (2)
                                     , 2081-2099. <a href="https://doi.org/10.3390/molecules20022081" title="DOI URL">https://doi.org/10.3390/molecules20022081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20022081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20022081%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEvaluation%252Bof%252Bthe%252BRadiolabeled%252BBoronic%252BAcid-Based%252BFAP%252BInhibitor%252BMIP-1232%252Bfor%252BAtherosclerotic%252BPlaque%252BImaging%26aulast%3DMeletta%26aufirst%3DRomana%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D2081%26epage%3D2099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth W.  Jackson</span>, <span class="hlFld-ContribAuthor ">Victoria J.  Christiansen</span>, <span class="hlFld-ContribAuthor ">Vivek R.  Yadav</span>, <span class="hlFld-ContribAuthor ">Robert  Silasi-Mansat</span>, <span class="hlFld-ContribAuthor ">Florea  Lupu</span>, <span class="hlFld-ContribAuthor ">Vibhudutta  Awasthi</span>, <span class="hlFld-ContribAuthor ">Roy R.  Zhang</span>, <span class="hlFld-ContribAuthor ">Patrick A.  McKee</span>. </span><span class="cited-content_cbyCitation_article-title">Suppression of Tumor Growth in Mice by Rationally Designed Pseudopeptide Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 43-54. <a href="https://doi.org/10.1016/j.neo.2014.11.002" title="DOI URL">https://doi.org/10.1016/j.neo.2014.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neo.2014.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neo.2014.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DSuppression%252Bof%252BTumor%252BGrowth%252Bin%252BMice%252Bby%252BRationally%252BDesigned%252BPseudopeptide%252BInhibitors%252Bof%252BFibroblast%252BActivation%252BProtein%252Band%252BProlyl%252BOligopeptidase%26aulast%3DJackson%26aufirst%3DKenneth%2BW.%26date%3D2015%26volume%3D17%26issue%3D1%26spage%3D43%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maloy  Nayak</span>, <span class="hlFld-ContribAuthor ">Ikyon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of benzo-fused indolizines, pyrrolo[1,2-a]quinolines via alkyne–carbonyl metathesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (37)
                                     , 9697-9708. <a href="https://doi.org/10.1039/C5OB01383F" title="DOI URL">https://doi.org/10.1039/C5OB01383F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01383F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01383F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DConstruction%252Bof%252Bbenzo-fused%252Bindolizines%25252C%252Bpyrrolo%25255B1%25252C2-a%25255Dquinolines%252Bvia%252Balkyne%2525E2%252580%252593carbonyl%252Bmetathesis%26aulast%3DNayak%26aufirst%3DMaloy%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D37%26spage%3D9697%26epage%3D9708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koen  Jansen</span>, <span class="hlFld-ContribAuthor ">Hans  De Winter</span>, <span class="hlFld-ContribAuthor ">Leen  Heirbaut</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Cheng</span>, <span class="hlFld-ContribAuthor ">Jurgen  Joossens</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Lambeir</span>, <span class="hlFld-ContribAuthor ">Ingrid  De Meester</span>, <span class="hlFld-ContribAuthor ">Koen  Augustyns</span>, <span class="hlFld-ContribAuthor ">Pieter  Van der Veken</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a xanthine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1700-1707. <a href="https://doi.org/10.1039/C4MD00167B" title="DOI URL">https://doi.org/10.1039/C4MD00167B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00167B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00167B%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DSelective%252Binhibitors%252Bof%252Bfibroblast%252Bactivation%252Bprotein%252B%252528FAP%252529%252Bwith%252Ba%252Bxanthine%252Bscaffold%26aulast%3DJansen%26aufirst%3DKoen%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D11%26spage%3D1700%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0011.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Relevant FAP inhibitors used as references in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of P2-Modified FAP Inhibitors <b>11</b>–<b>14</b> and <b>16</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, <i>N</i>-Boc-AA-OH, DIPEA, 75–80%; (b) TsOH 1.4 equiv, MeCN, 24 h, 84–86%; (c) 4-quinolinoyl chloride hydrochloride, DIPEA, 25–86%; (d) (2<i>S</i>)-(2-cyanopyrrolidine) tosylate, HATU, DIPEA, 64%; (e) K<sub>2</sub>CO<sub>3</sub>, RNH<sub>2</sub>, 13–52%; (f) K<sub>2</sub>CO<sub>3</sub>, quinolin-4-ylmethanamine, 25–49%; (g) NaN<sub>3</sub>, DMF; (h) CuI, THF, 17–50%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/medium/jm-2014-00031w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Strategies for the Synthesis of P1 and/or P3 Modified Target Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-7/jm500031w/production/images/large/jm-2014-00031w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500031w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) YCOOH, HATU, DIPEA, 3 h, 43–67%, or YCOOH, HOBT, EDC, DIPEA, 16 h, 84–86%, or YCOOH, (CH<sub>3</sub>)<sub>2</sub>C═C(Cl)N(CH<sub>3</sub>)<sub>2</sub>, DIPEA, 25–70%, or quinoline-4-carbonyl chloride hydrochloride, DIPEA, 55–59%; (b) pyrrolidine derivative, HOBT, EDC, DIPEA, 16 h, 65–86%; (c) phenylboronic acid, MTBE–H<sub>2</sub>O, 79%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salakian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sridhar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tennant, M. G.</span><span> </span><span class="NLM_article-title">Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">19441</span><span class="NLM_x">–</span> <span class="NLM_lpage">19444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=19441-19444&author=K.+Aertgeertsauthor=I.+Levinauthor=L.+Shiauthor=G.+P.+Snellauthor=A.+Jenningsauthor=G.+S.+Prasadauthor=Y.+Zhangauthor=M.+L.+Krausauthor=S.+Salakianauthor=V.+Sridharauthor=R.+Wijnandsauthor=M.+G.+Tennant&title=Structural+and+kinetic+analysis+of+the+substrate+specificity+of+human+fibroblast+activation+protein+alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DLevin%26aufirst%3DI.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DSalakian%26aufirst%3DS.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DWijnands%26aufirst%3DR.%26aulast%3DTennant%26aufirst%3DM.%2BG.%26atitle%3DStructural%2520and%2520kinetic%2520analysis%2520of%2520the%2520substrate%2520specificity%2520of%2520human%2520fibroblast%2520activation%2520protein%2520alpha%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D19441%26epage%3D19444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Acharya, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenstein, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pure, E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span> <span class="citation_source-journal">Hum. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.humpath.2005.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=16613331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=352-360&author=P.+S.+Acharyaauthor=A.+Zukasauthor=V.+Chandanauthor=A.+L.+Katzensteinauthor=E.+Pure&title=Fibroblast+activation+protein%3A+a+serine+protease+expressed+at+the+remodeling+interface+in+idiopathic+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Acharya, Pinak S.; Zukas, Alicia; Chandan, Vishal; Katzenstein, Anna-Luise A.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Human Pathology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">352-360</span>CODEN:
                <span class="NLM_cas:coden">HPCQA4</span>;
        ISSN:<span class="NLM_cas:issn">0046-8177</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Fibroblast activation protein (FAPα) is a member of the cell surface dipeptidyl peptidase (DPP) family of serine proteases.  In its dimer form, FAPα exhibits gelatinase, collagenase, and DPP activity in vitro.  Reactive fibroblasts in healing wounds and stromal fibroblasts assocd. with epithelial tumors express FAPα.  Idiopathic pulmonary fibrosis (IPF) is a disease of the lung characterized by progressive fibrosis with no clear etiol. or mol. marker for disease activity.  Recently, it has been shown that fibroblast FAPα expression is induced in liver cirrhosis, with an expression pattern distinct from alpha-smooth muscle actin (α-SMA).  In this study, we det. whether FAPα expression is selectively induced in areas of ongoing tissue remodeling characterized by fibroblast foci in IPF.  Human lung tissue was obtained from patients with IPF, centrilobular emphysema, and normal lung.  Immunohistochem. studies were performed using anti-FAPα antibody and antibodies against α-SMA and CD26 (DPPIV), another member of the DPP family.  We found that FAPα was not expressed in normal human lung tissue or tissue with evidence of centriacinar emphysema, but was induced in all patients with IPF and with a pattern distinct from that of CD26 found primarily on hyperplastic alveolar epithelium.  Specifically, FAPα was detected in fibroblast foci and in fibrotic interstitium and not in the interstitium of adjacent architecturally normal lung.  Alveolar/airway epithelium and vascular smooth muscle did not express FAPα.  This is the first report of FAPα expression in IPF and our results suggest that FAPα is selectively induced in fibrotic foci, but not in normal or emphysematous lung.  Future studies will address whether FAPα may be used as a marker for disease activity in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAUc6hzUMix7Vg90H21EOLACvtfcHk0lhvxJV3GHE6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVWgs7Y%253D&md5=ba036bf957422a280e73e40081daae30</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.humpath.2005.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humpath.2005.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DP.%2BS.%26aulast%3DZukas%26aufirst%3DA.%26aulast%3DChandan%26aufirst%3DV.%26aulast%3DKatzenstein%26aufirst%3DA.%2BL.%26aulast%3DPure%26aufirst%3DE.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520serine%2520protease%2520expressed%2520at%2520the%2520remodeling%2520interface%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DHum.%2520Pathol.%26date%3D2006%26volume%3D37%26spage%3D352%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadvi, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein and chronic liver disease</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3168</span><span class="NLM_x">–</span> <span class="NLM_lpage">3180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.2741%2F2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=17981786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Cnt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=3168-3180&author=X.+M.+Wangauthor=T.-W.+Yaoauthor=N.+A.+Nadviauthor=B.+Osborneauthor=G.+W.+McCaughanauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein+and+chronic+liver+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein and chronic liver disease</span></div><div class="casAuthors">Wang, Xin Maggie; Yao, Tsun-Wen; Nadvi, Naveed A.; Osborne, Brenna; McCaughan, Geoffrey W.; Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3168-3180</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Fibroblast activation protein (FAP) is the member of Dipeptidyl Peptidase IV (DPIV) gene family that is most similar to DPIV.  Four members of this family, DPIV, FAP, DP8 and DP9 possess a rare catalytic activity, hydrolysis of a prolyl bond two residues from the substrate N terminus.  Crystal structures show that the sol. form of FAP comprises two domains, an alpha/beta-hydrolase domain and an 8-blade beta-propeller domain.  The interface between these two domains forms the catalytic pocket, and an opening for substrate access to the internal active site.  The FAP homodimer is structurally very similar to DPIV but FAP glycoprotein expression is largely confined to mesenchymal cells in diseased and damaged tissue, notably the tissue remodelling region in chronically injured liver.  FAP peptide substrates include denatured collagen and alpha2-antiplasmin.  The functional roles of FAP in tumors and fibrotic tissue are not fully understood.  This review places FAP in the context of chronic liver injury pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7Sjq8tkR9ibVg90H21EOLACvtfcHk0lhvxJV3GHE6TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Cnt7o%253D&md5=0528a1f19ab337f0d303951d96613f83</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2741%2F2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F2918%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BM.%26aulast%3DYao%26aufirst%3DT.-W.%26aulast%3DNadvi%26aufirst%3DN.%2BA.%26aulast%3DOsborne%26aufirst%3DB.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%2520and%2520chronic%2520liver%2520disease%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D3168%26epage%3D3180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Keene, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadvi, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=1316-1332&issue=8&author=F.+M.+Keeneauthor=N.+A.+Nadviauthor=T.+W.+Yaoauthor=M.+D.+Gorrell&title=Neuropeptide+Y%2C+B-type+natriuretic+peptide%2C+substance+P+and+peptide+YY+are+novel+substrates+of+fibroblast+activation+protein-%CE%B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeene%26aufirst%3DF.%2BM.%26aulast%3DNadvi%26aufirst%3DN.%2BA.%26aulast%3DYao%26aufirst%3DT.%2BW.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DNeuropeptide%2520Y%252C%2520B-type%2520natriuretic%2520peptide%252C%2520substance%2520P%2520and%2520peptide%2520YY%2520are%2520novel%2520substrates%2520of%2520fibroblast%2520activation%2520protein-%25CE%25B1%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26issue%3D8%26spage%3D1316%26epage%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Levy, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaughan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1768</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1999&pages=1768-1778&author=M.+T.+Levyauthor=G.+W.+McCaughanauthor=C.+A.+Abbottauthor=J.+E.+Parkauthor=A.+M.+Cunninghamauthor=E.+Mullerauthor=W.+J.+Rettigauthor=M.+D.+Gorrell&title=Fibroblast+activation+protein%3A+a+cell+surface+dipeptidyl+peptidase+and+gelatinase+expressed+by+stellate+cells+at+the+tissue+remodelling+interface+in+human+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DM.%2BT.%26aulast%3DMcCaughan%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DC.%2BA.%26aulast%3DPark%26aufirst%3DJ.%2BE.%26aulast%3DCunningham%26aufirst%3DA.%2BM.%26aulast%3DMuller%26aufirst%3DE.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DFibroblast%2520activation%2520protein%253A%2520a%2520cell%2520surface%2520dipeptidyl%2520peptidase%2520and%2520gelatinase%2520expressed%2520by%2520stellate%2520cells%2520at%2520the%2520tissue%2520remodelling%2520interface%2520in%2520human%2520cirrhosis%26jtitle%3DHepatology%26date%3D1999%26volume%3D29%26spage%3D1768%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dienus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, O.</span><span> </span><span class="NLM_article-title">Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option</span> <span class="citation_source-journal">Arch. Dermatol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1007%2Fs00403-010-1084-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=20872224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlOrtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2010&pages=725-731&author=K.+Dienusauthor=A.+Bayatauthor=B.+F.+Gilmoreauthor=O.+Seifert&title=Increased+expression+of+fibroblast+activation+protein-alpha+in+keloid+fibroblasts%3A+implications+for+development+of+a+novel+treatment+option"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option</span></div><div class="casAuthors">Dienus, Kirstin; Bayat, Ardeshir; Gilmore, Brendan F.; Seifert, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">725-731</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Keloid scars are common benign fibroproliferative reticular dermal lesions with unknown etiol. and ill-defined management with high rate of recurrence post surgery.  The progression of keloids is characterized by increased deposition of extracellular matrix proteins, invasion into the surrounding healthy skin and inflammation.  Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars.  Fibroblast activation protein alpha (FAP-α) and dipeptidyl peptidase IV (DPPIV) are proteases located at the plasma membrane promoting cell invasiveness and tumor growth and have been previously assocd. with keloid scars.  Therefore, in this study we analyzed in further detail the expression of FAP-α in keloid fibroblasts compared to control skin fibroblasts.  Dermal fibroblasts were obtained from punch-biopsies from the active margin of four keloids and four control skin samples.  Flow cytometry was used to analyze FAP-α expression and the CytoSelect 24-Well Collagen I Cell Invasion Assay was applied to study fibroblast invasion.  Secretion of extracellular matrix (ECM) proteins was investigated by multiplexed particle-based flow cytometric assay and ELISA.  We found an increased expression of FAP-α in keloid fibroblasts compared to control skin fibroblasts (p < 0.001).  Inhibition of FAP-α/DPPIV activity using the irreversible inhibitor H2N-Gly-Pro diphenylphosphonate reduced the increased invasiveness of keloid fibroblasts (p < 0.001) indicating that keloid invasion may be partly FAP-α/DPPIV mediated.  FAP-α/DPPIV inhibition had no effect, (a) on the synthesis of the ECM proteins procollagen type I C-terminal peptide and fibronectin, (b) on the prodn. of fibroblast growth factor or vascular endothelial growth factor, (c) on the expression of the proinflammatory cytokines interleukin-6 (IL-6), interleukin 8 (IL-8) or monocyte chemotactic protein-1.  These results suggest a potential role for FAP-α and DPPIV in the invasive behavior of keloids.  FAP-α and DPPIV may increase the invasive capacity of keloid fibroblasts rather than by modulating inflammation or ECM prodn.  Since FAP-α expression is restricted to reactive fibroblasts in wound healing and normal adult tissues are generally FAP-α neg., inhibiting FAP-α/DPPIV activity may be a novel treatment option to prevent keloid progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWDsa4lmY6LVg90H21EOLACvtfcHk0lh7ODHYvg75Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlOrtLrL&md5=1466bf234d10c2acfda9f9964d22df94</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs00403-010-1084-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-010-1084-x%26sid%3Dliteratum%253Aachs%26aulast%3DDienus%26aufirst%3DK.%26aulast%3DBayat%26aufirst%3DA.%26aulast%3DGilmore%26aufirst%3DB.%2BF.%26aulast%3DSeifert%26aufirst%3DO.%26atitle%3DIncreased%2520expression%2520of%2520fibroblast%2520activation%2520protein-alpha%2520in%2520keloid%2520fibroblasts%253A%2520implications%2520for%2520development%2520of%2520a%2520novel%2520treatment%2520option%26jtitle%3DArch.%2520Dermatol.%2520Res.%26date%3D2010%26volume%3D302%26spage%3D725%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Milner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kevorkian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wait, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donell, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barksby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawston, T. E.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=R23&author=J.+M.+Milnerauthor=L.+Kevorkianauthor=D.+A.+Youngauthor=D.+Jonesauthor=R.+Waitauthor=S.+T.+Donellauthor=E.+Barksbyauthor=A.+M.+Pattersonauthor=J.+Middletonauthor=B.+F.+Cravattauthor=I.+M.+Clarkauthor=A.+D.+Rowanauthor=T.+E.+Cawston&title=Fibroblast+activation+protein+alpha+is+expressed+by+chondrocytes+following+a+pro-inflammatory+stimulus+and+is+elevated+in+osteoarthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMilner%26aufirst%3DJ.%2BM.%26aulast%3DKevorkian%26aufirst%3DL.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DWait%26aufirst%3DR.%26aulast%3DDonell%26aufirst%3DS.%2BT.%26aulast%3DBarksby%26aufirst%3DE.%26aulast%3DPatterson%26aufirst%3DA.%2BM.%26aulast%3DMiddleton%26aufirst%3DJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DClark%26aufirst%3DI.%2BM.%26aulast%3DRowan%26aufirst%3DA.%2BD.%26aulast%3DCawston%26aufirst%3DT.%2BE.%26atitle%3DFibroblast%2520activation%2520protein%2520alpha%2520is%2520expressed%2520by%2520chondrocytes%2520following%2520a%2520pro-inflammatory%2520stimulus%2520and%2520is%2520elevated%2520in%2520osteoarthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2006%26volume%3D8%26spage%3DR23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Milner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A. D.</span><span> </span><span class="NLM_article-title">Emerging roles of serine proteinases in tissue turnover in arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3644</span><span class="NLM_x">–</span> <span class="NLM_lpage">3656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1002%2Fart.24046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19035508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmt1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3644-3656&author=J.+M.+Milnerauthor=A.+Patelauthor=A.+D.+Rowan&title=Emerging+roles+of+serine+proteinases+in+tissue+turnover+in+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of serine proteinases in tissue turnover in arthritis</span></div><div class="casAuthors">Milner, J. M.; Patel, A.; Rowan, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3644-3656</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review on the traditional roles of serine proteinases (coagulation, complement, and fibrinolysis) and the new emerging roles of these and novel serine proteinases in relation to the tissue turnover assocd. with joint destruction in rheumatoid arthritis and osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnPTwcQH2_k7Vg90H21EOLACvtfcHk0lh7ODHYvg75Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmt1yntA%253D%253D&md5=c2ef997659a70930a14b4a654b39d62e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fart.24046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24046%26sid%3Dliteratum%253Aachs%26aulast%3DMilner%26aufirst%3DJ.%2BM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DRowan%26aufirst%3DA.%2BD.%26atitle%3DEmerging%2520roles%2520of%2520serine%2520proteinases%2520in%2520tissue%2520turnover%2520in%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3644%26epage%3D3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brokopp, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmert, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aikawa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüscher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoerstrup, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, C. M.</span><span> </span><span class="NLM_article-title">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1093%2Feurheartj%2Fehq519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=21292680" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=2713-2722&author=C.+E.+Brokoppauthor=R.+Schoenauerauthor=P.+Richardsauthor=S.+Bauerauthor=C.+Lohmannauthor=M.+Y.+Emmertauthor=B.+Weberauthor=S.+Winnikauthor=E.+Aikawaauthor=K.+Gravesauthor=M.+Genoniauthor=P.+Vogtauthor=T.+F.+L%C3%BCscherauthor=C.+Rennerauthor=S.+P.+Hoerstrupauthor=C.+M.+Matter&title=Fibroblast+activation+protein+is+induced+by+inflammation+and+degrades+type+I+collagen+in+thin-cap+fibroatheromata"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata</span></div><div class="casAuthors">Brokopp, Chad E.; Schoenauer, Roman; Richards, Peter; Bauer, Stefan; Lohmann, Christine; Emmert, Maximilian Y.; Weber, Benedikt; Winnik, Stephan; Aikawa, Elena; Graves, Kirk; Genoni, Michele; Vogt, Peter; Luescher, Thomas F.; Renner, Christoph; Hoerstrup, Simon P.; Matter, Christian M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2713-2722</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Collagen degrdn. in atherosclerotic plaques with thin fibrous caps renders them more prone to rupture.  Fibroblast activation protein (FAP) plays a role in arthritis and tumor formation through its collagenase activity.  However, the significance of FAP in thin-cap human fibroatheromata remains unknown.  Methods and results We detected enhanced FAP expression in type IV-V human aortic atheromata (n = 12), compared with type II-III lesions (n = 9; P < 0.01) and healthy aortae (n = 8; P < 0.01) by immunostaining and western blot analyses.  Fibroblast activation protein was also increased in thin-cap (<65 μm) vs. thick-cap (≥65 μm) human coronary fibroatheromata (n = 12; P < 0.01).  Fibroblast activation protein was expressed by human aortic smooth muscle cells (HASMC) as shown by colocalization on immunofluorescent aortic plaque stainings (n = 10; P < 0.01) and by flow cytometry in cell culture.  Although macrophages did not express FAP, macrophage burden in human aortic plaques correlated with FAP expression (n = 12; R2= 0.763; P < 0.05).  Enzyme-linked immunosorbent assays showed a time- and dose-dependent up-regulation of FAP in response to human tumor necrosis factor α (TNFα) in HASMC (n = 6; P < 0.01).  Moreover, supernatants from peripheral blood-derived macrophages induced FAP expression in cultured HASMC (n = 6; P < 0.01), an effect abolished by blocking TNFα (n = 6; P < 0.01).  Fibroblast activation protein assocd. with collagen-poor regions in human coronary fibrous caps and digested type I collagen and gelatin in vitro (n = 6; P < 0.01).  Zymog. revealed that FAP-mediated collagenase activity was neutralized by an antibody directed against the FAP catalytic domain both in HASMC (n = 6; P < 0.01) and in fibrous caps of atherosclerotic plaques (n = 10; P < 0.01).  Conclusion Fibroblast activation protein expression in HASMC is induced by macrophage-derived TNFα.  Fibroblast activation protein assocs. with thin-cap human coronary fibroatheromata and contributes to type I collagen breakdown in fibrous caps.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4eDr7Cnj1c7Vg90H21EOLACvtfcHk0li_ggME5xdM_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGnu7nO&md5=585eb7eb395d15ac6c5bb83f625da5b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq519%26sid%3Dliteratum%253Aachs%26aulast%3DBrokopp%26aufirst%3DC.%2BE.%26aulast%3DSchoenauer%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLohmann%26aufirst%3DC.%26aulast%3DEmmert%26aufirst%3DM.%2BY.%26aulast%3DWeber%26aufirst%3DB.%26aulast%3DWinnik%26aufirst%3DS.%26aulast%3DAikawa%26aufirst%3DE.%26aulast%3DGraves%26aufirst%3DK.%26aulast%3DGenoni%26aufirst%3DM.%26aulast%3DVogt%26aufirst%3DP.%26aulast%3DL%25C3%25BCscher%26aufirst%3DT.%2BF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DHoerstrup%26aufirst%3DS.%2BP.%26aulast%3DMatter%26aufirst%3DC.%2BM.%26atitle%3DFibroblast%2520activation%2520protein%2520is%2520induced%2520by%2520inflammation%2520and%2520degrades%2520type%2520I%2520collagen%2520in%2520thin-cap%2520fibroatheromata%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D2713%26epage%3D2722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">7235</span><span class="NLM_x">–</span> <span class="NLM_lpage">7239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=7235-7239&author=P.+Garin-Chesaauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Cell+surface+glycoprotein+of+reactive+stromal+fibroblasts+as+a+potential+antibody+target+in+human+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DCell%2520surface%2520glycoprotein%2520of%2520reactive%2520stromal%2520fibroblasts%2520as%2520a%2520potential%2520antibody%2520target%2520in%2520human%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D7235%26epage%3D7239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Scanlan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raj, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Moncasi, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healey, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">5657</span><span class="NLM_x">–</span> <span class="NLM_lpage">5661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=5657-5661&author=M.+J.+Scanlanauthor=B.+K.+Rajauthor=B.+Calvoauthor=P.+Garin-Chesaauthor=M.+P.+Sanz-Moncasiauthor=J.+H.+Healeyauthor=L.+J.+Oldauthor=W.+J.+Rettig&title=Molecular+cloning+of+fibroblast+activation+protein+alpha%2C+a+member+of+the+serine+protease+family+selectively+expressed+in+stromal+fibroblasts+of+epithelial+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScanlan%26aufirst%3DM.%2BJ.%26aulast%3DRaj%26aufirst%3DB.%2BK.%26aulast%3DCalvo%26aufirst%3DB.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DSanz-Moncasi%26aufirst%3DM.%2BP.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DMolecular%2520cloning%2520of%2520fibroblast%2520activation%2520protein%2520alpha%252C%2520a%2520member%2520of%2520the%2520serine%2520protease%2520family%2520selectively%2520expressed%2520in%2520stromal%2520fibroblasts%2520of%2520epithelial%2520cancers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D5657%26epage%3D5661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Santos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aziz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissil, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puré, E.</span><span> </span><span class="NLM_article-title">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">3613</span><span class="NLM_x">–</span> <span class="NLM_lpage">3625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1172%2FJCI38988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19920354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=3613-3625&author=A.+M.+Santosauthor=J.+Jungauthor=N.+Azizauthor=J.+L.+Kissilauthor=E.+Pur%C3%A9&title=Targeting+fibroblast+activation+protein+inhibits+tumor+stromagenesis+and+growth+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice</span></div><div class="casAuthors">Santos, Angelica M.; Jung, Jason; Aziz, Nazneen; Kissil, Joseph L.; Pure, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3613-3625</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Membrane-bound proteases have recently emerged as crit. mediators of tumorigenesis, angiogenesis, and metastasis.  However, the mechanisms by which they regulate these processes remain unknown.  As the cell surface serine protease fibroblast activation protein (FAP) is selectively expressed on tumor-assocd. fibroblasts and pericytes in epithelial tumors, we set out to investigate the role of FAP in mouse models of epithelial-derived solid tumors.  In this study, we demonstrate that genetic deletion and pharmacol. inhibition of FAP inhibited tumor growth in both an endogenous mouse model of lung cancer driven by the K-rasG12D mutant and a mouse model of colon cancer, in which CT26 mouse colon cancer cells were transplanted into immune competent syngeneic mice.  Interestingly, growth of only the K-rasG12D-driven lung tumors was also attenuated by inhibition of the closely related protease dipeptidyl peptidase IV (DPPIV).  Our results indicate that FAP depletion inhibits tumor cell proliferation indirectly, increases accumulation of collagen, decreases myofibroblast content, and decreases blood vessel d. in tumors.  These data provide proof of principle that targeting stromal cell-mediated modifications of the tumor microenvironment may be an effective approach to treating epithelial-derived solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY1-xywXMGHrVg90H21EOLACvtfcHk0li_ggME5xdM_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCit7jK&md5=20f20b9dbbcbe1f72a06d37f6ee19cde</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1172%2FJCI38988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38988%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DA.%2BM.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DAziz%26aufirst%3DN.%26aulast%3DKissil%26aufirst%3DJ.%2BL.%26aulast%3DPur%25C3%25A9%26aufirst%3DE.%26atitle%3DTargeting%2520fibroblast%2520activation%2520protein%2520inhibits%2520tumor%2520stromagenesis%2520and%2520growth%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26spage%3D3613%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valianou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canutescu, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span> </span><span class="NLM_article-title">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1158%2F1535-7163.MCT-05-0128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=15767544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=351-360&author=J.+D.+Chengauthor=M.+Valianouauthor=A.+A.+Canutescuauthor=E.+K.+Jaffeauthor=H.-O.+Leeauthor=H.+Wangauthor=J.+H.+Laiauthor=W.+W.+Bachovchinauthor=L.+M.+Weiner&title=Abrogation+of+fibroblast+activation+protein+enzymatic+activity+attenuates+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth</span></div><div class="casAuthors">Cheng, Jonathan D.; Valianou, Matthildi; Canutescu, Adrian A.; Jaffe, Eileen K.; Lee, Hyung-Ok; Wang, Hao; Lai, Jack H.; Bachovchin, William W.; Weiner, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">351-360</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor-assocd. fibroblasts are functionally and phenotypically distinct from normal fibroblasts that are not in the tumor microenvironment.  Fibroblast activation protein is a 95 kDa cell surface glycoprotein expressed by tumor stromal fibroblasts, and has been shown to have dipeptidyl peptidase and collagenase activity.  Site-directed mutagenesis at the catalytic site of fibroblast activation protein, Ser624 Ala624, resulted in an ∼100,000-fold loss of fibroblast activation protein dipeptidyl peptidase (DPP) activity.  HEK293 cells transfected with wild-type fibroblast activation protein, enzymic mutant (S624A) fibroblast activation protein, or vector alone, were inoculated s.c. into immunodeficient mouse to assess the contribution of fibroblast activation protein enzymic activity to tumor growth.  Overexpression of wild-type fibroblast activation protein showed growth potentiation and enhanced tumorigenicity compared with both fibroblast activation protein S624A and vector-transfected HEK293 xenografts.  HEK293 cells transfected with fibroblast activation protein S624A showed tumor growth rates and tumorigenicity potential similar only to vector-transfected HEK293.  In vivo assessment of fibroblast activation protein DPP activity of these tumors showed enhanced enzymic activity of wild-type fibroblast activation protein, with only baseline levels of fibroblast activation protein DPP activity in either fibroblast activation protein S624A or vector-only xenografts.  These results indicate that the enzymic activity of fibroblast activation protein is necessary for fibroblast activation protein-driven tumor growth in the HEK293 xenograft model system.  This establishes the proof-of-principle that the enzymic activity of fibroblast activation protein plays an important role in the promotion of tumor growth, and provides an attractive target for therapeutics designed to alter fibroblast activation protein-induced tumor growth by targeting its enzymic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJQ7ekEjT-O7Vg90H21EOLACvtfcHk0ljDL2E4yekaBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kgu7g%253D&md5=9ef5725b966bd47692ad130aecf56ba9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0128%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DValianou%26aufirst%3DM.%26aulast%3DCanutescu%26aufirst%3DA.%2BA.%26aulast%3DJaffe%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26atitle%3DAbrogation%2520of%2520fibroblast%2520activation%2520protein%2520enzymatic%2520activity%2520attenuates%2520tumor%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2712</span><span class="NLM_x">–</span> <span class="NLM_lpage">2716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=2712-2716&author=Y.+Huangauthor=S.+Wangauthor=T.+Kelly&title=Seprase+promotes+rapid+tumor+growth+and+increased+microvessel+density+in+a+mouse+model+of+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DSeprase%2520promotes%2520rapid%2520tumor%2520growth%2520and%2520increased%2520microvessel%2520density%2520in%2520a%2520mouse%2520model%2520of%2520human%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D2712%26epage%3D2716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">O’Brien, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B. F.</span><span> </span><span class="NLM_article-title">Seprase: an overview of an important matrix serine protease</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=1130-1145&author=P.+O%E2%80%99Brienauthor=B.+F.+O%E2%80%99Connor&title=Seprase%3A+an+overview+of+an+important+matrix+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%2BF.%26atitle%3DSeprase%253A%2520an%2520overview%2520of%2520an%2520important%2520matrix%2520serine%2520protease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D1130%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Walter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlank, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerenyi, T. D.</span><span> </span><span class="NLM_article-title">Leucylglycinamide released from oxytocin by human uterine enzyme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1971&pages=827-829&author=R.+Walterauthor=H.+Shlankauthor=J.+D.+Glassauthor=I.+L.+Schwartzauthor=T.+D.+Kerenyi&title=Leucylglycinamide+released+from+oxytocin+by+human+uterine+enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DShlank%26aufirst%3DH.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DSchwartz%26aufirst%3DI.%2BL.%26aulast%3DKerenyi%26aufirst%3DT.%2BD.%26atitle%3DLeucylglycinamide%2520released%2520from%2520oxytocin%2520by%2520human%2520uterine%2520enzyme%26jtitle%3DScience%26date%3D1971%26volume%3D173%26spage%3D827%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span> </span><span class="NLM_article-title">On the role of prolyl oligopeptidase in health and disease</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=1-24&author=J.+A.+Garc%C3%ADa-Horsmanauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+I.+Ven%C3%A4l%C3%A4inen&title=On+the+role+of+prolyl+oligopeptidase+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26atitle%3DOn%2520the%2520role%2520of%2520prolyl%2520oligopeptidase%2520in%2520health%2520and%2520disease%26jtitle%3DNeuropeptides%26date%3D2007%26volume%3D41%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jambunathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endsley, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodukula, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galande, A. K.</span><span> </span><span class="NLM_article-title">Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">586</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.febslet.2012.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=22750443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFCksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2012&pages=2507-2512&author=K.+Jambunathanauthor=D.+S.+Watsonauthor=A.+N.+Endsleyauthor=K.+Kodukulaauthor=A.+K.+Galande&title=Comparative+analysis+of+the+substrate+preferences+of+two+post-proline+cleaving+endopeptidases%2C+prolyl+oligopeptidase+and+fibroblast+activation+protein+%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α</span></div><div class="casAuthors">Jambunathan, Kalyani; Watson, Douglas S.; Endsley, Aaron N.; Kodukula, Krishna; Galande, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2507-2512</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Post-proline cleaving peptidases are promising therapeutic targets for neurodegenerative diseases, psychiatric conditions, metabolic disorders, and many cancers.  Prolyl oligopeptidase (POP; E.C. 3.4.21.26) and fibroblast activation protein α (FAP; E.C. 3.4.24.B28) are two post-proline cleaving endopeptidases with very similar substrate specificities.  Both enzymes are implicated in numerous human diseases, but their study is impeded by the lack of specific substrate probes.  We interrogated a combinatorial library of proteolytic substrates and identified novel and selective substrates of POP and FAP.  These new sequences will be useful as probes for fundamental biochem. study, scaffolds for inhibitor design, and triggers for controlled drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgLjBZTsaIE7Vg90H21EOLACvtfcHk0lg59qmwnRHzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFCksrw%253D&md5=29fe45e4ea2eaf8c4c59cae587cb5c64</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DJambunathan%26aufirst%3DK.%26aulast%3DWatson%26aufirst%3DD.%2BS.%26aulast%3DEndsley%26aufirst%3DA.%2BN.%26aulast%3DKodukula%26aufirst%3DK.%26aulast%3DGalande%26aufirst%3DA.%2BK.%26atitle%3DComparative%2520analysis%2520of%2520the%2520substrate%2520preferences%2520of%2520two%2520post-proline%2520cleaving%2520endopeptidases%252C%2520prolyl%2520oligopeptidase%2520and%2520fibroblast%2520activation%2520protein%2520%25CE%25B1%26jtitle%3DFEBS%2520Lett.%26date%3D2012%26volume%3D586%26spage%3D2507%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Christiansen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Targeting inhibition of fibroblast activation protein-alpha and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=348-358&author=V.+Christiansenauthor=K.+Jacksonauthor=K.+N.+Leeauthor=T.+D.+Downsauthor=P.+A.+McKee&title=Targeting+inhibition+of+fibroblast+activation+protein-alpha+and+prolyl+oligopeptidase+activities+on+cells+common+to+metastatic+tumor+microenvironments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristiansen%26aufirst%3DV.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DDowns%26aufirst%3DT.%2BD.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DTargeting%2520inhibition%2520of%2520fibroblast%2520activation%2520protein-alpha%2520and%2520prolyl%2520oligopeptidase%2520activities%2520on%2520cells%2520common%2520to%2520metastatic%2520tumor%2520microenvironments%26jtitle%3DNeoplasia%26date%3D2013%26volume%3D15%26spage%3D348%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">D’Agostino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diano, S.</span><span> </span><span class="NLM_article-title">Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2014</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1093%2Fcercor%2Fbhs199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=22767632" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=2007-2014&author=G.+D%E2%80%99Agostinoauthor=J.+D.+Kimauthor=Z.-W.+Liuauthor=J.+K.+Jeongauthor=S.+Suyamaauthor=A.+Calignanoauthor=X.-B.+Gaoauthor=M.+Schwartzauthor=S.+Diano&title=Prolyl+endopeptidase-deficient+mice+have+reduced+synaptic+spine+density+in+the+CA1+region+of+the+hippocampus%2C+impaired+LTP%2C+and+spatial+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2Fbhs199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252Fbhs199%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Agostino%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DZ.-W.%26aulast%3DJeong%26aufirst%3DJ.%2BK.%26aulast%3DSuyama%26aufirst%3DS.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DDiano%26aufirst%3DS.%26atitle%3DProlyl%2520endopeptidase-deficient%2520mice%2520have%2520reduced%2520synaptic%2520spine%2520density%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%252C%2520impaired%2520LTP%252C%2520and%2520spatial%2520learning%2520and%2520memory%26jtitle%3DCereb.%2520Cortex%26date%3D2012%26volume%3D23%26spage%3D2007%26epage%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Eager, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senzer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uprichard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemunaitis, J.</span><span> </span><span class="NLM_article-title">Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.clon.2009.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A280%3ADC%252BD1MvnslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=464-472&author=R.+M.+Eagerauthor=C.+C.+Cunninghamauthor=N.+Senzerauthor=D.+A.+Richardsauthor=R.+N.+Rajuauthor=B.+Jonesauthor=M.+Uprichardauthor=J.+Nemunaitis&title=Phase+II+trial+of+talabostat+and+docetaxel+in+advanced+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer</span></div><div class="casAuthors">Eager R M; Cunningham C C; Senzer N; Richards D A; Raju R N; Jones B; Uprichard M; Nemunaitis J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical oncology (Royal College of Radiologists (Great Britain))</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIMS:  Currently available therapies do improve survival in advanced stage non-small cell lung cancer (NSCLC), but only to a limited degree.  Talabostat mesilate (PT-100) is an orally available amino boronic dipeptide that specifically inhibits dipeptidyl peptidases (including fibroblast activation protein) and enhances an immune response.  The aim of this study was to determine the efficacy and safety of talabostat in NSCLC patients.  MATERIALS AND METHODS:  A phase II trial was conducted to evaluate talabostat in combination with docetaxel in patients with advanced NSCLC after failure of previous platinum-based chemotherapy.  In total, 42 patients were enrolled.  RESULTS:  Talabostat was well tolerated.  Two patients achieved a partial response and one achieved a complete response.  CONCLUSION:  There was no evidence that talabostat enhanced the clinical activity of docetaxel in patients with NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTzMVo_b7EzHWEEzDrymxmfW6udTcc2eYvWW056Mxf9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvnslCjtw%253D%253D&md5=ad5ab6406f54c4a919563b02f0e0ac76</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.clon.2009.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clon.2009.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26aulast%3DCunningham%26aufirst%3DC.%2BC.%26aulast%3DSenzer%26aufirst%3DN.%26aulast%3DRichards%26aufirst%3DD.%2BA.%26aulast%3DRaju%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DUprichard%26aufirst%3DM.%26aulast%3DNemunaitis%26aufirst%3DJ.%26atitle%3DPhase%2520II%2520trial%2520of%2520talabostat%2520and%2520docetaxel%2520in%2520advanced%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Oncol.%26date%3D2009%26volume%3D21%26spage%3D464%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Narra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strzemkowski-Brun, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magalong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egleston, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meropol, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span> </span><span class="NLM_article-title">Phase II trial of single agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.4161%2Fcbt.6.11.4874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18032930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1691-1699&author=K.+Narraauthor=S.+R.+Mullinsauthor=H.-O.+Leeauthor=B.+Strzemkowski-Brunauthor=K.+Magalongauthor=V.+J.+Christiansenauthor=P.+A.+McKeeauthor=B.+Eglestonauthor=S.+J.+Cohenauthor=L.+M.+Weinerauthor=N.+J.+Meropolauthor=J.+D.+Cheng&title=Phase+II+trial+of+single+agent+Val-boroPro+%28talabostat%29+inhibiting+fibroblast+activation+protein+in+patients+with+metastatic+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer</span></div><div class="casAuthors">Narra, Kalyani; Mullins, Stefanie R.; Lee, Hyung-Ok; Strzemkowski-Brun, Brenda; Magalong, Kimberly; Christiansen, Victoria J.; McKee, Patrick A.; Egleston, Brian; Cohen, Steven J.; Weiner, Louis M.; Meropol, Neal J.; Cheng, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1691-1699</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: Fibroblost Activation Protein (FAP) is a tumor fibroblast protease that has been shown to potentiate colorectal cancer growth.  The clin. impact of FAP inhibition was tested using Val-boroPro (Talabostat), the first clin. inhibitor of FAP enzymic activity, in a phase II study of patients with metastatic colorectal cancer.  Methods: Patients with metastatic colorectal cancer who had previously received systemic chemotherapies were treated with single agent Val-boroPro 200 μg p.o. BID continuously.  Eligibility included measurable disease, performance status of 0 to 2, and adequate organ function.  Lab. correlates evaluated the pharmacodynamic effects of Val-boroPro on FAP enzymic function in the peripheral blood.  Results: Twenty-eight patients (median age 62; 12 males, 16 females) were enrolled in this study.  There were no objective responses.  Six of 28 (21%) patients had stable disease for a median of 25 wk (range 11-38 wk).  Lab. anal. demonstrated significant, although incomplete inhibition of FAP enzymic activity in the peripheral blood.  Conclusion: This phase II trial of Val-boroPro demonstrated minimal clin. activity in patients with previously treated metastatic colorectal cancer.  However it provides the initial proof-of-concept that physiol. inhibition of FAP activity can be accomplished in patients with colorectal cancer, and lays the groundwork for future studies targeting the tumor stroma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_1F424osEbVg90H21EOLACvtfcHk0liUUaHrdiFw_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1Whsb8%253D&md5=7e69e1187b364d4c1ed43fef5d717c48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4161%2Fcbt.6.11.4874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.6.11.4874%26sid%3Dliteratum%253Aachs%26aulast%3DNarra%26aufirst%3DK.%26aulast%3DMullins%26aufirst%3DS.%2BR.%26aulast%3DLee%26aufirst%3DH.-O.%26aulast%3DStrzemkowski-Brun%26aufirst%3DB.%26aulast%3DMagalong%26aufirst%3DK.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26aulast%3DEgleston%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DS.%2BJ.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DMeropol%26aufirst%3DN.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26atitle%3DPhase%2520II%2520trial%2520of%2520single%2520agent%2520Val-boroPro%2520%2528talabostat%2529%2520inhibiting%2520fibroblast%2520activation%2520protein%2520in%2520patients%2520with%2520metastatic%2520colorectal%2520cancer%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D1691%26epage%3D1699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Eager, R. M.; Cunningham, C. C.; Senzer, N. N.; Stephenson, J.; Anthony, S. P.; O’Day, S. J.; Frenette, G.; Pavlick, A. C.; Jones, B.; Uprichard, M.; Nemunaitis, J.</span><span> </span><span class="NLM_article-title">Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma</span>.  <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span>, DOI: <span class="refDoi"> DOI: 10.1186/1471-2407-9-263</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1186%2F1471-2407-9-263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&author=R.+M.+Eager&author=C.+C.+Cunningham&author=N.+N.+Senzer&author=J.+Stephenson&author=S.+P.+Anthony&author=S.+J.+O%E2%80%99Day&author=G.+Frenette&author=A.+C.+Pavlick&author=B.+Jones&author=M.+Uprichard&author=J.+Nemunaitis&title=Phase+II+assessment+of+talabostat+and+cisplatin+in+second-line+stage+IV+melanoma&doi=10.1186%2F1471-2407-9-263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-9-263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-9-263%26sid%3Dliteratum%253Aachs%26aulast%3DEager%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520II%2520assessment%2520of%2520talabostat%2520and%2520cisplatin%2520in%2520second-line%2520stage%2520IV%2520melanoma%26jtitle%3DBMC%2520Cancer%26date%3D2009%26volume%3D9%26doi%3D10.1186%2F1471-2407-9-263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langkopf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span> </span><span class="NLM_article-title">(<i>R</i>)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 iinhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1124%2Fjpet.107.135723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18223196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=175-182&author=L.+Thomasauthor=M.+Eckhardtauthor=E.+Langkopfauthor=M.+Tadayyonauthor=F.+Himmelsbachauthor=M.+Mark&title=%28R%29-8-%283-Amino-piperidin-1-yl%29-7-but-2-ynyl-3-methyl-1-%284-methyl-quinazolin-2-ylmethyl%29-3%2C7-dihydro-purine-2%2C6-dione+%28BI+1356%29%2C+a+novel+xanthine-based+dipeptidyl+peptidase+4+iinhibitor%2C+has+a+superior+potency+and+longer+duration+of+action+compared+with+other+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2 -ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Thomas, Leo; Eckhardt, Matthias; Langkopf, Elke; Tadayyon, Moh; Himmelsbach, Frank; Mark, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">BI 1356 [proposed trade name ONDERO; (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2 -ylmethyl)-3,7-dihydro-purine-2,6-dione] is a novel dipeptidyl peptidase (DPP)-4 inhibitor under clin. development for the treatment of type 2 diabetes.  In this study, we investigated the potency, selectivity, mechanism, and duration of action of BI 1356 in vitro and in vivo and compared it with other DPP-4 inhibitors.  BI 1356 inhibited DPP-4 activity in vitro with an IC50 of approx. 1 nM, compared with sitagliptin (19 nM), alogliptin (24 nM), saxagliptin (50 nM), and vildagliptin (62 nM).  BI 1356 was a competitive inhibitor, with a Ki of 1 nM.  The calcd. koff rate for BI 1356 was 3.0 × 10-5/s (vs. 2.1 × 10-4/s for vildagliptin).  BI 1356 was ≥10,000-fold more selective for DPP-4 than DPP-8, DPP-9, aminopeptidases N and P, prolyloligopeptidase, trypsin, plasmin, and thrombin and was 90-fold more selective than for fibroblast activation protein in vitro.  In HanWistar rats, the DPP-4 inhibition 24 h after administration of BI 1356 was more profound than with any of the other DPP-4 inhibitors.  In C57BL/6J mice and Zucker fatty (fa/fa) rats, the duration of action on glucose tolerance decreased in the order BI 1356 > (sitagliptin/saxagliptin) > vildagliptin.  These effects were mediated through control of glucagon-like peptide-1 and insulin.  BI 1356 inhibited DPP-4 more effectively than vildagliptin, sitagliptin, saxagliptin, and alogliptin and has the potential to become the first truly once-a-day DPP-4 inhibitor for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCDp95uMTVH7Vg90H21EOLACvtfcHk0lgN74mBf9nBuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtLk%253D&md5=c66d67f9eb83ae3587457878a32a3452</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.135723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.135723%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DLangkopf%26aufirst%3DE.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DHimmelsbach%26aufirst%3DF.%26aulast%3DMark%26aufirst%3DM.%26atitle%3D%2528R%2529-8-%25283-Amino-piperidin-1-yl%2529-7-but-2-ynyl-3-methyl-1-%25284-methyl-quinazolin-2-ylmethyl%2529-3%252C7-dihydro-purine-2%252C6-dione%2520%2528BI%25201356%2529%252C%2520a%2520novel%2520xanthine-based%2520dipeptidyl%2520peptidase%25204%2520iinhibitor%252C%2520has%2520a%2520superior%2520potency%2520and%2520longer%2520duration%2520of%2520action%2520compared%2520with%2520other%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tsai, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, T.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W.-T.</span><span> </span><span class="NLM_article-title">Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1002556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6572-6583&author=T.-Y.+Tsaiauthor=T.-K.+Yehauthor=X.+Chenauthor=T.+Hsuauthor=Y.-C.+Jaoauthor=C.-H.+Huangauthor=J.-S.+Songauthor=Y.-C.+Huangauthor=C.-H.+Chienauthor=J.-H.+Chiuauthor=S.-C.+Yenauthor=H.-K.+Tangauthor=Y.-S.+Chaoauthor=W.-T.+Jiaang&title=Substituted+4-carboxymethylpyroglutamic+acid+diamides+as+potent+and+selective+inhibitors+of+fibroblast+activation+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm1002556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1002556%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DT.-Y.%26aulast%3DYeh%26aufirst%3DT.-K.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DJao%26aufirst%3DY.-C.%26aulast%3DHuang%26aufirst%3DC.-H.%26aulast%3DSong%26aufirst%3DJ.-S.%26aulast%3DHuang%26aufirst%3DY.-C.%26aulast%3DChien%26aufirst%3DC.-H.%26aulast%3DChiu%26aufirst%3DJ.-H.%26aulast%3DYen%26aufirst%3DS.-C.%26aulast%3DTang%26aufirst%3DH.-K.%26aulast%3DChao%26aufirst%3DY.-S.%26aulast%3DJiaang%26aufirst%3DW.-T.%26atitle%3DSubstituted%25204-carboxymethylpyroglutamic%2520acid%2520diamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6572%26epage%3D6583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heirbaut, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300410d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=491-496&author=K.+Jansenauthor=L.+Heirbautauthor=J.+D.+Chengauthor=J.+Joossensauthor=O.+Ryabtsovaauthor=P.+Cosauthor=L.+Maesauthor=A.-M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Selective+inhibitors+of+fibroblast+activation+protein+%28FAP%29+with+a+%284-quinolinoyl%29-glycyl-2-cyanopyrrolidine+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml300410d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300410d%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DHeirbaut%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DLambeir%26aufirst%3DA.-M.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DSelective%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520with%2520a%2520%25284-quinolinoyl%2529-glycyl-2-cyanopyrrolidine%2520scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D491%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lee, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolence, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, P. A.</span><span> </span><span class="NLM_article-title">Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor A2-antiplasmin</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">996</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1111%2Fj.1538-7836.2011.04195.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=21251197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=987-996&author=K.+N.+Leeauthor=K.+W.+Jacksonauthor=V.+J.+Christiansenauthor=E.+K.+Dolenceauthor=P.+A.+McKee&title=Enhancement+of+fibrinolysis+by+inhibiting+enzymatic+cleavage+of+precursor+A2-antiplasmin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin</span></div><div class="casAuthors">Lee, K. N.; Jackson, K. W.; Christiansen, V. J.; Dolence, E. K.; McKee, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-996</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Resistance of thrombi to plasmin digestion depends primarily on the amt. of α2-antiplasmin (α2AP) incorporated within fibrin.  Circulating prolyl-specific serine proteinase, antiplasmin-cleaving enzyme (APCE), a homolog of fibroblast activation protein (FAP), cleaves precursor Met-α2AP between -Pro12-Asn13- to yield Asn-α2AP, which is crosslinked to fibrin approx. 13× more rapidly than Met-α2AP and confers resistance to plasmin.  We reasoned that an APCE inhibitor might decrease conversion of Met-α2AP to Asn-α2AP and thereby enhance endogenous fibrinolysis.  We designed and synthesized several APCE inhibitors and assessed each vs. plasma dipeptidyl peptidase IV (DPPIV) and prolyl oligopeptidase (POP), which have amino acid sequence similarity with APCE.  Acetyl-Arg-(8-amino-3,6-dioxaoctanoic acid)-D-Ala-L-boroPro selectively inhibited APCE vs. DPPIV, with an apparent Ki of 5.7 nM vs. 6.1 μM, indicating that an approx. 1000-fold greater inhibitor concn. is required for DPPIV than for APCE.  An apparent Ki of 7.4 nM was found for POP inhibition, which is similar to 5.7 nM for APCE; however, the potential problem of overlapping FAP/APCE and POP inhibition was negated by our finding that normal human plasma lacks POP activity.  The inhibitor construct caused a dose-dependent decrease of APCE-mediated Met-α2AP cleavage, which ultimately shortened plasminogen activator-induced plasma clot lysis times.  Incubation of the inhibitor with human plasma for 22 h did not lessen its APCE inhibitory activity, with its IC50 value in plasma remaining comparable to that in phosphate buffer.  These data establish that inhibition of APCE might represent a therapeutic approach for enhancing thrombolytic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNDs9DkEyXZbVg90H21EOLACvtfcHk0lgcHgI-VFWfqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFymtb8%253D&md5=f045cb95788182a837ba9a75228d111b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2011.04195.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2011.04195.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BN.%26aulast%3DJackson%26aufirst%3DK.%2BW.%26aulast%3DChristiansen%26aufirst%3DV.%2BJ.%26aulast%3DDolence%26aufirst%3DE.%2BK.%26aulast%3DMcKee%26aufirst%3DP.%2BA.%26atitle%3DEnhancement%2520of%2520fibrinolysis%2520by%2520inhibiting%2520enzymatic%2520cleavage%2520of%2520precursor%2520A2-antiplasmin%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2011%26volume%3D9%26spage%3D987%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Poplawski, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudmeier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanford, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachovchin, W. W.</span><span> </span><span class="NLM_article-title">Identification of selective and potent inhibitors of fibroblast activation protein and prolyl ooligopeptidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3477</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400351a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3467-3477&author=S.+E.+Poplawskiauthor=J.+H.+Laiauthor=Y.+Liauthor=Z.+Jinauthor=Y.+Liuauthor=W.+Wuauthor=Y.+Wuauthor=Y.+Zhouauthor=J.+L.+Sudmeierauthor=D.+G.+Sanfordauthor=W.+W.+Bachovchin&title=Identification+of+selective+and+potent+inhibitors+of+fibroblast+activation+protein+and+prolyl+ooligopeptidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm400351a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400351a%26sid%3Dliteratum%253Aachs%26aulast%3DPoplawski%26aufirst%3DS.%2BE.%26aulast%3DLai%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DSudmeier%26aufirst%3DJ.%2BL.%26aulast%3DSanford%26aufirst%3DD.%2BG.%26aulast%3DBachovchin%26aufirst%3DW.%2BW.%26atitle%3DIdentification%2520of%2520selective%2520and%2520potent%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520and%2520prolyl%2520ooligopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3467%26epage%3D3477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ryabtsova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3412</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3412-3417&author=O.+Ryabtsovaauthor=K.+Jansenauthor=S.+Van+Goethemauthor=J.+Joossensauthor=J.+D.+Chengauthor=A.-M.+Lambeirauthor=I.+De+Meesterauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Acylated+Gly-%282-cyano%29pyrrolidines+as+inhibitors+of+fibroblast+activation+protein+%28FAP%29+and+the+issue+of+FAP%2Fprolyl+oligopeptidase+%28PREP%29-selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyabtsova%26aufirst%3DO.%26aulast%3DJansen%26aufirst%3DK.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DLambeir%26aufirst%3DA.-M.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DAcylated%2520Gly-%25282-cyano%2529pyrrolidines%2520as%2520inhibitors%2520of%2520fibroblast%2520activation%2520protein%2520%2528FAP%2529%2520and%2520the%2520issue%2520of%2520FAP%252Fprolyl%2520oligopeptidase%2520%2528PREP%2529-selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3412%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: Isoindoline containing inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4159-4162&author=S.+Van+Goethemauthor=P.+Van+der+Vekenauthor=V.+Duboisauthor=A.+Sorokaauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=I.+De+Meesterauthor=K.+Augustyns&title=Inhibitors+of+dipeptidyl+peptidase+8+and+dipeptidyl+peptidase+9.+Part+2%3A+Isoindoline+containing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DDubois%26aufirst%3DV.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%25208%2520and%2520dipeptidyl%2520peptidase%25209.%2520Part%25202%253A%2520Isoindoline%2520containing%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4159%26epage%3D4162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5568</span><span class="NLM_x">–</span> <span class="NLM_lpage">5570</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701005a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5568-5570&author=P.+Van+der+Vekenauthor=A.+Sorokaauthor=I.+Brandtauthor=Y.+S.+Chenauthor=M.+B.+Maesauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=K.+Augustynsauthor=I.+De+Meester&title=Irreversible+inhibition+of+dipeptidyl+peptidase+8+by+dipeptide-derived+diaryl+phosphonates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1021%2Fjm701005a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701005a%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DY.%2BS.%26aulast%3DMaes%26aufirst%3DM.%2BB.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DIrreversible%2520inhibition%2520of%2520dipeptidyl%2520peptidase%25208%2520by%2520dipeptide-derived%2520diaryl%2520phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5568%26epage%3D5570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Singh, S. K.; Manne, N.; Pal, M.</span><span> </span><span class="NLM_article-title">Synthesis of (<i>S</i>)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: a key intermediate for dipeptidyl peptidase IV inhibitors</span>.  <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span>, DOI: <span class="refDoi"> DOI: 10.3762/bjoc.4.20</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.3762%2Fbjoc.4.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=18941490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=20&author=S.+K.+Singh&author=N.+Manne&author=M.+Pal&title=Synthesis+of+%28S%29-1-%282-chloroacetyl%29pyrrolidine-2-carbonitrile%3A+a+key+intermediate+for+dipeptidyl+peptidase+IV+inhibitors&doi=10.3762%2Fbjoc.4.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile: A key intermediate for dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Singh, Santosh Kumar; Manne, Narendra; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">No. 20, No pp. given</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">An alternative and practical synthesis of (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile was achieved.  Reaction of L-proline with chloroacetyl chloride was followed by conversion of the carboxylic acid moiety of the resulting N-acylated product into the carbonitrile via the corresponding amide intermediate.  The synthesized pyrrolidine deriv. was utilized to prep. DPP-IV inhibitor Vildagliptin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvAWVRF6xot7Vg90H21EOLACvtfcHk0liTY2dfhynxow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVaktrg%253D&md5=580782da81b6f0cd36bdc3055ec588e4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.4.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.4.20%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520of%2520%2528S%2529-1-%25282-chloroacetyl%2529pyrrolidine-2-carbonitrile%253A%2520a%2520key%2520intermediate%2520for%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D4%26spage%3D20%26doi%3D10.3762%2Fbjoc.4.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: Identification of dipeptide derived leads</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4154</span><span class="NLM_x">–</span> <span class="NLM_lpage">4158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4154-4158&author=P.+Van+der+Vekenauthor=I.+De+Meesterauthor=V.+Duboisauthor=A.+Sorokaauthor=S.+Van+Goethemauthor=M.+B.+Maesauthor=I.+Brandtauthor=A.+M.+Lambeirauthor=X.+Chenauthor=A.+Haemersauthor=S.+Scharpeauthor=K.+Augustyns&title=Inhibitors+of+dipeptidyl+peptidase+8+and+dipeptidyl+peptidase+9.+Part+1%3A+Identification+of+dipeptide+derived+leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DDubois%26aufirst%3DV.%26aulast%3DSoroka%26aufirst%3DA.%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DM.%2BB.%26aulast%3DBrandt%26aufirst%3DI.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DInhibitors%2520of%2520dipeptidyl%2520peptidase%25208%2520and%2520dipeptidyl%2520peptidase%25209.%2520Part%25201%253A%2520Identification%2520of%2520dipeptide%2520derived%2520leads%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4154%26epage%3D4158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito-Hori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munetomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of potent 1-(2-substituted-aminoacetyl)-4-fluoro-2-cyanopyrrolidine dipeptidyl-peptidase IV inhibitors</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1110-1117&author=H.+Fukushimaauthor=A.+Hiratateauthor=M.+Takahishiauthor=M.+Saito-Horiauthor=E.+Munetomoauthor=K.+Kitanoauthor=H.+Saitoauthor=Y.+Takaokaauthor=K.+Yamamoto&title=Synthesis+and+structure%E2%80%93activity+relationships+of+potent+1-%282-substituted-aminoacetyl%29-4-fluoro-2-cyanopyrrolidine+dipeptidyl-peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DHiratate%26aufirst%3DA.%26aulast%3DTakahishi%26aufirst%3DM.%26aulast%3DSaito-Hori%26aufirst%3DM.%26aulast%3DMunetomo%26aufirst%3DE.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520potent%25201-%25282-substituted-aminoacetyl%2529-4-fluoro-2-cyanopyrrolidine%2520dipeptidyl-peptidase%2520IV%2520inhibitors%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D1110%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kaila, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBernardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedard, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camphausen, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, D. H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young-Sciame, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=21-39&author=N.+Kailaauthor=K.+Janzauthor=S.+DeBernardoauthor=P.+W.+Bedardauthor=R.+T.+Camphausenauthor=S.+Tamauthor=D.+H.+H.+Tsaoauthor=J.+C.+Keithauthor=C.+Nickerson-Nutterauthor=A.+Shillingauthor=R.+Young-Sciameauthor=Q.+Wang&title=Synthesis+and+biological+evaluation+of+quinoline+salicylic+acids+as+P-selectin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0602256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602256%26sid%3Dliteratum%253Aachs%26aulast%3DKaila%26aufirst%3DN.%26aulast%3DJanz%26aufirst%3DK.%26aulast%3DDeBernardo%26aufirst%3DS.%26aulast%3DBedard%26aufirst%3DP.%2BW.%26aulast%3DCamphausen%26aufirst%3DR.%2BT.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DTsao%26aufirst%3DD.%2BH.%2BH.%26aulast%3DKeith%26aufirst%3DJ.%2BC.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%26aulast%3DShilling%26aufirst%3DA.%26aulast%3DYoung-Sciame%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520quinoline%2520salicylic%2520acids%2520as%2520P-selectin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D21%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Facile and efficient synthesis of quinoline-4-carboxylic acids under microwave irradiation</span> <span class="citation_source-journal">Chin. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.cclet.2009.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=35-38&author=H.+Zhuauthor=R.+F.+Yangauthor=L.+H.+Yunauthor=J.+Li&title=Facile+and+efficient+synthesis+of+quinoline-4-carboxylic+acids+under+microwave+irradiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Facile and efficient synthesis of quinoline-4-carboxylic acids under microwave irradiation</span></div><div class="casAuthors">Zhu, Hui; Yang, Ri Fang; Yun, Liu Hong; Li, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Chinese Chemical Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">CCLEE7</span>;
        ISSN:<span class="NLM_cas:issn">1001-8417</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A facile and efficient method for the prepn. of 2-non-substituted quinoline-4-carboxylic acids was described via the Pfitzinger reaction of isatins with sodium pyruvate following consequent decarboxylation under microwave irradn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ1nY29NGr3LVg90H21EOLACvtfcHk0liTY2dfhynxow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFeqsLs%253D&md5=e0c608e98502645f881df2ee67fd203c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cclet.2009.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cclet.2009.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DR.%2BF.%26aulast%3DYun%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DFacile%2520and%2520efficient%2520synthesis%2520of%2520quinoline-4-carboxylic%2520acids%2520under%2520microwave%2520irradiation%26jtitle%3DChin.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D21%26spage%3D35%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, P. T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thottathil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polniaszek, R. P.</span><span> </span><span class="NLM_article-title">A practical method for the preparation of A′-chloroketones of <i>N</i>-carbamate protected-α-aminoacids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3175</span><span class="NLM_x">–</span> <span class="NLM_lpage">3178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=3175-3178&author=P.+Chenauthor=P.+T.+W.+Chengauthor=S.+H.+Spergelauthor=R.+Zahlerauthor=X.+Wangauthor=J.+Thottathilauthor=J.+C.+Barrishauthor=R.+P.+Polniaszek&title=A+practical+method+for+the+preparation+of+A%E2%80%B2-chloroketones+of+N-carbamate+protected-%CE%B1-aminoacids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DP.%2BT.%2BW.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DZahler%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DThottathil%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DPolniaszek%26aufirst%3DR.%2BP.%26atitle%3DA%2520practical%2520method%2520for%2520the%2520preparation%2520of%2520A%25E2%2580%25B2-chloroketones%2520of%2520N-carbamate%2520protected-%25CE%25B1-aminoacids%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D3175%26epage%3D3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kelly, T.</span><span> </span><span class="NLM_article-title">The efficient synthesis and simple resolution of a prolineboronate ester suitable for enzyme-inhibition studies</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1993&pages=1009-1016&author=T.+Kelly&title=The+efficient+synthesis+and+simple+resolution+of+a+prolineboronate+ester+suitable+for+enzyme-inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DT.%26atitle%3DThe%2520efficient%2520synthesis%2520and%2520simple%2520resolution%2520of%2520a%2520prolineboronate%2520ester%2520suitable%2520for%2520enzyme-inhibition%2520studies%26jtitle%3DTetrahedron%26date%3D1993%26volume%3D49%26spage%3D1009%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Edosada, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, B. B.</span><span> </span><span class="NLM_article-title">Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">580</span><span class="NLM_x">, </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1586</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=580&publication_year=2006&pages=1581-1586&author=C.+Y.+Edosadaauthor=C.+Quanauthor=T.+Tranauthor=V.+Phamauthor=C.+Wiesmannauthor=W.+Fairbrotherauthor=B.+B.+Wolf&title=Peptide+substrate+profiling+defines+fibroblast+activation+protein+as+an+endopeptidase+of+strict+Gly%282%29-Pro%281%29-cleaving+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdosada%26aufirst%3DC.%2BY.%26aulast%3DQuan%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DFairbrother%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DB.%2BB.%26atitle%3DPeptide%2520substrate%2520profiling%2520defines%2520fibroblast%2520activation%2520protein%2520as%2520an%2520endopeptidase%2520of%2520strict%2520Gly%25282%2529-Pro%25281%2529-cleaving%2520specificity%26jtitle%3DFEBS%2520Lett.%26date%3D2006%26volume%3D580%26spage%3D1581%26epage%3D1586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Pandey, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naduthambi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zondlo, N. J.</span><span> </span><span class="NLM_article-title">Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">4333</span><span class="NLM_x">–</span> <span class="NLM_lpage">4363</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja3109664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisVCrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=4333-4363&author=A.+K.+Pandeyauthor=D.+Naduthambiauthor=K.+M.+Thomasauthor=N.+J.+Zondlo&title=Proline+editing%3A+a+general+and+practical+approach+to+the+synthesis+of+functionally+and+structurally+diverse+peptides.+Analysis+of+steric+versus+stereoelectronic+effects+of+4-substituted+prolines+on+conformation+within+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Proline Editing: A General and Practical Approach to the Synthesis of Functionally and Structurally Diverse Peptides. Analysis of Steric versus Stereoelectronic Effects of 4-Substituted Prolines on Conformation within Peptides</span></div><div class="casAuthors">Pandey, Anil K.; Naduthambi, Devan; Thomas, Krista M.; Zondlo, Neal J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4333-4363</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functionalized proline residues have diverse applications.  Herein, the authors describe a practical approach, proline editing, for the synthesis of peptides with stereospecifically modified proline residues.  Peptides are synthesized by std. solid-phase peptide synthesis to incorporate Fmoc-hydroxyproline (4R-Hyp).  In an automated manner, the Hyp hydroxyl is protected and the remainder of the peptide synthesized.  After peptide synthesis, the Hyp protecting group is orthogonally removed and Hyp selectively modified to generate substituted proline amino acids, with the peptide main chain functioning to "protect" the proline amino and carboxyl groups.  In a model tetrapeptide (Ac-TYPN-NH2), 4R-Hyp was stereospecifically converted to 122 different 4-substituted prolyl amino acids, with 4R or 4S stereochem., via Mitsunobu, oxidn., redn., acylation, and substitution reactions.  4-Substituted prolines synthesized via proline editing include incorporated structured amino acid mimetics (Cys, Asp/Glu, Phe, Lys, Arg, pSer/pThr), recognition motifs (biotin, RGD), electron-withdrawing groups to induce stereoelectronic effects (fluoro, nitrobenzoate), handles for heteronuclear NMR (19F:fluoro; pentafluorophenyl or perfluoro-tert-Bu ether; 4,4-difluoro; 77SePh) and other spectroscopies (fluorescence, IR: cyanophenyl ether), leaving groups (sulfonate, halide, NHS, bromoacetate), and other reactive handles (amine, thiol, thioester, ketone, hydroxylamine, maleimide, acrylate, azide, alkene, alkyne, aryl halide, tetrazine, 1,2-aminothiol).  Proline editing provides access to these proline derivs. with no soln.-phase synthesis.  All peptides were analyzed by NMR to identify stereoelectronic and steric effects on conformation.  Proline derivs. were synthesized to permit bioorthogonal conjugation reactions, including azide-alkyne, tetrazine-trans-cyclooctene, oxime, reductive amination, native chem. ligation, Suzuki, Sonogashira, cross-metathesis, and Diels-Alder reactions.  These proline derivs. allowed three parallel bioorthogonal reactions to be conducted in one soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvheFC_32tnbVg90H21EOLACvtfcHk0lhrLhBZTWHvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisVCrsL8%253D&md5=f9102ce8cda0f0b4900006b90252ccdb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fja3109664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3109664%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DA.%2BK.%26aulast%3DNaduthambi%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DK.%2BM.%26aulast%3DZondlo%26aufirst%3DN.%2BJ.%26atitle%3DProline%2520editing%253A%2520a%2520general%2520and%2520practical%2520approach%2520to%2520the%2520synthesis%2520of%2520functionally%2520and%2520structurally%2520diverse%2520peptides.%2520Analysis%2520of%2520steric%2520versus%2520stereoelectronic%2520effects%2520of%25204-substituted%2520prolines%2520on%2520conformation%2520within%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D4333%26epage%3D4363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shoulders, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raines, R. T.</span><span> </span><span class="NLM_article-title">Origin of the stability conferred upon collagen by fluorination</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3859</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.bmcl.2009.03.168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm500031w&amp;key=19423349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm500031w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3859-3862&author=M.+D.+Shouldersauthor=K.+J.+Kamerauthor=R.+T.+Raines&title=Origin+of+the+stability+conferred+upon+collagen+by+fluorination"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Origin of the stability conferred upon collagen by fluorination</span></div><div class="casAuthors">Shoulders, Matthew D.; Kamer, Kimberli J.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3859-3862</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">According to a prevailing theory, (2S,4R)-4-hydroxyproline (Hyp) residues stabilize the collagen triple helix via a stereoelectronic effect that preorganizes appropriate backbone torsion angles for triple-helix formation.  This theory is consistent with the marked stability that results from replacing the hydroxyl group with the more electron-withdrawing fluoro group, as in (2S,4R)-4-fluoroproline (Flp).  Nonetheless, the hyperstability of triple helixes contg. Flp has been attributed by others to the hydrophobic effect rather than a stereoelectronic effect.  We tested this hypothesis by replacing Hyp with 4,4-difluoroproline (Dfp) in collagen-related peptides.  Dfp retains the hydrophobicity of Flp, but lacks the ability of Flp to preorganize backbone torsion angles.  Unlike Flp, Dfp does not endow triple helixes with elevated stability, indicating that the hyperstability conferred by Flp is not due to the hydrophobic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqor9GAQnbIsbVg90H21EOLACvtfcHk0lg7tjtM7VK--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGnsb8%253D&md5=8ae527760e72313f474dbccf58136757</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.168%26sid%3Dliteratum%253Aachs%26aulast%3DShoulders%26aufirst%3DM.%2BD.%26aulast%3DKamer%26aufirst%3DK.%2BJ.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DOrigin%2520of%2520the%2520stability%2520conferred%2520upon%2520collagen%2520by%2520fluorination%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3859%26epage%3D3862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Mattheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungraithmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEntee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpé, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Method comparison of DPP IV activity assays and their application in biological samples containing reversible inhibitors</span> <span class="citation_source-journal">Clin. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500031w&amp;key=10.1016%2Fj.cca.2011.10.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2012&pages=456-462&author=V.+Mattheeussenauthor=A.+M.+Lambeirauthor=W.+Jungraithmayrauthor=N.+Gomezauthor=K.+McEnteeauthor=P.+Van+der+Vekenauthor=S.+Scharp%C3%A9author=I.+De+Meester&title=Method+comparison+of+DPP+IV+activity+assays+and+their+application+in+biological+samples+containing+reversible+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2011.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2011.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DMattheeussen%26aufirst%3DV.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DJungraithmayr%26aufirst%3DW.%26aulast%3DGomez%26aufirst%3DN.%26aulast%3DMcEntee%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DScharp%25C3%25A9%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DMethod%2520comparison%2520of%2520DPP%2520IV%2520activity%2520assays%2520and%2520their%2520application%2520in%2520biological%2520samples%2520containing%2520reversible%2520inhibitors%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D412%26spage%3D456%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Van Goethem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mateeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Veken, P.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 8 (DPP8, DPP9): Is DPP8-selectivity attainable?</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5737</span><span class="NLM_x">–</span> <span class="NLM_lpage">5746</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200383j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5737-5746&author=S.+Van+Goethemauthor=V.+Mateeussenauthor=J.+Joossensauthor=A.+M.+Lambeirauthor=X.+Chenauthor=I.+De+Meesterauthor=A.+Haemersauthor=K.+Augustynsauthor=P.+Van+der+Veken&title=Structure%E2%80%93activity+relationship+studies+on+isoindoline+inhibitors+of+dipeptidyl+peptidases+8+and+8+%28DPP8%2C+DPP9%29%3A+Is+DPP8-selectivity+attainable%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm200383j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200383j%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoethem%26aufirst%3DS.%26aulast%3DMateeussen%26aufirst%3DV.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520on%2520isoindoline%2520inhibitors%2520of%2520dipeptidyl%2520peptidases%25208%2520and%25208%2520%2528DPP8%252C%2520DPP9%2529%253A%2520Is%2520DPP8-selectivity%2520attainable%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5737%26epage%3D5746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a href="/doi/suppl/10.1021/jm500031w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80457"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthetic procedures and analytical data for intermediates, protocols of the enzymatic assays used, and procedures and extended data series for in vitro and in vivo pharmacokinetic analyses. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500031w/suppl_file/jm500031w_si_001.pdf">jm500031w_si_001.pdf (531.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500031w&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm500031w%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500031w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990cdf6d982495","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
